Equitable Financial Life Insurance 10-Q 5 Nov 20 2020 Q3 Quarterly report Financial data

COVER

COVER - shares	9 Months Ended
	Sep. 30, 2020	Nov. 03, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2020
Document Transition Report	false
Entity File Number	000-20501
Entity Registrant Name	Equitable Financial Life Insurance Company
Entity Incorporation, State or Country Code	NY
Entity Tax Identification Number	13-5570651
Entity Address, Address Line One	1290 Avenue of the Americas
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10104
City Area Code	212
Local Phone Number	554-1234
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		2,000,000
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2020
Amendment Flag	false
Entity Central Index Key	0000727920
Current Fiscal Year End Date	--12-31

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions		Sep. 30, 2020	Dec. 31, 2019
Investments:
Fixed maturities available-for-sale, at fair value (amortized cost of $66,277 and $59,278) (allowance for credit losses of $13 at September 30, 2020)		$ 74,814	$ 62,362
Mortgage loans on real estate (net of allowance for credit losses of $70 at September 30, 2020)		12,785	12,090
Policy loans		3,647	3,270
Other equity investments	[1]	1,260	1,149
Trading securities, at fair value		5,787	6,598
Other invested assets		1,523	2,156
Total investments		99,816	87,625
Cash and cash equivalents		3,962	1,492
Deferred policy acquisition costs		3,735	4,222
Amounts due from reinsurers (allowance for credit losses of $0 at September 30, 2020)		3,032	3,002
Loans to affiliates		1,200	1,200
GMIB reinsurance contract asset, at fair value		3,247	2,466
Current and deferred income taxes		0	249
Other assets		3,854	3,050
Separate Accounts assets		121,099	124,646
Total Assets		239,945	227,952
LIABILITIES
Policyholders’ account balances		59,099	55,421
Future policy benefits and other policyholders' liabilities		41,117	33,979
Broker-dealer related payables		432	428
Amounts due to reinsurers		112	105
Current and deferred income taxes		1,130	0
Other liabilities		2,519	1,769
Separate Accounts liabilities		121,099	124,646
Total Liabilities		225,508	216,348
Redeemable noncontrolling interest	[2]	38	39
Commitments and contingent liabilities
Equity attributable to Equitable Financial:
Common stock, $1.25 par value; 2,000,000 shares authorized, issued and outstanding		2	2
Additional paid-in capital		7,831	7,809
Retained earnings		1,634	2,145
Accumulated other comprehensive income (loss)		4,923	1,596
Total equity attributable to Equitable Financial		14,390	11,552
Noncontrolling interest		9	13
Total Equity		14,399	11,565
Total Liabilities, Redeemable Noncontrolling Interest and Equity		$ 239,945	$ 227,952
[1]	See Note 2 for details of balances with variable interest entities.
[2]	See Note 12 for details of Redeemable noncontrolling interest.

CONSOLIDATED BALANCE SHEETS (PA

CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Fixed maturities available-for-sale, amortized cost	$ 66,264
Fixed maturities available-for-sale, allowance for credit losses	(13)	$ 0
Mortgage loans on real estate, valuation allowances	70
Reinsurance recoverable, allowance for credit loss	$ 0
Common stock par value (in dollars per share)	$ 1.25	$ 1.25
Common stock authorized (in shares)	2,000,000	2,000,000
Common stock issued (in shares)	2,000,000	2,000,000
Common stock outstanding (in shares)	2,000,000	2,000,000
Fixed maturities
Fixed maturities available-for-sale, amortized cost	$ 66,277	$ 59,278
Fixed maturities available-for-sale, allowance for credit losses	$ 13

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
REVENUES
Policy charges and fee income	$ 853	$ 899	$ 2,582	$ 2,619
Premiums	178	232	613	696
Net derivative gains (losses)	(1,527)	(343)	2,097	(2,080)
Net investment income (loss)	809	744	2,334	2,527
Investment gains (losses), net:
Credit losses on AFS debt securities and loans	(4)	0	(47)	0
Other investment gains (losses), net	19	201	262	181
Total investment gains (losses), net	15	201	215	181
Investment management and service fees	257	258	744	761
Other income	18	(1)	43	39
Total revenues	603	1,990	8,628	4,743
BENEFITS AND OTHER DEDUCTIONS
Policyholders’ benefits	950	1,642	4,267	3,356
Interest credited to policyholders’ account balances	277	296	845	859
Compensation and benefits	76	70	210	237
Commissions	153	153	462	462
Interest expense	0	0	0	4
Amortization of deferred policy acquisition costs	119	54	1,290	345
Other operating costs and expenses	221	214	653	614
Total benefits and other deductions	1,796	2,429	7,727	5,877
Income (loss) from continuing operations, before income taxes	(1,193)	(439)	901	(1,134)
Income tax (expense) benefit	249	175	(181)	289
Net income (loss)	(944)	(264)	720	(845)
Less: Net income (loss) attributable to the noncontrolling interest	2	0	(1)	3
Net income (loss) attributable to Equitable Financial	$ (946)	$ (264)	$ 721	$ (848)

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended								6 Months Ended		9 Months Ended				12 Months Ended
	Sep. 30, 2020		Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019		Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2020		Sep. 30, 2019		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
COMPREHENSIVE INCOME (LOSS)
Net income (loss)	$ (944)		$ (4,086)	$ 5,750	$ (264)		$ 268	$ (849)	$ 1,664	$ (581)	$ 720		$ (845)		$ (1,884)	$ (902)	$ 2,791
Other comprehensive income (loss), net of income taxes:
Change in unrealized gains (losses), net of adjustment	247		1,569	1,510	730	[1]	1,226	765	3,079	1,991	3,327	[1]	2,721	[1]	2,095	(1,221)	564
Other comprehensive income (loss), net of income taxes	247		1,570	1,510	730		1,226	765	3,080	1,991	3,327		2,721		2,097	(1,225)	582
Comprehensive income (loss)	(697)		(2,516)	7,260	466		1,494	(84)	4,744	1,410	4,047		1,876	[2]	213	(2,127)	3,373
Less: Comprehensive income (loss) attributable to the noncontrolling interest	2	[2]	4		0	[2]	1	2	(3)	3	(1)	[2]	3	[2]	5	(3)	1
Comprehensive income (loss) attributable to Equitable Financial	$ (699)		$ (2,520)	$ 7,267	$ 466		$ 1,493	$ (86)	$ 4,747	$ 1,407	$ 4,048		$ 1,873		$ 208	$ (2,124)	$ 3,372
[1]	See Note 11 for details of Change in unrealized gains (losses), net of adjustments.
[2]	Amounts for the three and nine months ended September 30, 2019 were reclassified to conform to the current year’s presentation.

CONSOLIDATED STATEMENTS OF EQUI

CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Millions	Total	Cumulative effect of period of adoption, adjusted balance	Parent	ParentCumulative effect of period of adoption, adjusted balance	Common Stock	Additional Paid-in Capital	Retained Earnings	Retained EarningsCumulative effect of period of adoption, adjusted balance	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest
Beginning balance at Dec. 31, 2016							$ 6,070		$ (3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	$ 582								582
Ending balance at Dec. 31, 2017	19,395		$ 16,300				8,860		579
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	(1,225)								(1,225)
Ending balance at Dec. 31, 2018	12,359		12,347		$ 2	$ 7,807	5,039		(501)	$ 12
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	765								765
Ending balance at Mar. 31, 2019	12,281		12,269				4,188		264
Beginning balance at Dec. 31, 2018	12,359		12,347		2	7,807	5,039		(501)	12
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	1,991								1,991
Ending balance at Jun. 30, 2019	13,781		13,769		2	7,822	4,455		1,490	12
Beginning balance at Dec. 31, 2018	12,359		12,347		2	7,807	5,039		(501)	12
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividend to parent company	(1,000)						(1,000)
Net income (loss)	(848)		(848)				(848)
Other comprehensive income (loss)	2,721		2,721						2,721
Other	22		22			22
Ending balance at Sep. 30, 2019	13,254		13,242		2	7,829	3,191		2,220	12
Beginning balance at Dec. 31, 2018	12,359		12,347		2	7,807	5,039		(501)	12
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	2,097								2,097
Ending balance at Dec. 31, 2019	11,565	$ (32)	11,552	$ (32)	2	7,809	2,145	$ (32)	1,596	13
Beginning balance at Mar. 31, 2019	12,281		12,269				4,188		264
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	1,226								1,226
Ending balance at Jun. 30, 2019	13,781		13,769		2	7,822	4,455		1,490	12
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividend to parent company	(1,000)						(1,000)
Net income (loss)	(264)		(264)				(264)
Other comprehensive income (loss)	730		730						730
Other	7		7			7
Ending balance at Sep. 30, 2019	13,254		13,242		2	7,829	3,191		2,220	12
Beginning balance at Dec. 31, 2019	11,565	(32)	11,552	(32)	2	7,809	2,145	(32)	1,596	13
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	1,510
Ending balance at Mar. 31, 2020	18,798		18,789				7,870		3,106
Beginning balance at Dec. 31, 2019	11,565	(32)	11,552	(32)	2	7,809	2,145	(32)	1,596	13
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	3,080
Ending balance at Jun. 30, 2020	15,088		15,079		2	7,821	2,580		4,676	9
Beginning balance at Dec. 31, 2019	11,565	$ (32)	11,552	$ (32)	2	7,809	2,145	$ (32)	1,596	13
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividend to parent company	(1,200)		(1,200)				(1,200)			0
Net income (loss)	719		721				721			(2)
Other comprehensive income (loss)	3,327		3,327						3,327
Other	20		22			22				(2)
Ending balance at Sep. 30, 2020	$ 14,399		14,390		2	7,831	1,634		4,923	9
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting standards update [extensible list]	us-gaap:AccountingStandardsUpdate201613Member
Beginning balance at Mar. 31, 2020	$ 18,798		18,789				7,870		3,106
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	1,570
Ending balance at Jun. 30, 2020	15,088		15,079		2	7,821	2,580		4,676	9
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividend to parent company	0		0				0
Net income (loss)	(946)		(946)				(946)
Other comprehensive income (loss)	247		247						247
Other	10		10			10
Ending balance at Sep. 30, 2020	$ 14,399		$ 14,390		$ 2	$ 7,831	$ 1,634		$ 4,923	$ 9

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Statement of Cash Flows [Abstract]
Net income (loss)	$ 720	$ (845)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances	845	859
Policy charges and fee income	(2,582)	(2,619)
Net derivative (gains) losses	(2,097)	2,080
Credit losses on AFS debt securities and loans	47	0
Investment (gains) losses, net	(262)	(181)
Realized and unrealized (gains) losses on trading securities	(98)	(421)
Non-cash long-term incentive compensation expense	21	23
Amortization and depreciation	1,230	271
Equity (income) loss from limited partnerships	13	(63)
Changes in:
Reinsurance recoverable	(202)	(127)
Capitalization of deferred policy acquisition costs	(414)	(466)
Future policy benefits	1,811	1,075
Current and deferred income taxes	502	(86)
Other, net	(171)	(212)
Net cash provided by (used in) operating activities	(637)	(712)
Proceeds from the sale/maturity/prepayment of:
Fixed maturities, available-for-sale	10,002	9,394
Mortgage loans on real estate	454	708
Trading account securities	1,320	8,216
Real estate joint ventures	0	3
Short-term investments	1,431	1,916
Other	519	145
Payment for the purchase/origination of:
Fixed maturities, available-for-sale	(16,620)	(23,834)
Mortgage loans on real estate	(1,208)	(913)
Trading account securities	(403)	(923)
Short-term investments	(1,098)	(2,134)
Other	(678)	(305)
Cash settlements related to derivative instruments, net	2,560	191
Investment in capitalized software, leasehold improvements and EDP equipment	(31)	(49)
Other, net	(397)	0
Net cash provided by (used in) investing activities	(4,149)	(7,585)
Cash flows from financing activities:
Deposits	7,542	9,464
Withdrawals	(3,144)	(3,433)
Transfer (to) from Separate Accounts	1,966	1,427
Change in collateralized pledged assets	58	3
Change in collateralized pledged liabilities	1,981	1,898
Shareholder dividend paid	(1,200)	(1,000)
Purchase (redemption) of noncontrolling interests of consolidated company-sponsored investment funds	4	14
Repayment of loans from affiliates	0	(572)
Increase (decrease) in securities sold under agreement to repurchase	0	(573)
Other, net	49	0
Net cash provided by (used in) financing activities	7,256	7,228
Change in cash and cash equivalents	2,470	(1,069)
Cash and cash equivalents, beginning of year	1,492	2,622
Cash and cash equivalents, end of year	3,962	1,553
Non-cash transactions:
Right-of-use assets obtained in exchange for lease obligations	$ 20	$ 42

ORGANIZATION

ORGANIZATION	9 Months Ended
	Sep. 30, 2020
Organization [Abstract]
ORGANIZATION	ORGANIZATION Equitable Financial Life Insurance Company’s (“Equitable Financial” and, collectively with its consolidated subsidiaries, the “Company”) primary business is providing variable annuity, life insurance and employee benefit products to both individuals and businesses. The Company is an indirect, wholly-owned subsidiary of Equitable Holdings, Inc. (“Holdings”). Equitable Financial is a stock life insurance company organized in 1859 under the laws of the State of New York. The Company’s two principal subsidiaries include Equitable Distributors, LLC (“Equitable Distributors”) and Equitable Investment Management, LLC (“EIM”). Both Equitable Distributors and EIM are wholly-owned Delaware limited liability companies.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Principles of Consolidation The unaudited interim consolidated financial statements (the “consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP” or “GAAP”) on a basis consistent with reporting interim financial information in accordance with instructions to the Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments necessary for a fair statement of the financial position and results of operations have been made. All such adjustments are of a normal, recurring nature, with the exception of the Company’s update of its interest rate assumption and adoption of new economic scenario generator as further described below in Assumption Updates and Model Changes. Interim results are not necessarily indicative of the results that may be expected for the full year. These financial statements should be read in conjunction with the Company’s consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. The accompanying unaudited consolidated financial statements present the consolidated results of operations, financial condition and cash flows of the Company and its subsidiaries and those investment companies, partnerships and joint ventures in which the Company has control and a majority economic interest as well as those variable interest entities (“VIEs”) that meet the requirements for consolidation. All significant intercompany transactions and balances have been eliminated in consolidation. The terms “third quarter 2020” and “third quarter 2019” refer to the three months ended September 30, 2020 and 2019, respectively. The terms “first nine months of 2020” and “first nine months of 2019” refer to the nine months ended September 30, 2020 and 2019, respectively. Certain prior year amounts have been reclassified to conform to the current year’s presentation. Adoption of New Accounting Pronouncements Description Effect on the Financial Statement or Other Significant Matters ASU 2016-13: Financial Instruments—Credit Losses (Topic 326), as clarified and amended by ASU 2018-19: Codification Improvements to Topic 326, Financial Instruments—Credit Losses, ASU 2019-04: Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments and ASU 2019-05: Financial Instruments—Credit Losses (Topic 326) Targeted Transition Relief, ASU 2019-11: Codification Improvements to Topic 326, Financial Instruments-Credit Losses ASU 2016-13 contains new guidance which introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. On January 1, 2020, the Company adopted the new standard and completed implementation of its updated current expected credit losses (“CECL”) models, processes and controls related to the identified financial assets that fall within the scope of the new standard. Upon adoption, the Company recorded a cumulative effect adjustment to reduce the opening retained earnings balance by approximately $40 million, on a pre-tax and pre-DAC basis. The adjustment is primarily attributable to an increase in the allowance for credit losses associated with the Company’s commercial and agricultural mortgage loan portfolios and reinsurance. ASU 2018-13 : Fair Value Measurement (Topic 820) This ASU improves the effectiveness of fair value disclosures in the notes to financial statements. Amendments in this ASU impact the disclosure requirements in Topic 820, including the removal, modification and addition to existing disclosure requirements. The Company elected to early adopt during 2019 the removal of disclosures relating to transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels and valuation processes for Level 3 fair value measurements. The Company adopted the additional disclosures related to Level 3 fair value information on January 1, 2020. ASU 2018-17: Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities This ASU provides guidance requiring that indirect interests held through related parties in common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. The Company adopted this new standard effective for January 1, 2020. Adoption of this standard did not materially impact the Company’s financial position or results of operations. Future Adoption of New Accounting Pronouncements Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-12 : Financial Services - Insurance (Topic 944); ASU 2019-09: Financial Services - Insurance (Topic 944): Effective Date This ASU provides targeted improvements to existing recognition, measurement, presentation, and disclosure requirements for long-duration contracts issued by an insurance entity. The ASU primarily impacts four key areas, including: In November 2019, ASU 2019-09 was issued which modified ASU 2018-12 to be effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021. Early adoption is permitted. On September 30, 2020, the FASB tentatively affirmed its decision to defer the effective date of the amendments in ASU 2018-12, for all insurance entities by one year. Early adoption would still be allowed. The Company is currently evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements, however the adoption of the ASU is expected to have a significant impact on the Company’s consolidated financial condition, results of operations, cash flows and required disclosures, as well as processes and controls. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters 2. Measurement of market risk benefits (“MRBs”). MRBs, as defined under the ASU, will encompass certain variable annuity guaranteed benefit (“GMxB”) features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in Other comprehensive income (“OCI”). For MRBs, the ASU should be applied retrospectively as of the beginning of the earliest period presented. ASU 2019-12: Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740, as well as clarifying and amending existing guidance. Effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the impact adopting the guidance will have on the Company’s consolidated financial statements, however the adoption is not expected to materially impact the Company’s financial position, results of operation, or cash flows. ASU2020-04: Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting The amendments in this ASU provide optional expedients and exceptions to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This ASU is effective as of March 12, 2020 through December 31, 2022. The Company will determine the applicability of the optional expedients and exceptions provided under the ASU as reference rate reform continues to develop. Investments The carrying values of fixed maturities classified as available-for-sale (“AFS”) are reported at fair value. Changes in fair value are reported in OCI, net of allowance for credit losses, policy related amounts and deferred income taxes. With the adoption of the new Financial Instruments-Credit Losses standard, changes in credit losses are recognized in Investment gains (losses), net. The redeemable preferred stock investments that are reported in fixed maturities include real estate investment trusts (“REIT”), perpetual preferred stock and redeemable preferred stock. These securities may not have a stated maturity, may not be cumulative, and do not provide for mandatory redemption by the issuer. The Company determines the fair values of fixed maturities and equity securities based upon quoted prices in active markets, when available, or through the use of alternative approaches when market quotes are not readily accessible or available. These alternative approaches include matrix or model pricing and use of independent pricing services, each supported by reference to principal market trades or other observable market assumptions for similar securities. More specifically, the matrix pricing approach to fair value is a discounted cash flow methodology that incorporates market interest rates commensurate with the credit quality and duration of the investment. The Company’s management, with the assistance of its investment advisors, evaluates AFS debt securities that experienced a decline in fair value below amortized cost for credit losses which are evaluated in accordance with the new financial instruments credit losses guidance effective January 1, 2020. Integral to this review is an assessment made each quarter, on a security-by-security basis, by the Company’s Investments Under Surveillance (“IUS”) Committee, of various indicators of credit deterioration to determine whether the investment security has experienced a credit loss. This assessment includes, but is not limited to, consideration of the severity of the unrealized loss, failure, if any, of the issuer of the security to make scheduled payments, actions taken by rating agencies, adverse conditions specifically related to the security or sector, and the financial strength, liquidity and continued viability of the issuer. The Company recognizes an allowance for credit losses on AFS debt securities with a corresponding adjustment to earnings rather than a direct write down that reduces the cost basis of the investment, and credit losses are limited to the amount by which the security’s amortized cost basis exceeds its fair value. Any improvements in estimated credit losses on AFS debt securities are recognized immediately in earnings. Management does not use the length of time a security has been in an unrealized loss position as a factor, either by itself or in combination with other factors, to conclude that a credit loss does not exist, as they were permitted to do prior to January 1, 2020. When the Company determines that there is more than 50% likelihood that it is not going to recover the principal and interest cash flows related to an AFS debt security, the security is placed on nonaccrual status and the Company reverses accrued interest receivable against interest income. Since the nonaccrual policy results in a timely reversal of accrued interest receivable, the Company does not record an allowance for credit losses on accrued interest receivable. If there is no intent to sell or likely requirement to dispose of the fixed maturity security before its recovery, only the credit loss component of any resulting allowance is recognized in income (loss) and the remainder of the fair value loss is recognized in OCI. The amount of credit loss is the shortfall of the present value of the cash flows expected to be collected as compared to the amortized cost basis of the security. The present value is calculated by discounting management’s best estimate of projected future cash flows at the effective interest rate implicit in the debt security at the date of acquisition. Projections of future cash flows are based on assumptions regarding probability of default and estimates regarding the amount and timing of recoveries. These assumptions and estimates require use of management judgment and consider internal credit analyses as well as market observable data relevant to the collectability of the security. Write-offs of AFS debt securities are recorded when all or a portion of a financial asset is deemed uncollectible. Full or partial write-offs are recorded as reductions to the amortized cost basis of the AFS debt security and deducted from the allowance in the period in which the financial assets are deemed uncollectible. The Company elected to reverse accrued interest deemed uncollectible as a reversal of interest income. In instances where the Company collects cash that it has previously written off, the recovery will be recognized through earnings or as a reduction of the amortized cost basis for interest and principal, respectively. Real estate held for the production of income is stated at depreciated cost less allowance for credit losses. Depreciation of real estate held for production of income is computed using the straight-line method over the estimated useful lives of the properties, which generally range from 40 to 50 years. Policy loans represent funds loaned to policyholders up to the cash surrender value of the associated insurance policies and are carried at the unpaid principal balances due to the Company from the policyholders. Interest income on policy loans is recognized in net investment income at the contract interest rate when earned. Policy loans are fully collateralized by the cash surrender value of the associated insurance policies. Partnerships, investment companies and joint venture interests that the Company has control of and has an economic interest in or those that meet the requirements for consolidation under accounting guidance for consolidation of VIEs are consolidated. Those that the Company does not have control of and does not have a majority economic interest in and those that do not meet the VIE requirements for consolidation are reported on the equity method of accounting and are reported in other equity investments. The Company records its interests in certain of these partnerships on a month or one quarter lag. Trading securities, which include equity securities and fixed maturities, are carried at fair value based on quoted market prices, with realized and unrealized gains (losses) reported in net investment income (loss) in the consolidated statements of income (loss). Corporate owned life insurance (“COLI”) has been purchased by the Company and certain subsidiaries on the lives of certain key employees and the Company and these subsidiaries are named as beneficiaries under these policies. COLI is carried at the cash surrender value of the policies. At September 30, 2020 and December 31, 2019, the carrying value of COLI was $962 million and $942 million, respectively, and is reported in Other invested assets in the consolidated balance sheets. Cash and cash equivalents includes cash on hand, demand deposits, money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less. Due to the short-term nature of these investments, the recorded value is deemed to approximate fair value. All securities owned, including U.S. government and agency securities, mortgage-backed securities, futures and forwards transactions, are reported in the consolidated financial statements on a trade-date basis. Mortgage Loans on Real Estate Mortgage loans are stated at unpaid principal balances, net of unamortized discounts and the allowance for credit losses. The Company calculates the allowance for credit losses in accordance with the CECL model in order to provide for the risk of credit losses in the lending process. Expected credit losses for loans with similar risk characteristics are estimated on a collective (i.e., pool) basis in order to meet CECL’s risk of loss concept which requires the Company to consider possibilities of loss, even if remote. For collectively evaluated mortgages, the Company estimates the allowance for credit losses based on the amortized cost basis of its mortgages over their expected life using a probability of default (“PD”) / loss given default (“LGD”) model. The PD/LGD model incorporates the Company’s reasonable and supportable forecast of macroeconomic information over a specified period. The length of the reasonable and supportable forecast period is reassessed on a quarterly basis and may be adjusted as appropriate over time to be consistent with macroeconomic conditions and the environment as of the reporting date. For periods beyond the reasonable and supportable forecast period, the model reverts to historical loss information. The PD and LGD are estimated at the loan-level based on loans’ current and forecasted risk characteristics as well as macroeconomic forecasts. The PD is estimated using both macroeconomic conditions as well as individual loan risk characteristics including LTV ratios, DSC ratios, seasoning, collateral type, geography, and underlying credit. The LGD is driven primarily by the type and value of collateral, and secondarily by expected liquidation costs and time to recovery. The CECL model is configured to the Company’s specifications and takes into consideration the detailed risk attributes of each discrete loan in the mortgage portfolio which include, but are not limited to the following: • Loan-to-value (“LTV”) ratio - Derived from current loan balance divided by the fair market value of the property. An LTV ratio in excess of 100% indicates an underwater mortgage. • Debt service coverage (“DSC”) ratio - Derived from actual operating earnings divided by annual debt service. If the ratio is below 1.0x, then the income from the property does not support the debt. • Occupancy - Criteria varies by property type but low or below market occupancy is an indicator of sub-par property performance. • Lease expirations - The percentage of leases expiring in the upcoming 12 to 36 months are monitored as a decline in rent and/or occupancy may negatively impact the debt service coverage ratio. In the case of single-tenant properties or properties with large tenant exposure, the lease expiration is a material risk factor. • Other - Any other factors such as maturity, borrower/tenant related issues, payment status, property condition, or current economic conditions may call into question the performance of the loan. Mortgage loans that do not share similar risk characteristics with other loans in the portfolio are individually evaluated quarterly by the Company’s IUS Committee. The allowance for credit losses on these individually evaluated mortgages is a loan-specific reserve as a result of the loan review process that is recorded based on the present value of expected future cash flows discounted at the loan’s effective interest rate or based on the fair value of the collateral. The individually assessed allowance for mortgage loans can increase or decrease from period to period based on such factors. Individually assessed loans may include, but are not limited to, mortgages that have deteriorated in credit quality such as troubled debt restructurings (“TDR”) and reasonably expected TDRs, mortgages for which foreclosure is probable, and mortgages which have been classified as “potential problem” or “problem” loans within the Company’s IUS Committee processes as described below. Within the IUS process, Commercial mortgages 60 days or more past due and agricultural mortgages 90 days or more past due, as well as all mortgages in the process of foreclosure, are identified as problem loans. Based on its monthly monitoring of mortgages, a class of potential problem loans are also identified, consisting of mortgage loans not currently classified as problem loans but for which management has doubts as to the ability of the borrower to comply with the present loan payment terms and which may result in the loan becoming a problem or being modified. The decision whether to classify a performing mortgage loan as a potential problem involves judgments by management as to likely future industry conditions and developments with respect to the borrower or the individual mortgaged property. Individually assessed mortgage loans without provision for losses are mortgage loans where the fair value of the collateral or the net present value of the expected future cash flows related to the loan equals or exceeds the recorded investment. Interest income earned on mortgage loans where the collateral value is used to measure impairment is recorded on a cash basis. Interest income on mortgage loans where the present value method is used to measure impairment is accrued on the net carrying value amount of the loan at the interest rate used to discount the cash flows. Mortgage loans are placed on nonaccrual status once management believes the collection of accrued interest is not probable. Once mortgage loans are classified as nonaccrual mortgage loans, interest income is recognized under the cash basis of accounting and the resumption of the interest accrual would commence only after all past due interest has been collected or the mortgage loan has been restructured to where the collection of interest is considered likely. The Company charges off loan balances and accrued interest that are deemed uncollectible. The components of amortized cost for mortgage loans on the consolidated balance sheets excludes accrued interest amounts because the Company presents accrued interest receivables within Other assets. Once mortgage loans are placed on nonaccrual status, the Company reverses accrued interest receivable against interest income. Since the nonaccrual policy results in the timely reversal of accrued interest receivable, the Company does not record an allowance for credit losses on accrued interest receivable. Troubled Debt Restructuring The Company invests in commercial and agricultural mortgage loans included in the balance sheet as Mortgage loans on real estate and privately negotiated fixed maturities included in the balance sheet as Fixed maturities AFS. Under certain circumstances, modifications are granted to these contracts. Each modification is evaluated as to whether a troubled debt restructuring has occurred. A modification is a troubled debt restructuring when the borrower is in financial difficulty and the creditor makes concessions. Generally, the types of concessions may include reducing the face amount or maturity amount of the debt as originally stated, reducing the contractual interest rate, extending the maturity date at an interest rate lower than current market interest rates and/or reducing accrued interest. The Company considers the amount, timing and extent of the concession granted in determining any impairment or changes in the specific credit allowance recorded in connection with the troubled debt restructuring. A credit allowance may have been recorded prior to the quarter when the loan is modified in a troubled debt restructuring. Accordingly, the carrying value (net of the allowance) before and after modification through a troubled debt restructuring may not change significantly, or may increase if the expected recovery is higher than the pre-modification recovery assessment. Net Investment Income (Loss), Investment Gains (Losses), Net, and Unrealized Investment Gains (Losses) Realized investment gains (losses) are determined by identification with the specific asset and are presented as a component of revenue. Changes in the allowance for credit losses are included in Investment gains (losses), net. Realized and unrealized holding gains (losses) on trading and equity securities are reflected in Net investment income (loss). Unrealized investment gains (losses) on fixed maturities designated as AFS held by the Company are accounted for as a separate component of AOCI, net of related deferred income taxes, as are amounts attributable to certain pension operations, Closed Block’s policyholders’ dividend obligation, insurance liability loss recognition, DAC related to UL policies, investment-type products and participating traditional life policies. Changes in unrealized gains (losses) reflect changes in fair value of only those fixed maturities classified as AFS and do not reflect any change in fair value of policyholders’ account balances and future policy benefits. Accounting and Consolidation of VIEs For all new investment products and entities developed by the Company (other than Collateralized Debt Obligations (“CDOs”)), the Company first determines whether the entity is a VIE, which involves determining an entity’s variability and variable interests, identifying the holders of the equity investment at risk and assessing the five characteristics of a VIE. Once an entity has been determined to be a VIE, the Company then identifies the primary beneficiary of the VIE. If the Company is deemed to be the primary beneficiary of the VIE, then the Company consolidates the entity. Management of the Company reviews quarterly its investment management agreements and its investments in, and other financial arrangements with, certain entities that hold client assets under management (“AUM”) to determine the entities that the Company is required to consolidate under this guidance. These entities include certain mutual fund products, hedge funds, structured products, group trusts, collective investment trusts and limited partnerships. The analysis performed to identify variable interests held, determine whether entities are VIEs or voting interest entities (“VOEs”), and evaluate whether the Company has a controlling financial interest in such entities requires the exercise of judgment and is updated on a continuous basis as circumstances change or new entities are developed. The primary beneficiary evaluation generally is performed qualitatively based on all facts and circumstances, including consideration of economic interests in the VIE held directly and indirectly through related parties and entities under common control, as well as quantitatively, as appropriate. Consolidated VIEs At September 30, 2020 and December 31, 2019, the Company consolidated one real estate joint venture for which it was identified as the primary beneficiary under the VIE model. The consolidated entity is jointly owned by Equitable Financial and AXA France and holds an investment in a real estate venture. Included in Other invested assets in the Company’s consolidated balance sheets at September 30, 2020 and December 31, 2019 are total assets of $31 million an d $32 million, respectively related to this VIE, primarily resulting from the consolidated presentation of this real estate joint venture as real estate held for sale. Redeemable noncontrolling interests are presented in mezzanine equity and non-redeemable noncontrolling interests are presented within permanent equity. Non-Consolidated VIEs At September 30, 2020 and December 31, 2019, respectively, the Company held approximately $1.2 billion and $1.1 billion of investment assets in the form of equity interests issued by non-corporate legal entities determined under the guidance to be VIEs, such as limited partnerships and limited liability companies, including hedge funds, private equity funds and real estate-related funds. Additionally, as of September 30, 2020, Equitable Financial holds $18 million of equity interests in a newly formed Special Purpose Entity (“SPE”) established to purchase loans from the market in anticipation of a Collateralized Loan Obligation (“CLO”) transaction. As an equity investor, the Company is considered to have a variable interest in each of these VIEs as a result of its participation in the risks and/or rewards these funds were designed to create by their defined portfolio objectives and strategies. Primarily through qualitative assessment, including consideration of related party interests or other financial arrangements, if any, the Company was not identified as primary beneficiary of any of these VIEs, largely due to its inability to direct the activities that most significantly impact their economic performance. Consequently, the Company continues to reflect these equity interests in the consolidated balance sheets as Other equity investments and applies the equity method of accounting for these positions. The net assets of these non-consolidated VIEs are approximately $156.6 billion and $160.2 billion at September 30, 2020 and December 31, 2019, respectively. The Company’s maximum exposure to loss from its direct involvement with these VIEs is the carrying value of its investment of $1.2 billion and $1.1 billion and approximately $1.2 billion and $1.1 billion of unfunded commitments at September 30, 2020 and December 31, 2019, respectively. The Company has no further economic interest in these VIEs in the form of guarantees, derivatives, credit enhancements or similar instruments and obligations. Assumption Updates and Model Changes The Company conducts its annual review of its assumptions and models during the third quarter of each year. The annual review encompasses assumptions underlying the valuation of unearned revenue liabilities, embedded derivatives for our insurance business, liabilities for future policyholder benefits, DAC and deferred sales inducement (“DSI”) assets. However, the Company updates its assumptions as needed in the event it becomes aware of economic conditions or events that could require a change in assumptions that it believes may have a significant impact to the carrying value of product liabilities and assets and consequently materially impact its earnings in the period of the change. Annual Update The net impact of assumption changes in the third quarter of 2020 decreased Policy charges and fee income by $21 million, increased Policyholders’ benefits by $175 million, increased Interest credited to policyholders’ account balances by $8 million, increased Net derivative gains by $106 million, and increased Amortization of DAC by $26 million. This resulted in a decrease in Income (loss) from operations, before income taxes of $124 million and decreased Net income (loss) by $98 million. Third quarter 2020 assumption updates include a pre-tax gain of $421 million attributable to the removal of the credit risk adjustment from our fair value scenario calibration to better align with U.S. valuation practices, offset by updates to our mortality and policyholder behavior assumptions to reflect emerging experience. The net impact of assumption changes in the third quarter of 2019 decreased Policy charges and fee income by $11 million, increased Policyholders’ benefits by $886 million, decreased Interest credited to policyholders’ account balances by $14 million, increased Net derivative losses by $548 million and decreased Amortization of DAC by $77 million. This resulted in a decrease in Income (loss) from operations, before income taxes of $1.4 billion and decreased Net income (loss) by $1.1 billion. First Quarter Update In the first quarter of 2020, due to the extraordinary economic conditions driven by the COVID-19 pandemic, the Company updated its interest rate assumption to grade from the current interest rate environment to an ultimate five-year historical average over a 10-year period. As such, the 10-year U.S. Treasury yield grades from the current level to an ultimate 5-year average of 2.25%. The Company determined that no assumption updates were necessary in the second quarter of 2020. The low interest rate environment and update to the interest rate assumption caused a loss recognition event for the Company’s life interest-sensitive products, as well as to certain run-off business. This loss recognition event caused an acceleration of DAC amortization on the life interest-sensitive products and an increase in the premium deficiency reserve on the run-off business in the first quarter of 2020. The net impact of the economic assumption update in the first quarter of 2020 increased Policy charges and fee income by $54 million, increased Policyhold

INVESTMENTS

INVESTMENTS	9 Months Ended
	Sep. 30, 2020
Investments, Debt and Equity Securities [Abstract]
INVESTMENTS	INVESTMENTS Fixed Maturities Available-for-Sale Accounting for credit impairments of fixed maturities classified as AFS has changed from a direct write-down, or other-than-temporary impairment (“OTTI”) approach to an allowance for credit loss model starting in 2020 upon adoption of CECL (see Note 2, Significant Accounting Policies – Investments). The components of fair value and amortized cost for fixed maturities classified as AFS on the consolidated balance sheets excludes accrued interest receivable because the Company elected to present accrued interest receivable within Other assets. Accrued interest receivable on AFS fixed maturities at September 30, 2020 was $510 million. There was no accrued interest written off for AFS fixed maturities for the three and nine months ended September 30, 2020. Comparative tables as of December 31, 2019 include OTTI, reported net of tax in OCI and in AOCI until realized. The following tables provide information relating to the Company’s fixed maturities classified as AFS. AFS Fixed Maturities by Classification Amortized Allowance for Credit Losses (4) Gross Gross Fair Value (in millions) September 30, 2020: Fixed Maturities: Corporate (1) $ 47,421 $ 13 $ 4,281 $ 170 $ 51,519 U.S. Treasury, government and agency 13,126 — 4,158 — 17,284 States and political subdivisions 706 — 109 — 815 Foreign governments 828 — 80 6 902 Residential mortgage-backed (2) 132 — 13 — 145 Asset-backed (3) 2,584 — 25 18 2,591 Commercial mortgage-backed 1,067 — 50 — 1,117 Redeemable preferred stock 413 — 31 3 441 Total at September 30, 2020 $ 66,277 $ 13 $ 8,747 $ 197 $ 74,814 December 31, 2019: Fixed Maturities: Corporate (1) $ 42,347 $ — $ 2,178 $ 61 $ 44,464 U.S. Treasury, government and agency 14,385 — 1,151 305 15,231 States and political subdivisions 584 — 68 3 649 Foreign governments 460 — 35 5 490 Residential mortgage-backed (2) 161 — 12 — 173 Asset-backed (3) 843 — 3 2 844 Redeemable preferred stock 498 — 18 5 511 Total at December 31, 2019 $ 59,278 $ — $ 3,465 $ 381 $ 62,362 ______________ (1) Corporate fixed maturities include both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (4) Amounts represent the allowance for credit losses for 2020 - (see Note 2 Significant Accounting Policies - Investments). The contractual maturities of AFS fixed maturities at September 30, 2020 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Contractual Maturities of AFS Fixed Maturities Amortized Cost (Less Allowance for Credit Losses) Fair Value (in millions) September 30, 2020: Contractual maturities: Due in one year or less $ 4,094 $ 4,126 Due in years two through five 14,862 15,722 Due in years six through ten 16,872 18,691 Due after ten years 26,240 31,981 Subtotal 62,068 70,520 Residential mortgage-backed 132 145 Asset-backed 2,584 2,591 Commercial mortgage-backed 1,067 1,117 Redeemable preferred stock 413 441 Total at September 30, 2020 $ 66,264 $ 74,814 The following table shows proceeds from sales, gross gains (losses) from sales and credit losses for AFS fixed maturities for the three and nine months ended September 30, 2020 and 2019: Proceeds from Sales, Gross Gains (Losses) from Sales and Credit Losses for AFS Fixed Maturities Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (in millions) Proceeds from sales $ 1,399 $ 3,839 $ 5,985 $ 6,756 Gross gains on sales $ 23 $ 207 $ 297 $ 224 Gross losses on sales $ (5) $ (4) $ (32) $ (25) Credit losses (1) $ — $ — $ (13) $ — ______________ (1) Commencing with the Company’s adoption of ASU 2016-13 on January 1, 2020, credit losses on AFS debt securities were recognized as an allowance for credit losses. Prior to this, credit losses on AFS fixed maturities were recognized as OTTI. The following table sets forth the amount of credit loss impairments on AFS fixed maturities held by the Company at the dates indicated and the corresponding changes in such amounts. AFS Fixed Maturities - Credit Loss Impairments Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (in millions) Balance, beginning of period $ 28 $ 18 $ 15 $ 46 Previously recognized impairments on securities that matured, paid, prepaid or sold — (3) — (31) Recognized impairments on securities impaired to fair value this period (1) — — — — Credit losses recognized this period on securities for which credit losses were not previously recognized (2) — 7 — Additional credit losses this period on securities previously impaired 2 — 6 — Increases due to passage of time on previously recorded credit losses — — — — Accretion of previously recognized impairments due to increases in expected cash flows (for OTTI securities 2019 and prior) — — — — Balance at September 30, $ 28 $ 15 $ 28 $ 15 ______________ (1) Represents circumstances where the Company determined in the current period that it intends to sell the security, or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost. The tables that follow below present a roll-forward of net unrealized investment gains (losses) recognized in AOCI, split between amounts related to fixed maturities on which a credit loss has been recognized, and all other. Net Unrealized Gains (Losses) on AFS Fixed Maturities Net Unrealized Gains (Losses) on Investments DAC Policyholders’ Liabilities Deferred Income Tax Asset (Liability) AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) (in millions) Balance, July 1, 2020 $ 8,207 $ (494) $ (1,801) $ (1,242) $ 4,670 Net investment gains (losses) arising during the period 345 — — — 345 Reclassification adjustment: — Included in Net income (loss) (18) — — — (18) Excluded from Net income (loss) — — — — — Impact of net unrealized investment gains (losses) — 54 (6) (79) (31) Net unrealized investment gains (losses) excluding credit losses 8,534 (440) (1,807) (1,321) 4,966 Net unrealized investment gains (losses) with credit losses 3 — (1) — 2 Balance, September 30, 2020 $ 8,537 $ (440) $ (1,808) $ (1,321) $ 4,968 Balance, July 1, 2019 $ 2,622 $ (616) $ (98) $ (420) $ 1,488 Net investment gains (losses) arising during the period 1,548 — — — 1,548 Reclassification adjustment: — Included in Net income (loss) (201) — — — (201) Excluded from Net income (loss) — — — — — Impact of net unrealized investment gains (losses) — (324) (122) (156) (602) Net unrealized investment gains (losses) excluding credit losses 3,969 (940) (220) (576) 2,233 Net unrealized investment gains (losses) with credit losses (1) 1 — — — 1 Balance, September 30, 2019 $ 3,970 $ (940) $ (220) $ (576) $ 2,234 Net Unrealized Gains (Losses) on Investments DAC Policyholders’ Liabilities Deferred Income Tax Asset (Liability) AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) (in millions) Balance, January 1, 2020 $ 3,084 $ (826) $ (192) $ (433) $ 1,633 Net investment gains (losses) arising during the period 5,707 — — — 5,707 Reclassification adjustment: — Included in Net income (loss) (248) — — — (248) Excluded from Net income (loss) — — — — — Impact of net unrealized investment gains (losses) — 386 (1,617) (889) (2,120) Net unrealized investment gains (losses) excluding credit losses 8,543 (440) (1,809) (1,322) 4,972 Net unrealized investment gains (losses) with credit losses (6) — 1 1 (4) Balance, September 30, 2020 $ 8,537 $ (440) $ (1,808) $ (1,321) $ 4,968 Balance, January 1, 2019 $ (577) $ 37 $ (69) $ 125 $ (484) Net investment gains (losses) arising during the period 4,754 — — — 4,754 Reclassification adjustment: Included in Net income (loss) (208) — — — (208) Excluded from Net income (loss) — — — — — Impact of net unrealized investment gains (losses) — (977) (151) (701) (1,829) Net unrealized investment gains (losses) excluding credit losses 3,969 (940) (220) (576) 2,233 Net unrealized investment gains (losses) with credit losses (1) 1 — — — 1 Balance, September 30, 2019 $ 3,970 $ (940) $ (220) $ (576) $ 2,234 ______________ (1) Credit losses for 2019 were OTTI losses. The following tables disclose the fair values and gross unrealized losses of the 709 issues at September 30, 2020 and the 390 issues at December 31, 2019 that are not deemed to have credit losses, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated: AFS Fixed Maturities in an Unrealized Loss Position for Which No Allowance Is Recorded Less Than 12 Months 12 Months or Longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses (in millions) September 30, 2020: Fixed Maturities: Corporate $ 4,063 $ 116 $ 365 $ 49 $ 4,428 $ 165 Foreign governments 88 1 31 5 119 6 Asset-backed 1,324 16 74 2 1,398 18 Redeemable preferred stock 59 1 11 2 70 3 Total at September 30, 2020 $ 5,534 $ 134 $ 481 $ 58 $ 6,015 $ 192 December 31, 2019: (1) Less Than 12 Months 12 Months or Longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses (in millions) Fixed Maturities: Corporate $ 2,669 $ 41 $ 366 $ 20 $ 3,035 $ 61 U.S. Treasury, government and agency 4,245 305 2 — 4,247 305 States and political subdivisions 123 3 — — 123 3 Foreign governments 11 — 47 5 58 5 Asset-backed 319 — 201 2 520 2 Redeemable preferred stock 29 — 49 5 78 5 Total at December 31, 2019 $ 7,396 $ 349 $ 665 $ 32 $ 8,061 $ 381 ______________ (1) Amounts represents fixed maturities in an unrealized loss position that are not deemed to be OTTI for 2019. The Company’s investments in fixed maturities do not include concentrations of credit risk of any single issuer greater than 10% of the consolidated equity of the Company, other than securities of the U.S. government, U.S. government agencies, and certain securities guaranteed by the U.S. government. The Company maintains a diversified portfolio of corporate securities across industries and issuers and does not have exposure to any single issuer in excess of 0.6% of total corporate securities. The largest exposures to a single issuer of corporate securities held at September 30, 2020 and December 31, 2019 were $321 million and $279 million, respectively, representing 2.2% and 2.4% of the consolidated equity of the Company. Corporate high yield securities, consisting primarily of public high yield bonds, are classified as other than investment grade by the various rating agencies, i.e., a rating below Baa3/BBB- or the National Association of Insurance Commissioners (“NAIC”) designation of 3 (medium investment grade), 4 or 5 (below investment grade) or 6 (in or near default). At September 30, 2020 and December 31, 2019, respectively, approximately $2.0 billion and $1.4 billion, or 3.0% and 2.3%, of the $66.3 billion and $59.3 billion aggregate amortized cost of fixed maturities held by the Company were considered to be other than investment grade. These securities had gross unrealized losses of $81 million and $21 million at September 30, 2020 and December 31, 2019, respectively. At September 30, 2020 and December 31, 2019, respectively, the $58 million and $32 million of gross unrealized losses of twelve months or more were primarily concentrated in corporate securities, as applicable. In accordance with the policy described in Note 2, the Company concluded that an adjustment to income for OTTI (prior to January 1, 2020) nor an allowance for credit losses (after January 1, 2020) for these securities was not warranted at either September 30, 2020 or December 31, 2019. At September 30, 2020 and December 31, 2019, the Company did not intend to sell the securities nor will it likely be required to dispose of the securities before the anticipated recovery of their remaining amortized cost basis. Based on the Company’s evaluation both qualitatively and quantitatively of the drivers of the decline in fair value of fixed maturity securities as of September 30, 2020, the Company determined that the unrealized loss was primarily due to increases in credit spreads and changes in credit ratings due to the impact of the COVID-19 pandemic on financial markets and assessments of fundamental risks. Mortgage Loans on Real Estate Accrued interest receivable on commercial and agricultural mortgage loans at September 30, 2020 was $29 million and $32 million, respectively. There was no accrued interest written off for commercial and agricultural mortgage loans for the three and nine months ended September 30, 2020. At September 30, 2020, the Company had no loans for which foreclosure was probable included within the individually assessed mortgage loans, and accordingly had no associated allowance for credit losses. Allowance for Credit Losses on Mortgage Loans The change in the allowance for credit losses for commercial mortgage loans and agricultural mortgage loans during the three and nine months ended September 30, 2020 was as follows: Three Months Ended September 30, 2020 Nine Months Ended September 30, 2020 (in millions) Allowance for credit losses on mortgage loans (1): Commercial mortgages: Balance, beginning of period $ 62 $ 33 Current-period provision for expected credit losses 4 33 Write-offs charged against the allowance — — Recoveries of amounts previously written off — — Net change in allowance 4 33 Ending Balance, September 30, $ 66 $ 66 Agricultural mortgages: Balance, beginning of period $ 4 $ 3 Current-period provision for expected credit losses — 1 Write-offs charged against the allowance — — Recoveries of amounts previously written off — — Net change in allowance — 1 Ending Balance, September 30, $ 4 $ 4 Total allowance for credit losses $ 70 $ 70 ____________ (1) See Note 2 for discussion of the allowance of credit losses transition balance, which is included in the Balance, beginning of period. The change in the allowance for credit losses is attributable to: • increases/decreases in the loan balance due to new originations, maturing mortgages, and loan amortization; • changes in credit quality; and • changes in market assumptions primarily related to COVID-19 driven economic changes. Credit Quality Information The following tables summarize the Company’s mortgage loans segregated by risk rating exposure at September 30, 2020. LTV Ratios (1) At September 30, 2020 Amortized Cost Basis by Origination Year 2020 2019 2018 2017 2016 Prior Total (in millions) Mortgage loans: Commercial: 0% - 50% $ — $ — $ — $ 324 $ 170 $ 650 $ 1,144 50% - 70% 935 411 885 760 2,432 1,608 7,031 70% - 90% 90 394 368 115 153 574 1,694 90% plus — — 12 5 — 216 233 Total commercial $ 1,025 $ 805 $ 1,265 $ 1,204 $ 2,755 $ 3,048 $ 10,102 At September 30, 2020 Amortized Cost Basis by Origination Year 2020 2019 2018 2017 2016 Prior Total (in millions) Agricultural: 0% - 50% $ 181 $ 137 $ 168 $ 161 $ 232 $ 679 $ 1,558 50% - 70% 253 131 172 110 136 372 1,174 70% - 90% — — 3 — — 18 21 90% plus — — — — — — — Total agricultural $ 434 $ 268 $ 343 $ 271 $ 368 $ 1,069 $ 2,753 Total mortgage loans: 0% - 50% $ 181 $ 137 $ 168 $ 485 $ 402 $ 1,329 $ 2,702 50% - 70% 1,188 542 1,057 870 2,568 1,980 8,205 70% - 90% 90 394 371 115 153 592 1,715 90% plus — — 12 5 — 216 233 Total mortgage loans $ 1,459 $ 1,073 $ 1,608 $ 1,475 $ 3,123 $ 4,117 $ 12,855 Debt Service Coverage Ratios (2) At September 30, 2020 Amortized Cost Basis by Origination Year 2020 2019 2018 2017 2016 Prior Total (in millions) Mortgage loans: Commercial: Greater than 2.0x $ 749 $ 492 $ 772 $ 268 $ 2,036 $ 1,268 $ 5,585 1.8x to 2.0x 227 77 118 378 184 524 1,508 1.5x to 1.8x 49 138 186 480 437 569 1,859 1.2x to 1.5x — 56 154 78 97 533 918 1.0x to 1.2x — 42 35 — 1 82 160 Less than 1.0x — — — — — 72 72 Total commercial $ 1,025 $ 805 $ 1,265 $ 1,204 $ 2,755 $ 3,048 $ 10,102 Agricultural Greater than 2.0x $ 52 $ 27 $ 39 $ 38 $ 73 $ 158 $ 387 1.8x to 2.0x 33 36 14 15 21 90 209 1.5x to 1.8x 103 38 45 41 52 212 491 1.2x to 1.5x 165 118 146 105 147 327 1,008 1.0x to 1.2x 77 39 91 71 57 265 600 Less than 1.0x 4 10 8 1 18 17 58 Total agricultural $ 434 $ 268 $ 343 $ 271 $ 368 $ 1,069 $ 2,753 Total mortgage loans Greater than 2.0x $ 801 $ 519 $ 811 $ 306 $ 2,109 $ 1,426 $ 5,972 1.8x to 2.0x 260 113 132 393 205 614 1,717 1.5x to 1.8x 152 176 231 521 489 781 2,350 1.2x to 1.5x 165 174 300 183 244 860 1,926 1.0x to 1.2x 77 81 126 71 58 347 760 Less than 1.0x 4 10 8 1 18 89 130 Total mortgage loans $ 1,459 $ 1,073 $ 1,608 $ 1,475 $ 3,123 $ 4,117 $ 12,855 _____________ (1) The LTV ratio is derived from current loan balance divided by the fair value of the property. The fair value of the underlying commercial properties is updated annually for each mortgage loan. (2) The DSC ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service. The following tables provide information relating to the LTV and DSC ratios for commercial and agricultural mortgage loans at September 30, 2020 and December 31, 2019. The values used in these ratio calculations were developed as part of the periodic review of the commercial and agricultural mortgage loan portfolio, which includes an evaluation of the underlying collateral value. Mortgage Loans by LTV and DSC Ratios DSC Ratio (2) (3) LTV Ratio (1) (3): Greater than 2.0x 1.8x to 2.0x 1.5x to 1.8x 1.2x to 1.5x 1.0x to 1.2x Less than 1.0x Total (in millions) September 30, 2020: Mortgage loans: Commercial: 0% - 50% $ 935 $ — $ 185 $ 24 $ — $ — $ 1,144 50% - 70% 3,992 1,160 1,342 511 26 — 7,031 70% - 90% 574 348 332 306 134 — 1,694 90% plus 84 — — 77 — 72 233 Total commercial $ 5,585 $ 1,508 $ 1,859 $ 918 $ 160 $ 72 $ 10,102 Agricultural: 0% - 50% $ 283 $ 107 $ 271 $ 529 $ 335 $ 33 $ 1,558 50% - 70% 104 100 220 460 265 25 1,174 70% - 90% — 2 — 19 — — 21 90% plus — — — — — — — Total agricultural $ 387 $ 209 $ 491 $ 1,008 $ 600 $ 58 $ 2,753 Total mortgage loans: 0% - 50% $ 1,218 $ 107 $ 456 $ 553 $ 335 $ 33 $ 2,702 50% - 70% 4,096 1,260 1,562 971 291 25 8,205 70% - 90% 574 350 332 325 134 — 1,715 90% plus 84 — — 77 — 72 233 Total mortgage loans $ 5,972 $ 1,717 $ 2,350 $ 1,926 $ 760 $ 130 $ 12,855 December 31, 2019: Mortgage loans: Commercial: 0% - 50% $ 887 $ 38 $ 214 $ 24 $ — $ — $ 1,163 50% - 70% 4,097 1,195 1,118 795 242 — 7,447 70% - 90% 251 98 214 154 46 — 763 90% plus — — — — — — — Total commercial $ 5,235 $ 1,331 $ 1,546 $ 973 $ 288 $ — $ 9,373 DSC Ratio (2) (3) LTV Ratio (1) (3): Greater than 2.0x 1.8x to 2.0x 1.5x to 1.8x 1.2x to 1.5x 1.0x to 1.2x Less than 1.0x Total (in millions) Agricultural: 0% - 50% $ 322 $ 104 $ 241 $ 545 $ 321 $ 50 $ 1,583 50% - 70% 82 87 236 426 251 33 1,115 70% - 90% — — — 19 — — 19 90% plus — — — — — — — Total agricultural $ 404 $ 191 $ 477 $ 990 $ 572 $ 83 $ 2,717 Total mortgage loans: 0% - 50% $ 1,209 $ 142 $ 455 $ 569 $ 321 $ 50 $ 2,746 50% - 70% 4,179 1,282 1,354 1,221 493 33 8,562 70% - 90% 251 98 214 173 46 — 782 90% plus — — — — — — — Total mortgage loans $ 5,639 $ 1,522 $ 2,023 $ 1,963 $ 860 $ 83 $ 12,090 ______________ (1) The LTV ratio is derived from current loan balance divided by the fair value of the property. The fair value of the underlying commercial properties is updated annually for each mortgage loan. (2) The DSC ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service. (3) Amounts presented at amortized cost basis. Past-Due and Nonaccrual Mortgage Loan Status The following table provides information relating to the aging analysis of past-due mortgage loans at September 30, 2020 and December 31, 2019, respectively: Age Analysis of Past Due Mortgage Loans (1) Accruing Loans Non-accruing Loans Total Loans Non-accruing Loans with No Allowance Interest Income on Non-accruing Loans(2) Past Due Current Total 30-59 Days 60-89 Days 90 Days or More Total (in millions) September 30, 2020: Mortgage loans: Commercial $ — $ — $ — $ — $ 10,102 $ 10,102 $ — $ 10,102 $ — $ — Agricultural 24 6 135 165 2,588 2,753 — 2,753 — — Total $ 24 $ 6 $ 135 $ 165 $ 12,690 $ 12,855 $ — $ 12,855 $ — $ — December 31, 2019: Mortgage loans: Commercial $ — $ — $ — $ — $ 9,373 $ 9,373 $ — $ 9,373 $ — $ — Agricultural 57 1 66 124 2,593 2,717 — 2,717 — — Total $ 57 $ 1 $ 66 $ 124 $ 11,966 $ 12,090 $ — $ 12,090 $ — $ — _______________ (1) Amounts presented at amortized cost basis. (2) Amounts for 2020 represent results for both the three and nine months ended September 30, 2020. At September 30, 2020 and December 31, 2019, the carrying values of problem mortgage loans that had been classified as non-accrual loans were $0 million and $0 million, respectively. Troubled Debt Restructuring For the nine months ended September 30, 2020, the Company had one commercial mortgage loan on real estate accounted for as a TDR with a pre-modification cost basis of $75 million and post-modification carrying value of $75 million. The one commercial mortgage loan TDR is 0.07% of the Company’s total invested assets. For the nine months ended September 30, 2020, the Company had six new privately negotiated fixed maturity TDRs with a pre-modification cost basis of $50 million and post-modification carrying value of $44 million. These TDRs did not have subsequent payment defaults nor additional commitments to lend. The six privately negotiated fixed maturity TDRs are 0.04% of the Company’s total invested assets. There were no mortgage loan on real estate or fixed maturities accounted for as a TDR during 2019. Trading Securities At September 30, 2020 and December 31, 2019, respectively, the fair value of the Company’s trading securities was $5.8 billion and $6.6 billion. At September 30, 2020 and December 31, 2019, respectively, trading securities included the General Account’s investment in Separate Accounts, which had carrying values of $37 million and $58 million. The table below shows a breakdown of Net investment income (loss) from trading securities during the three and nine months ended September 30, 2020 and 2019: Net Investment Income (Loss) from Trading Securities Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (in millions) Net investment gains (losses) recognized during the period on securities held at the end of the period $ (1) $ 7 $ 86 $ 431 Net investment gains (losses) recognized on securities sold during the period (5) 13 12 (10) Unrealized and realized gains (losses) on trading securities (6) 20 98 421 Interest and dividend income from trading securities 58 59 152 220 Net investment income (loss) from trading securities $ 52 $ 79 $ 250 $ 641

DERIVATIVES

DERIVATIVES	9 Months Ended
	Sep. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVES	DERIVATIVES The Company uses derivatives as part of its overall asset/liability risk management primarily to reduce exposures to equity market and interest rate risks. Derivative hedging strategies are designed to reduce these risks from an economic perspective and are all executed within the framework of a “Derivative Use Plan” approved by applicable states’ insurance law. Derivatives are generally not accounted for using hedge accounting, with the exception of Treasury Inflation-Protected Securities (“TIPS”), which is discussed further below. Operation of these hedging programs is based on models involving numerous estimates and assumptions, including, among others, mortality, lapse, surrender and withdrawal rates, election rates, fund performance, market volatility and interest rates. A wide range of derivative contracts are used in these hedging programs, including exchange traded equity, currency and interest rate futures contracts, total return and/or other equity swaps, interest rate swap and floor contracts, bond and bond-index total return swaps, swaptions, variance swaps and equity options, credit and foreign exchange derivatives, as well as bond and repo transactions to support the hedging. The derivative contracts are collectively managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in capital markets. In addition, as part of its hedging strategy, the Company targets an asset level for all variable annuity products at or above a CTE98 level under most economic scenarios (Conditional Tail Expectation, or “CTE”, is a statistical measure of tail risk which quantifies the total asset requirement to sustain a loss if an event outside a given probability level has occurred. CTE98 denotes the financial resources a company would need to cover the average of the worst 2% of scenarios.) Derivatives Utilized to Hedge Exposure to Variable Annuities with Guarantee Features The Company has issued and continues to offer variable annuity products with GMxB features. The risk associated with the GMDB feature is that under-performance of the financial markets could result in GMDB benefits, in the event of death, being higher than what accumulated policyholders’ account balances would support. The risk associated with the GMIB feature is that under-performance of the financial markets could result in the present value of GMIB, in the event of annuitization, being higher than what accumulated policyholders’ account balances would support, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. The risk associated with products that have a GMxB derivative features liability is that under-performance of the financial markets could result in the GMxB derivative features’ benefits being higher than what accumulated policyholders’ account balances would support. For GMxB features, the Company retains certain risks including basis, credit spread and some volatility risk and risk associated with actual versus expected actuarial assumptions for mortality, lapse and surrender, withdrawal and policyholder election rates, among other things. The derivative contracts are managed to correlate with changes in the value of the GMxB features that result from financial markets movements. A portion of exposure to realized equity volatility is hedged using equity options and variance swaps and a portion of exposure to credit risk is hedged using total return swaps on fixed income indices. Additionally, the Company is party to total return swaps for which the reference U.S. Treasury securities are contemporaneously purchased from the market and sold to the swap counterparty. As these transactions result in a transfer of control of the U.S. Treasury securities to the swap counterparty, the Company derecognizes these securities with consequent gain or loss from the sale. The Company has also purchased reinsurance contracts to mitigate the risks associated with GMDB features and the impact of potential market fluctuations on future policyholder elections of GMIB features contained in certain annuity contracts issued by the Company. The reinsurance of the GMIB features is accounted for as a derivative. The Company has in place an economic hedge program using interest rate swaps and U.S. Treasury futures to partially protect the overall profitability of future variable annuity sales against declining interest rates. Derivatives Utilized to Hedge Crediting Rate Exposure on SCS, SIO, MSO and IUL Products/Investment Options The Company hedges crediting rates in the Structured Capital Strategies (“SCS”) variable annuity, Structured Investment Option in the EQUI-VEST variable annuity series (“SIO”), Market Stabilizer Option (“MSO”) in the variable life insurance products and Indexed Universal Life (“IUL”) insurance products. These products permit the contract owner to participate in the performance of an index, Exchange Traded Funds (“ETF”) or commodity price movement up to a cap for a set period of time. They also contain a protection feature, in which the Company will absorb, up to a certain percentage, the loss of value in an index, ETF or commodity price, which varies by product segment. In order to support the returns associated with these features, the Company enters into derivative contracts whose payouts, in combination with fixed income investments, emulate those of the index, ETF or commodity price, subject to caps and buffers, thereby substantially reducing any exposure to market-related earnings volatility. Derivatives Used to Hedge Equity Market Risks Associated with the General Account’s Seed Money Investments in Retail Mutual Funds The Company’s General Account seed money investments in retail mutual funds expose us to market risk, including equity market risk which is partially hedged through equity-index futures contracts to minimize such risk. Derivatives Used to Hedge Universal Life Products with Secondary Guarantee (“ULSG”) Policy The Company implemented a hedge program using fixed income total return swaps to mitigate the interest rate exposure in the ULSG policy statutory liability. Derivatives Used for General Account Investment Portfolio The Company maintains a strategy in its General Account investment portfolio to replicate the credit exposure of fixed maturity securities otherwise permissible for investment under its investment guidelines through the sale of credit default swaps (“CDS”). Under the terms of these swaps, the Company receives quarterly fixed premiums that, together with any initial amount paid or received at trade inception, replicate the credit spread otherwise currently obtainable by purchasing the referenced entity’s bonds of similar maturity. These credit derivatives generally have remaining terms of five years or less and are recorded at fair value with changes in fair value, including the yield component that emerges from initial amounts paid or received, reported in Net derivative gains (losses). The Company manages its credit exposure taking into consideration both cash and derivatives based positions and selects the reference entities in its replicated credit exposures in a manner consistent with its selection of fixed maturities. In addition, the Company generally transacts the sale of CDS in single name reference entities of investment grade credit quality and with counterparties subject to collateral posting requirements. If there is an event of default by the reference entity or other such credit event as defined under the terms of the swap contract, the Company is obligated to perform under the credit derivative and, at the counterparty’s option, either pay the referenced amount of the contract less an auction-determined recovery amount or pay the referenced amount of the contract and receive in return the defaulted or similar security of the reference entity for recovery by sale at the contract settlement auction. The Company purchased CDS to mitigate its exposure to a reference entity through cash positions. These positions do not replicate credit spreads. To date, there have been no events of default or circumstances indicative of a deterioration in the credit quality of the named referenced entities to require or suggest that the Company will have to perform under these CDS. The maximum potential amount of future payments the Company could be required to make under these credit derivatives is limited to the par value of the referenced securities which is the dollar or euro-equivalent of the derivative’s notional amount. The Standard North American CDS Contract (“SNAC”) or Standard European Corporate Contract (“STEC”) under which the Company executes these CDS sales transactions does not contain recourse provisions for recovery of amounts paid under the credit derivative. The Company purchased 30-year TIPS and other sovereign bonds, both inflation-linked and non-inflation linked, as General Account investments and enters into asset or cross-currency basis swaps, to result in payment of the given bond’s coupons and principal at maturity in the bond’s specified currency to the swap counterparty in return for fixed dollar amounts. These swaps, when considered in combination with the bonds, together result in a net position that is intended to replicate a dollar-denominated fixed-coupon cash bond with a yield higher than a term-equivalent U.S. Treasury bond. The tables below present quantitative disclosures about the Company’s derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments: Derivative Instruments by Category At September 30, 2020 Nine Months Ended September 30, 2020 Fair Value Notional Derivative Assets Derivative Liabilities Net Derivative Gains (Losses) (2) (in millions) Derivative instruments: Freestanding derivatives (1): Equity contracts: Futures $ 3,739 $ — $ — $ (347) Swaps 20,667 27 18 (594) Options 31,679 5,543 2,791 (480) Interest rate contracts: Swaps 23,952 1,696 338 3,588 Futures 19,484 — — 2,058 Swaptions — — — 9 Credit contracts: Credit default swaps 1,252 9 4 (4) Other freestanding contracts: Foreign currency contracts 347 — — (3) Margin — 40 125 — Collateral — 14 4,959 — Embedded derivatives: GMIB reinsurance contracts (3) — 3,247 — 849 GMxB derivative features liability (4) — — 11,985 (3,382) SCS, SIO, MSO and IUL indexed features (5) — — 2,502 410 Total derivative instruments $ 101,120 $ 10,576 $ 22,722 Net derivative gains (losses) (6) $ 2,104 ______________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Net derivative gains (losses) in the consolidated statements of income (loss). (3) Reported in GMIB reinsurance contract asset in the consolidated balance sheets. (4) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (5) Reported in Policyholders’ account balances in the consolidated balance sheets. (6) Investment fees of $9 million are reported in Net derivative gains (losses) in the consolidated statements of income (loss). Derivative Instruments by Category At December 31, 2019 Nine Months Ended September 30, 2019 Fair Value Notional Derivative Assets Derivative Liabilities Net Derivative Gains (Losses) (2) (in millions) Derivative instruments: Freestanding derivatives (1): Equity contracts: Futures $ 3,510 $ — $ — $ (967) Swaps 17,064 9 279 (1,263) Options 47,766 5,080 1,749 1,241 Interest rate contracts: Swaps 23,700 467 523 2,844 Futures 20,424 — — 183 Swaptions 3,201 16 — 146 Credit contracts: Credit default swaps 1,232 18 — 13 Other freestanding contracts: Foreign currency contracts 501 3 — (13) Margin — 140 — — Collateral — 72 3,001 — Embedded derivatives: GMIB reinsurance contracts (3) — 2,466 — 881 GMxB derivative features liability (4) — — 8,316 (3,656) SCS, SIO, MSO and IUL indexed features (5) — — 3,150 (1,489) Total derivative instruments $ 117,398 $ 8,271 $ 17,018 Net derivative gains (losses) $ (2,080) ______________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Net derivative gains (losses) in the consolidated statements of income (loss). (3) Reported in GMIB reinsurance contract asset in the consolidated balance sheets. (4) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (5) Reported in Policyholders’ account balances in the consolidated balance sheets. Equity-Based and Treasury Futures Contracts Margin All outstanding equity-based and treasury futures contracts at September 30, 2020 and December 31, 2019 are exchange-traded and net settled daily in cash. At September 30, 2020 and December 31, 2019, respectively, the Company had open exchange-traded futures positions on: (i) the S&P 500, Russell 2000 and Emerging Market indices, having initial margin requirements of $205 million and $58 million, (ii) the 2-year, 5-year and 10-year U.S. Treasury Notes on U.S. Treasury bonds and ultra-long bonds, having initial margin requirements of $314 million and $165 million, and (iii) the Euro Stoxx, FTSE 100, Topix, ASX 200 and European, Australasia, and Far East (“EAFE”) indices as well as corresponding currency futures on the Euro/U.S. dollar, Pound/U.S. dollar, Australian dollar/U.S. dollar, and Yen/U.S. dollar, having initial margin requirements of $40 million and $60 million. Collateral Arrangements The Company generally has executed a Credit Support Annex (“CSA”) under the International Swaps and Derivatives Association Master Agreement (“ISDA Master Agreement”) it maintains with each of its over-the-counter (“OTC”) derivative counterparties that requires both posting and accepting collateral either in the form of cash or high-quality securities, such as U.S. Treasury securities, U.S. government and government agency securities and investment grade corporate bonds. The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related CSA have been executed. At September 30, 2020 and December 31, 2019, respectively, the Company held $5.0 billion and $3.0 billion in cash and securities collateral delivered by trade counterparties, representing the fair value of the related derivative agreements. The unrestricted cash collateral is reported in Other invested assets. The Company posted collateral of $14 million and $72 million at September 30, 2020 and December 31, 2019, respectively, in the normal operation of its collateral arrangements. The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at September 30, 2020: Offsetting of Financial Assets and Liabilities and Derivative Instruments At September 30, 2020 Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets Gross Amount not Offset in the Balance Sheets (1) Net Amount (in millions) Assets: Derivative assets $ 7,330 $ 7,241 $ 89 $ (54) $ 35 Other financial assets 1,434 — 1,434 — 1,434 Other invested assets $ 8,764 $ 7,241 $ 1,523 $ (54) $ 1,469 Liabilities: Derivative liabilities $ 8,181 $ 7,241 $ 940 $ — $ 940 Other financial liabilities 1,579 — 1,579 — 1,579 Other liabilities $ 9,760 $ 7,241 $ 2,519 $ — $ 2,519 ______________ (1) Financial instruments sent (held). The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at December 31, 2019. Offsetting of Financial Assets and Liabilities and Derivative Instruments At December 31, 2019 Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets Gross Amount not Offset in the Balance Sheets (1) Net Amount (in millions) Assets: Derivative assets $ 5,804 $ 5,429 $ 375 $ (77) $ 298 Other financial instruments 1,781 — 1,781 — 1,781 Other invested assets $ 7,585 $ 5,429 $ 2,156 $ (77) $ 2,079 Liabilities: Derivative liabilities $ 5,474 $ 5,429 $ 45 $ — $ 45 Other financial liabilities 1,724 — 1,724 — 1,724 Other liabilities $ 7,198 $ 5,429 $ 1,769 $ — $ 1,769 ______________ (1) Financial instruments sent (held).

CLOSED BLOCK

CLOSED BLOCK	9 Months Ended
	Sep. 30, 2020
Closed Block Disclosure [Abstract]
CLOSED BLOCK	CLOSED BLOCK As a result of demutualization, the Company’s Closed Block was established in 1992 for the benefit of certain individual participating policies that were in force on that date. Assets, liabilities and earnings of the Closed Block are specifically identified to support its participating policyholders. Assets allocated to the Closed Block inure solely to the benefit of the Closed Block policyholders and will not revert to the benefit of the Company. No reallocation, transfer, borrowing or lending of assets can be made between the Closed Block and other portions of the Company’s General Account, any of its Separate Accounts or any affiliate of the Summarized financial information for the Company’s Closed Block is as follows: September 30, 2020 December 31, 2019 (in millions) Closed Block Liabilities: Future policy benefits, policyholders’ account balances and other $ 6,260 $ 6,478 Policyholder dividend obligation 149 2 Other liabilities 58 38 Total Closed Block liabilities 6,467 6,518 Assets Designated to the Closed Block: Fixed maturities available-for-sale, at fair value (amortized cost of $3,440 and $3,558) (allowance for credit losses of $0 at September 30, 2020) 3,788 3,754 Mortgage loans on real estate (net of allowance for credit losses of $6 at September 30, 2020) 1,782 1,759 Policy loans 656 706 Cash and other invested assets 3 82 Other assets 172 145 Total assets designated to the Closed Block 6,401 6,446 Excess of Closed Block liabilities over assets designated to the Closed Block 66 72 Amounts included in accumulated other comprehensive income (loss): Net unrealized investment gains (losses), net of policyholders’ dividend obligation: $149 and $2; and net of income tax: $42 and $41 168 164 Maximum future earnings to be recognized from Closed Block assets and liabilities $ 234 $ 236 The Company’s Closed Block revenues and expenses were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (in millions) Revenues: Premiums and other income $ 36 $ 42 $ 118 $ 136 Net investment income (loss) 61 69 190 208 Investment gains (losses), net 1 — (1) (1) Total revenues 98 111 307 343 Benefits and Other Deductions: Policyholders’ benefits and dividends 96 108 302 343 Other operating costs and expenses — — 1 1 Total benefits and other deductions 96 108 303 344 Net income (loss), before income taxes 2 3 4 (1) Income tax (expense) benefit (1) — (2) (2) Net income (loss) $ 1 $ 3 $ 2 $ (3)

INSURANCE LIABILITIES

INSURANCE LIABILITIES	9 Months Ended
	Sep. 30, 2020
Insurance [Abstract]
INSURANCE LIABILITIES	INSURANCE LIABILITIES Variable Annuity Contracts – GMDB, GMIB, GIB and GWBL and Other Features The Company has certain variable annuity contracts with GMDB, GMIB, GIB and GWBL and other features in-force that guarantee one of the following: • Return of Premium: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals); • Ratchet: the benefit is the greatest of current account value, premiums paid (adjusted for withdrawals), or the highest account value on any anniversary up to contractually specified ages (adjusted for withdrawals); • Roll-Up: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals) accumulated at contractually specified interest rates up to specified ages; • Combo: the benefit is the greater of the ratchet benefit or the roll-up benefit, which may include either a five year or an annual reset; or • Withdrawal: the withdrawal is guaranteed up to a maximum amount per year for life. Liabilities for Variable Annuity Contracts with GMDB and GMIB Features without No-Lapse Guarantee Rider (“NLG”) Feature The change in the liabilities for variable annuity contracts with GMDB and GMIB features and without a NLG feature are summarized in the tables below. The amounts for the direct contracts (before reinsurance ceded) and assumed contracts are reflected in the consolidated balance sheets in Future policy benefits and other policyholders’ liabilities. The amounts for the ceded contracts are reflected in the consolidated balance sheets in Amounts due from reinsurers. The amounts for the ceded IB are reflected in the consolidated balance sheets in GMIB reinsurance contract asset, at fair value. Change in Liability for Variable Annuity Contracts with GMDB and GMIB Features and No NLG Feature For the Three and Nine Months Ended September 30, 2020 and 2019 GMDB GMIB Direct Ceded Direct Ceded (in millions) Balance at July 1, 2020 $ 4,998 $ (99) $ 6,121 $ (3,433) Paid guarantee benefits (121) 3 (110) 21 Other changes in reserve 235 9 113 165 Balance at September 30, 2020 $ 5,112 $ (87) $ 6,124 $ (3,247) Balance at July 1, 2019 $ 4,709 $ (100) $ 3,757 $ (2,197) Paid guarantee benefits (102) 3 (70) 20 Other changes in reserve 155 (4) 979 (676) Balance at September 30, 2019 $ 4,762 $ (101) $ 4,666 $ (2,853) GMDB GMIB Direct Ceded Direct Ceded (in millions) Balance at January 1, 2020 $ 4,775 $ (99) $ 4,671 $ (2,466) Paid guarantee benefits (372) 12 (287) 58 Other changes in reserve 709 — 1,740 (839) Balance at September 30, 2020 $ 5,112 $ (87) $ 6,124 $ (3,247) Balance at January 1, 2019 $ 4,657 $ (107) $ 3,744 $ (1,993) Paid guarantee benefits (328) 11 (182) 55 Other changes in reserve 433 (5) 1,104 (915) Balance at September 30, 2019 $ 4,762 $ (101) $ 4,666 $ (2,853) Liabilities for Embedded and Freestanding Insurance Related Derivatives The liability for the GMxB derivative features, the liability for SCS, SIO, MSO and IUL indexed features and the asset and liability for the GMIB reinsurance contracts are considered embedded or freestanding insurance derivatives and are reported at fair value. For the fair value of the assets and liabilities associated with these embedded or freestanding insurance derivatives, see Note 7 Fair Value Disclosures. Account Values and Net Amount at Risk Account Values and Net Amount at Risk (“NAR”) for direct variable annuity contracts in force with GMDB and GMIB features as of September 30, 2020 are presented in the following tables by guarantee type. For contracts with the GMDB feature, the NAR in the event of death is the amount by which the GMDB feature exceeds the related Account Values. For contracts with the GMIB feature, the NAR in the event of annuitization is the amount by which the present value of the GMIB benefits exceed the related Account Values, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. Since variable annuity contracts with GMDB features may also offer GMIB guarantees in the same contract, the GMDB and GMIB amounts listed are not mutually exclusive. Direct Variable Annuity Contracts with GMDB and GMIB Features at September 30, 2020 Guarantee Type Return of Premium Ratchet Roll-Up Combo Total (in millions, except age and interest rate) Variable annuity contracts with GMDB features Account Values invested in: General Account $ 15,155 $ 89 $ 57 $ 171 $ 15,472 Separate Accounts 48,407 8,812 3,021 31,083 91,323 Total Account Values $ 63,562 $ 8,901 $ 3,078 $ 31,254 $ 106,795 Net Amount at Risk, gross $ 125 $ 94 $ 1,864 $ 19,561 $ 21,644 Net Amount at Risk, net of amounts reinsured $ 125 $ 91 $ 1,319 $ 19,561 $ 21,096 Average attained age of policyholders (in years) 51.3 68.1 74.7 70.0 55.3 Percentage of policyholders over age 70 11.0 % 47.7 % 69.8 % 53.3 % 20.0 % Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5% Variable annuity contracts with GMIB features Account Values invested in: General Account $ — $ — $ 17 $ 220 $ 237 Separate Accounts — — 23,124 33,217 56,341 Total Account Values $ — $ — $ 23,141 $ 33,437 $ 56,578 Net Amount at Risk, gross $ — $ — $ 1,100 $ 14,461 $ 15,561 Net Amount at Risk, net of amounts reinsured $ — $ — $ 349 $ 13,066 $ 13,415 Average attained age of policyholders (in years) N/A N/A 64.0 70.0 67.8 Weighted average years remaining until annuitization N/A N/A 5.7 0.7 2.5 Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5% For more information about the reinsurance programs of the Company’s GMDB and GMIB exposure, see “Reinsurance” in Note 10 to the Company’s consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2019. Separate Accounts Investments by Investment Category Underlying Variable Annuity Contracts with GMDB and GMIB Features The total Account Values of variable annuity contracts with GMDB and GMIB features include amounts allocated to the guaranteed interest option, which is part of the General Account and variable investment options that invest through Separate Accounts in variable insurance trusts. The following table presents the aggregate fair value of assets, by major investment category, held by Separate Accounts that support variable annuity contracts with GMDB and GMIB features. The investment performance of the assets impacts the related Account Values and, consequently, the NAR associated with the GMDB and GMIB benefits and guarantees. Because the Company’s variable annuity contracts offer both GMDB and GMIB features, GMDB and GMIB amounts are not mutually exclusive. Investment in Variable Insurance Trust Mutual Funds September 30, 2020 December 31, 2019 Mutual Fund Type GMDB GMIB GMDB GMIB (in millions) Equity $ 41,259 $ 16,739 $ 42,489 $ 17,941 Fixed income 5,371 2,679 5,263 2,699 Balanced 43,685 36,656 45,872 38,445 Other 1,008 267 865 263 Total $ 91,323 $ 56,341 $ 94,489 $ 59,348 Hedging Programs for GMDB, GMIB, GIB and Other Features The Company has a program intended to hedge certain risks associated first with the GMDB feature and with the GMIB feature of the Accumulator series of variable annuity products. The program has also been extended to cover other guaranteed benefits as they have been made available. This program utilizes derivative contracts, such as exchange-traded equity, currency and interest rate futures contracts, total return and/or equity swaps, interest rate swap and floor contracts, swaptions, variance swaps as well as equity options, that collectively are managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in the capital markets. At the present time, this program hedges certain economic risks on products sold from 2001 forward, to the extent such risks are not externally reinsured. These programs do not qualify for hedge accounting treatment. Therefore, gains (losses) on the derivatives contracts used in these programs, including current period changes in fair value, are recognized in Net derivative gains (losses) in the period in which they occur, and may contribute to income (loss) volatility. Variable and Interest-Sensitive Life Insurance Policies - NLG The NLG feature contained in variable and interest-sensitive life insurance policies keeps them in force in situations where the policy value is not sufficient to cover monthly charges then due. The NLG remains in effect so long as the policy meets a contractually specified premium funding test and certain other requirements. The change in the NLG liabilities, reflected in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets, is summarized in the table below. 2020 2019 Direct Liability Reinsurance Ceded Net Direct Liability Reinsurance Ceded Net (in millions) 2020 2019 Direct Liability Reinsurance Ceded Net Direct Liability Reinsurance Ceded Net Balance at July 1, $ 941 $ (841) $ 100 $ 821 $ (756) $ 65 Paid guarantee benefits (6) — (6) (7) — (7) Other changes in reserves 61 (31) 30 54 (31) 23 Balance at September 30, $ 996 $ (872) $ 124 $ 868 $ (787) $ 81 Balance at January 1, $ 894 $ (808) $ 86 $ 788 $ (734) $ 54 Paid guarantee benefits (32) — (32) (16) — (16) Other changes in reserves 134 (64) 70 96 (53) 43 Balance at September 30, $ 996 $ (872) $ 124 $ 868 $ (787) $ 81

FAIR VALUE DISCLOSURES

FAIR VALUE DISCLOSURES	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
FAIR VALUE DISCLOSURES	FAIR VALUE DISCLOSURES U.S. GAAP establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value, and identifies three levels of inputs that may be used to measure fair value: Level 1 Unadjusted quoted prices for identical instruments in active markets. Level 1 fair values generally are supported by market transactions that occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar instruments, quoted prices in markets that are not active, and inputs to model-derived valuations that are directly observable or can be corroborated by observable market data. Level 3 Unobservable inputs supported by little or no market activity and often requiring significant management judgment or estimation, such as an entity’s own assumptions about the cash flows or other significant components of value that market participants would use in pricing the asset or liability. The Company uses unadjusted quoted market prices to measure fair value for those instruments that are actively traded in financial markets. In cases where quoted market prices are not available, fair values are measured using present value or other valuation techniques. The fair value determinations are made at a specific point in time, based on available market information and judgments about the financial instrument, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such adjustments do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value cannot be substantiated by direct comparison to independent markets, nor can the disclosed value be realized in immediate settlement of the instrument. Management is responsible for the determination of the value of investments carried at fair value and the supporting methodologies and assumptions. Under the terms of various service agreements, the Company often utilizes independent valuation service providers to gather, analyze, and interpret market information and derive fair values based upon relevant methodologies and assumptions for individual securities. These independent valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of widely accepted valuation models, provide a single fair value measurement for individual securities for which a fair value has been requested. As further described below with respect to specific asset classes, these inputs include, but are not limited to, market prices for recent trades and transactions in comparable securities, benchmark yields, interest rate yield curves, credit spreads, quoted prices for similar securities, and other market-observable information, as applicable. Specific attributes of the security being valued also are considered, including its term, interest rate, credit rating, industry sector, and when applicable, collateral quality and other security- or issuer-specific information. When insufficient market observable information is available upon which to measure fair value, the Company either will request brokers knowledgeable about these securities to provide a non-binding quote or will employ internal valuation models. Fair values received from independent valuation service providers and brokers and those internally modeled or otherwise estimated are assessed for reasonableness. Assets and Liabilities Measured at Fair Value on a Recurring Basis Assets and liabilities measured at fair value on a recurring basis are summarized below. At September 30, 2020 and December 31, 2019, no assets were required to be measured at fair value on a non-recurring basis. Fair value measurements are required on a non-recurring basis for certain assets, including goodwill and mortgage loans on real estate, only when an impairment or other event occurs. When such fair value measurements are recorded, they must be classified and disclosed within the fair value hierarchy. Fair Value Measurements at September 30, 2020 Level 1 Level 2 Level 3 Total (in millions) Assets: Investments: Fixed maturities, AFS: Corporate (1) $ — $ 50,040 $ 1,479 $ 51,519 U.S. Treasury, government and agency — 17,284 — 17,284 States and political subdivisions — 776 39 815 Foreign governments — 902 — 902 Residential mortgage-backed (2) — 145 — 145 Asset-backed (3) — 2,578 13 2,591 Commercial mortgage-backed — 1,117 — 1,117 Redeemable preferred stock 367 74 — 441 Total fixed maturities, AFS 367 72,916 1,531 74,814 Other equity investments 20 — 4 24 Trading securities 258 5,529 — 5,787 Other invested assets: Short-term investments — 106 — 106 Assets of consolidated VIEs/VOEs — — 12 12 Swaps — 1,367 — 1,367 Credit default swaps — 5 — 5 Options — 2,752 — 2,752 Total other invested assets — 4,230 12 4,242 Cash equivalents 2,488 1,031 — 3,519 GMIB reinsurance contracts asset — — 3,247 3,247 Separate Accounts assets (4) 118,085 2,424 — 120,509 Total Assets $ 121,218 $ 86,130 $ 4,794 $ 212,142 Liabilities: GMxB derivative features’ liability $ — $ — $ 11,985 $ 11,985 SCS, SIO, MSO and IUL indexed features’ liability — 2,502 — 2,502 Total Liabilities $ — $ 2,502 $ 11,985 $ 14,487 ______________ (1) Corporate fixed maturities includes both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (4) Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate and commercial mortgages. At September 30, 2020 the fair value of such investments was $356 million. Fair Value Measurements at December 31, 2019 Level 1 Level 2 Level 3 Total (in millions) Assets: Investments: Fixed maturities, AFS: Corporate (1) $ — $ 43,218 $ 1,246 $ 44,464 U.S. Treasury, government and agency — 15,231 — 15,231 States and political subdivisions — 610 39 649 Foreign governments — 490 — 490 Residential mortgage-backed (2) — 173 — 173 Asset-backed (3) — 744 100 844 Redeemable preferred stock 237 274 — 511 Total fixed maturities, AFS 237 60,740 1,385 62,362 Other equity investments 13 — — 13 Trading securities 321 6,277 — 6,598 Other invested assets: Short-term investments — 468 — 468 Assets of consolidated VIEs/VOEs — — 16 16 Swaps — (326) — (326) Credit default swaps — 18 — 18 Options — 3,331 — 3,331 Total other invested assets — 3,491 16 3,507 Cash equivalents 1,155 — — 1,155 GMIB reinsurance contracts asset — — 2,466 2,466 Separate Accounts assets (4) 121,184 2,878 — 124,062 Total Assets $ 122,910 $ 73,386 $ 3,867 $ 200,163 Liabilities: GMxB derivative features’ liability $ — $ — $ 8,316 $ 8,316 SCS, SIO, MSO and IUL indexed features’ liability — 3,150 — 3,150 Total Liabilities $ — $ 3,150 $ 8,316 $ 11,466 ______________ (1) Corporate fixed maturities includes both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (4) Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate and commercial mortgages. At December 31, 2019 the fair value of such investments was $356 million. Public Fixed Maturities The fair values of the Company’s public fixed maturities are generally based on prices obtained from independent valuation service providers and for which the Company maintains a vendor hierarchy by asset type based on historical pricing experience and vendor expertise. Although each security generally is priced by multiple independent valuation service providers, the Company ultimately uses the price received from the independent valuation service provider highest in the vendor hierarchy based on the respective asset type, with limited exception. To validate reasonableness, prices also are internally reviewed by those with relevant expertise through comparison with directly observed recent market trades. Consistent with the fair value hierarchy, public fixed maturities validated in this manner generally are reflected within Level 2, as they are primarily based on observable pricing for similar assets and/or other market observable inputs. Private Fixed Maturities The fair values of the Company’s private fixed maturities are determined from prices obtained from independent valuation service providers. Prices not obtained from an independent valuation service provider are determined by using a discounted cash flow model or a market comparable company valuation technique. In certain cases, these models use observable inputs with a discount rate based upon the average of spread surveys collected from private market intermediaries who are active in both primary and secondary transactions, taking into account, among other factors, the credit quality and industry sector of the issuer and the reduced liquidity associated with private placements. Generally, these securities have been reflected within Level 2. For certain private fixed maturities, the discounted cash flow model or a market comparable company valuation technique may also incorporate unobservable inputs, which reflect the Company’s own assumptions about the inputs market participants would use in pricing the asset. To the extent management determines that such unobservable inputs are significant to the fair value measurement of a security, a Level 3 classification generally is made. Freestanding Derivative Positions The net fair value of the Company’s freestanding derivative positions as disclosed in Note 4 are generally based on prices obtained either from independent valuation service providers or derived by applying market inputs from recognized vendors into industry standard pricing models. The majority of these derivative contracts are traded in the OTC derivative market and are classified in Level 2. The fair values of derivative assets and liabilities traded in the OTC market are determined using quantitative models that require use of the contractual terms of the derivative instruments and multiple market inputs, including interest rates, prices, and indices to generate continuous yield or pricing curves, including overnight index swap (“OIS”) curves, and volatility factors, which then are applied to value the positions. The predominance of market inputs is actively quoted and can be validated through external sources or reliably interpolated if less observable. Level Classifications of the Company’s Financial Instruments Financial Instruments Classified as Level 1 Investments classified as Level 1 primarily include redeemable preferred stock, trading securities, cash equivalents and Separate Accounts assets. Fair value measurements classified as Level 1 include exchange-traded prices of fixed maturities, equity securities and derivative contracts, and net asset values for transacting subscriptions and redemptions of mutual fund shares held by Separate Accounts. Cash equivalents classified as Level 1 include money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less and are carried at cost as a proxy for fair value measurement due to their short-term nature. Financial Instruments Classified as Level 2 Investments classified as Level 2 are measured at fair value on a recurring basis and primarily include U.S. government and agency securities and certain corporate debt securities, such as public and private fixed maturities. As market quotes generally are not readily available or accessible for these securities, their fair value measures are determined utilizing relevant information generated by market transactions involving comparable securities and often are based on model pricing techniques that effectively discount prospective cash flows to present value using appropriate sector-adjusted credit spreads commensurate with the security’s duration, also taking into consideration issuer-specific credit quality and liquidity. Observable inputs generally used to measure the fair value of securities classified as Level 2 include benchmark yields, reported secondary trades, issuer spreads, benchmark securities and other reference data. Additional observable inputs are used when available, and as may be appropriate, for certain security types, such as prepayment, default, and collateral information for the purpose of measuring the fair value of mortgage- and asset-backed securities. The Company’s AAA-rated mortgage- and asset-backed securities are classified as Level 2 for which the observability of market inputs to their pricing models is supported by sufficient, albeit more recently contracted, market activity in these sectors. Certain Company products, such as the SCS and EQUI-VEST variable annuity products, IUL and the MSO fund available in some life contracts offer investment options which permit the contract owner to participate in the performance of an index, ETF or commodity price. These investment options, which depending on the product and on the index selected can currently have one, three, five or six year terms, provide for participation in the performance of specified indices, ETF or commodity price movement up to a segment-specific declared maximum rate. Under certain conditions that vary by product, e.g., holding these segments for the full term, these segments also shield policyholders from some or all negative investment performance associated with these indices, ETF or commodity prices. These investment options have defined formulaic liability amounts, and the current values of the option component of these segment reserves are accounted for as Level 2 embedded derivatives. The fair values of these embedded derivatives are based on data obtained from independent valuation service providers. Financial Instruments Classified as Level 3 The Company’s investments classified as Level 3 primarily include corporate debt securities, such as private fixed maturities and asset-backed securities. Determinations to classify fair value measures within Level 3 of the valuation hierarchy generally are based upon the significance of the unobservable factors to the overall fair value measurement. Included in the Level 3 classification are fixed maturities with indicative pricing obtained from brokers that otherwise could not be corroborated to market observable data. The Company also issues certain benefits on its variable annuity products that are accounted for as derivatives and are also considered Level 3. The GMIBNLG feature allows the policyholder to receive guaranteed minimum lifetime annuity payments based on predetermined annuity purchase rates applied to the contract’s benefit base if and when the contract account value is depleted and the NLG feature is activated. The GMWB feature allows the policyholder to withdraw at minimum, over the life of the contract, an amount based on the contract’s benefit base. The GWBL feature allows the policyholder to withdraw, each year for the life of the contract, a specified annual percentage of an amount based on the contract’s benefit base. The GMAB feature increases the contract account value at the end of a specified period to a GMAB base. The GIB feature provides a lifetime annuity based on predetermined annuity purchase rates if and when the contract account value is depleted. This lifetime annuity is based on predetermined annuity purchase rates applied to a GIB base. Level 3 also includes the GMIB reinsurance contract assets which are accounted for as derivative contracts. The GMIB reinsurance contract asset and liabilities’ fair value reflects the present value of reinsurance premiums and recoveries and risk margins over a range of market consistent economic scenarios while GMxB derivative features liability reflects the present value of expected future payments (benefits) less fees, adjusted for risk margins and nonperformance risk, attributable to GMxB derivative features’ liability over a range of market-consistent economic scenarios. The valuations of the GMIB reinsurance contract asset and GMxB derivative features liability incorporate significant non-observable assumptions related to policyholder behavior, risk margins and projections of equity Separate Accounts funds. The credit risks of the counterparty and of the Company are considered in determining the fair values of its GMIB reinsurance contract asset and GMxB derivative features liability positions, respectively, after taking into account the effects of collateral arrangements. Incremental adjustment to the swap curve for non-performance risk is made to the fair values of the GMIB reinsurance contract asset and liabilities and GMIBNLG feature to reflect the claims-paying ratings of counterparties and the Company. Equity and fixed income volatilities were modeled to reflect current market volatilities. Due to the unique, long duration of the GMIBNLG feature, adjustments were made to the equity volatilities to remove the illiquidity bias associated with the longer tenors and risk margins were applied to the non-capital markets inputs to the GMIBNLG valuations. After giving consideration to collateral arrangements, the Company reduced the fair value of its GMIB reinsurance contract asset by $263 million and $175 million at September 30, 2020 and December 31, 2019, respectively, to recognize incremental counterparty non-performance risk. Lapse rates are adjusted at the contract level based on a comparison of the actuarial calculated guaranteed values and the current policyholder account value, which include other factors such as considering surrender charges. Generally, lapse rates are assumed to be lower in periods when a surrender charge applies. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. For valuing the embedded derivative, lapse rates vary throughout the period over which cash flows are projected. The Company’s consolidated VIEs/VOEs hold investments that are classified as Level 3, primarily corporate bonds that are vendor priced with no ratings available, bank loans, non-agency collateralized mortgage obligations and asset-backed securities. Transfers of Financial Instruments Between Levels 2 and 3 During the nine months ended September 30, 2020, AFS fixed maturities with fair values of $103 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, AFS fixed maturities with fair value of $189 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 2.0% of total equity at September 30, 2020. During the nine months ended September 30, 2019, AFS fixed maturities with fair values of $104 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, AFS fixed maturities with fair value of $14 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 0.9% of total equity at September 30, 2019. The tables below present reconciliations for all Level 3 assets and liabilities for the three and nine months ended September 30, 2020 and 2019, respectively. Level 3 Instruments - Fair Value Measurements Corporate State and Political Subdivisions Asset-backed (in millions) Balance, July 1, 2020 $ 1,652 $ 40 $ — Total gains and (losses), realized and unrealized, included in: Net income (loss) as: Net investment income (loss) — — — Investment gains (losses), net (1) — — Subtotal (1) — — Other comprehensive income (loss) 18 (1) — Purchases (138) — 13 Sales (22) — — Transfers into Level 3 (1) (30) — — Transfers out of Level 3 (1) — — — Balance, September 30, 2020 $ 1,479 $ 39 $ 13 Balance, July 1, 2019 $ 1,290 $ 39 $ 534 Total gains and (losses), realized and unrealized, included in: Net income (loss) as: Net investment income (loss) — — — Investment gains (losses), net — — — Subtotal — — — Other comprehensive income (loss) (7) 1 — Purchases (2) — 71 Sales (42) (1) (73) Transfers into Level 3 (1) — — — Transfers out of Level 3 (1) (31) — — Balance, September 30, 2019 $ 1,208 $ 39 $ 532 ______________ (1) Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values. Corporate State and Political Subdivisions Asset-backed (in millions) Balance, January 1, 2020 $ 1,246 $ 39 $ 100 Total gains and (losses), realized and unrealized, included in: Net income (loss) as: Net investment income (loss) 2 — — Investment gains (losses), net (14) — — Subtotal (12) — — Corporate State and Political Subdivisions Asset-backed (in millions) Other comprehensive income (loss) (36) 1 — Purchases 207 — 13 Sales (112) (1) — Transfers into Level 3 (1) 189 — — Transfers out of Level 3 (1) (3) — (100) Balance, September 30, 2020 $ 1,479 $ 39 $ 13 Balance, January 1, 2019 $ 1,174 $ 38 $ 519 Total gains and (losses), realized and unrealized, included in: Net income (loss) as: Net investment income (loss) 3 — — Investment gains (losses), net — — — Subtotal 3 — — Other comprehensive income (loss) 3 3 5 Purchases 219 — 81 Sales (101) (2) (73) Transfers into Level 3 (1) 14 — — Transfers out of Level 3 (1) (104) — — Balance, September 30, 2019 $ 1,208 $ 39 $ 532 ______________ (1) Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values. Other Equity Investments GMIB Reinsurance Contract Asset Separate Accounts Assets GMxB Derivative Features Liability (in millions) Balance, July 1, 2020 $ 16 $ 3,433 $ — $ (12,458) Realized and unrealized gains (losses), included in Net income (loss) as: Investment gains (losses), net — — — — Net derivative gains (losses) (1) — (177) — 570 Total realized and unrealized gains (losses) — (177) — 570 Other comprehensive income (loss) — — — — Purchases (2) 3 11 — (113) Sales (3) — (21) — 16 Change in estimate (4) — 1 — — Activity related to consolidated VIEs/VOEs (3) — — — Transfers into Level 3 (5) — — — — Transfers out of Level 3 (5) — — — — Balance, September 30, 2020 $ 16 $ 3,247 $ — $ (11,985) Balance, July 1, 2019 $ 16 $ 2,198 $ 25 $ (6,813) Realized and unrealized gains (losses), included in Net income (loss) as: Investment gains (losses), net — — — — Net derivative gains (losses) — 664 — (2,535) Total realized and unrealized gains (losses) — 664 — (2,535) Other comprehensive income (loss) — — — — Purchases (2) — 11 (5) (100) Sales (3) — (20) (1) 12 Settlements — — (1) — Activity related to consolidated VIEs/VOEs — — — — Transfers into Level 3 (5) — — — — Transfers out of Level 3 (5) — — (11) — Balance, September 30, 2019 $ 16 $ 2,853 $ 7 $ (9,436) ______________ (1) The Company’s nonperformance risk impact of ($458) million for the GMxB derivative features liability and $6 million for the GMIB reinsurance contract asset the three months ended September 2020, respectively, is recorded through Net derivative gains (losses). (2) For the GMIB reinsurance contract asset and GMxB derivative features liability, represents attributed fee. (3) For the GMIB reinsurance contract asset, represents recoveries from reinsurers and for GMxB derivative features liability, represents benefits paid. (4) For the GMIB reinsurance contract asset, represents a transfer from amounts due from reinsurers. (5) Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values. Other Equity Investments GMIB Reinsurance Contract Asset Separate Accounts Assets GMxB Derivative Features Liability (in millions) Balance, January 1, 2020 $ 16 $ 2,466 $ — $ (8,316) Realized and unrealized gains (losses), included in Net income (loss) as: Investment gains (losses), net — — — — Net derivative gains (losses) (1) — 849 — (3,382) Total realized and unrealized gains (losses) — 849 — (3,382) Other comprehensive income (loss) — Purchases (2) 4 34 — (328) Sales (3) — (58) — 41 Settlements — — — — Change in estimate (4) — (44) — — Activity related to consolidated VIEs/VOEs (4) — — — Transfers into Level 3 (5) — — — — Transfers out of Level 3 (5) — — — — Balance, September 30, 2020 $ 16 $ 3,247 $ — $ (11,985) Balance, January 1, 2019 $ 48 $ 1,993 $ 21 $ (5,491) Realized and unrealized gains (losses), included in Net income (loss) as: Investment gains (losses), net — — — — Net derivative gains (losses) — 881 — (3,656) Total realized and unrealized gains (losses) — 881 — (3,656) Other comprehensive income (loss) — — — — Purchases (2) — 34 3 (309) Sales (3) — (55) (1) 20 Settlements — — (4) — Activity related to consolidated VIEs/VOEs (3) — — — Transfers into Level 3 (5) — — — — Transfers out of Level 3 (5) (29) — (12) — Balance, September 30, 2019 $ 16 $ 2,853 $ 7 $ (9,436) ______________ (1) The Company’s nonperformance risk impact of $35 million for the GMxB derivative features liability and ($50) million for the GMIB reinsurance contract asset the nine months ended September 2020, respectively, is recorded through Net derivative gains (losses). (2) For the GMIB reinsurance contract asset and GMxB derivative features liability, represents attributed fee. (3) For the GMIB reinsurance contract asset, represents recoveries from reinsurers and for GMxB derivative features liability, represents benefits paid. (4) For the GMIB reinsurance contract asset, represents a transfer from amounts due from reinsurers. (5) Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values. The table below details changes in unrealized gains (losses) for the nine months ended September 30, 2020 and 2019 by category for Level 3 assets and liabilities still held at September 30, 2020 and 2019, respectively. Change in Unrealized Gains (Losses) for Level 3 Instruments Net Income (Loss) Investment Gains (Losses), Net Net Derivative Gains (Losses) OCI (in millions) Held at September 30, 2020: Change in unrealized gains (losses): Fixed maturities, AFS: Corporate $ — $ — $ (37) State and political subdivisions — — 2 Total fixed maturities, AFS — — (35) GMIB reinsurance contracts — 849 — GMxB derivative features liability — (3,382) — Total $ — $ (2,533) $ (35) Held at September 30, 2019: Change in unrealized gains (losses): Fixed maturities, AFS: Corporate $ — $ — $ 3 State and political subdivisions — — 3 Asset-backed — — 4 Total fixed maturities, AFS — — 10 GMIB reinsurance contracts — 881 — Separate Account assets (14) — — GMxB derivative features liability — (3,656) — Total $ (14) $ (2,775) $ 10 Quantitative and Qualitative Information about Level 3 Fair Value Measurements The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities at September 30, 2020 and December 31, 2019, respectively. Quantitative Information about Level 3 Fair Value Measurements at September 30, 2020 Fair Value Valuation Technique Significant Unobservable Input Range Weighted Average (2) (in millions) Assets: Investments: Fixed maturities, AFS: Corporate $ 25 Matrix pricing Spread over Benchmark 270 - 610 bps 288 bps 1,105 Market EBITDA multiples 3.5x-31.8x 14.4x Fair Value Valuation Technique Significant Unobservable Input Range Weighted Average (2) (in millions) Other equity investments 4 Market comparable companies Revenue multiple 3.5x - 18.0x 9.5x GMIB reinsurance contract asset 3,247 Discounted cash flow Non-performance risk 60 - 125 bps 72 bps Liabilities: GMIBNLG 11,682 Discounted cash flow Non-performance risk 141.0 bps GWBL/GMWB 220 Discounted cash flow Non-performance risk 141.0 bps GIB 77 Discounted cash flow Non-performance risk 141.0 bps GMAB 6 Discounted cash flow Non-performance risk 141.0 bps ______________ (1) Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives. (2) For Lapses, Withdrawals, and Utilizations the rates were weighted by counts, for Mortality weighted average rates are shown for all ages combined and for Withdrawals the weighted averages were based on an estimated split of partial withdrawal and dollar-for-dollar withdrawals. Quantitative Information about Level 3 Fair Value Measurements at December 31, 2019 Fair Value Valuation Technique Significant Unobservable Input Range Weighted Average (in millions) Assets: Investments: Fixed maturities, AFS: Corporate $ 51 Matrix pricing model Spread over benchmark 65 - 580 bps 186 bps 1,025 Market comparable companies EBITDA multiples 3.3x - 56.7x 14.3x GMIB reinsurance contract asset 2,466 Discounted cash flow Non-performance risk 55 - 109 bps Liabilities: GMIBNLG 8,135 Discounted cash flow Non-performance risk 124 bps GWBL/GMWB 172 Discounted cash flow Non-performance risk 124 bps GIB 5 Discounted cash flow Non-performance risk 124 bps GMAB 4 Discounted cash flow Lapse rates 1.0% - 10.0% ______________ (1) Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives. Level 3 Financial Instruments for which Quantitative Inputs are Not Available Certain Privately Placed Debt Securities with Limited Trading Activity Excluded from the tables above at September 30, 2020 and December 31, 2019, respectively, are approximately $417 million and $325 million of Level 3 fair value measurements of investments for which the underlying quantitative inputs are not developed by the Company and are not readily available. These investments primarily consist of certain privately placed debt securities with limited trading activity, including residential mortgage- and asset-backed instruments, and their fair values generally reflect unadjusted prices obtained from independent valuation service providers and indicative, non-binding quotes obtained from third-party broker-dealers recognized as market participants. Significant increases or decreases in the fair value amounts received from these pricing sources may result in the Company’s reporting significantly higher or lower fair value measurements for these Level 3 investments. • The fair value of private placement securities is determined by application of a matrix pricing model or a market comparable company value technique. The significant unobservable input to the matrix pricing model valuation technique is the spread over the industry-specific benchmark yield curve. Generally, an increase or decrease in spreads would lead to directionally inverse movement in the fair value measurements of these securities. The significant unobservable input to the market comparable company valuation technique is the discount rate. Generally, a significant increase (decrease) in the discount rate would result in significantly lower (higher) fair value measurements of these securities. • Residential mortgage-backed securities classified as Level 3 primarily consist of non-agency paper with low trading activity. Included in the tables above at September 30, 2020 and December 31, 2019, there were no Level 3 securities that were determined by application of a matrix pricing model and for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Generally, a

LOANS TO AFFILIATES

LOANS TO AFFILIATES	9 Months Ended
	Sep. 30, 2020
Related Party Transactions [Abstract]
LOANS TO AFFILIATES	LOANS TO AFFILIATES Loans Issued to Holdings In April 2018, Equitable Financial made a $800 million loan to Holdings. The loan has an interest rate of 3.69% and matures in April 2021. In December 2018 and in December 2019, Holdings repaid $200 million and $300 million in principal, respectively. At September 30, 2020, the amount outstanding was $300 million. In November 2019, Equitable Financial made a $900 million loan to Holdings. The loan has an interest rate of one-month LIBOR plus 1.33%. The loan matures on November 24, 2024. At September 30, 2020, the amount outstanding was $900 million.

INCOME TAXES

INCOME TAXES	9 Months Ended
	Sep. 30, 2020
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Income tax expense for the three and nine months ended September 30, 2020 and 2019 was computed using an estimated annual effective tax rate (“ETR”), with discrete items recognized in the period in which they occur. The estimated ETR is revised, as necessary, at the end of successive interim reporting periods.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS The Company did not enter into any new significant transactions with related parties during the nine months ended September 30, 2020.

EQUITY

EQUITY	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
EQUITY	EQUITY AOCI represents cumulative gains (losses) on items that are not reflected in Net income (loss). The balances as of September 30, 2020 and 2019 follow: September 30, 2020 2019 (in millions) Unrealized gains (losses) on investments $ 4,927 $ 2,226 Defined benefit pension plans (4) (7) Accumulated other comprehensive income (loss) attributable to Equitable Financial $ 4,923 $ 2,220 The components of OCI, net of taxes for the three and nine months ended September 30, 2020 and 2019, follow: Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (in millions) Change in net unrealized gains (losses) on investments: Net unrealized gains (losses) arising during the period $ 295 $ 1,224 $ 4,524 $ 3,750 (Gains) losses reclassified into net income (loss) during the period (1) (23) (159) (205) (157) Net unrealized gains (losses) on investments 271 1,065 4,318 3,593 Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other (24) (335) (992) (872) Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of 66, $194, $884 and $718) 247 730 3,327 2,721 Other comprehensive income (loss), attributable to Equitable Financial $ 247 $ 730 $ 3,327 $ 2,721 ____________ (1) See “Reclassification adjustments” in Note 3. Reclassification amounts presented net of income tax expense (benefit) of $(6) million, $(42) million, $(55) million and $(42) million for the three and nine months ended September 30, 2020 and 2019, respectively. Investment gains and losses reclassified from AOCI to Net income (loss) primarily consist of realized gains (losses) on sales and credit losses of AFS securities and are included in Total investment gains (losses), net on the consolidated statements of income (loss). Amounts reclassified from AOCI to Net income (loss) as related to defined benefit plans

REDEEMABLE NONCONTROLLING INTER

REDEEMABLE NONCONTROLLING INTEREST	9 Months Ended
	Sep. 30, 2020
Noncontrolling Interest [Abstract]
REDEEMABLE NONCONTROLLING INTEREST	REDEEMABLE NONCONTROLLING INTEREST The changes in the components of redeemable noncontrolling interests are presented in the table that follows: Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (in millions) Balance, beginning of period $ 36 $ 42 $ 39 $ 39 Net earnings (loss) attributable to redeemable noncontrolling interests 3 — — 3 Purchase/change of redeemable noncontrolling interests (1) 4 (1) 4 Balance, end of period $ 38 $ 46 $ 38 $ 46

COMMITMENTS AND CONTINGENT LIAB

COMMITMENTS AND CONTINGENT LIABILITIES	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENT LIABILITIES	COMMITMENTS AND CONTINGENT LIABILITIES Litigation Litigation, regulatory and other loss contingencies arise in the ordinary course of the Company’s activities as a diversified financial services firm. The Company is a defendant in a number of litigation matters arising from the conduct of its business. In some of these matters, claimants seek to recover very large or indeterminate amounts, including compensatory, punitive, treble and exemplary damages. Modern pleading practice permits considerable variation in the assertion of monetary damages and other relief. Claimants are not always required to specify the monetary damages they seek, or they may be required only to state an amount sufficient to meet a court’s jurisdictional requirements. Moreover, some jurisdictions allow claimants to allege monetary damages that far exceed any reasonably possible verdict. The variability in pleading requirements and past experience demonstrates that the monetary and other relief that may be requested in a lawsuit or claim often bears little relevance to the merits or potential value of a claim. Litigation against the Company includes a variety of claims including, among other things, insurers’ sales practices, alleged agent misconduct, alleged failure to properly supervise agents, contract administration, product design, features and accompanying disclosure, cost of insurance increases, payments of death benefits and the reporting and escheatment of unclaimed property, alleged breach of fiduciary duties, alleged mismanagement of client funds and other matters. As with other financial services companies, the Company periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations in connection with inquiries and investigations of the products and practices of the Company or the financial services industry. It is the practice of the Company to cooperate fully in these matters. The outcome of a litigation or regulatory matter is difficult to predict, and the amount or range of potential losses associated with these or other loss contingencies requires significant management judgment. It is not possible to predict the ultimate outcome or to provide reasonably possible losses or ranges of losses for all pending regulatory matters, litigation and other loss contingencies. While it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company’s financial position, based on information currently known, management believes that neither the outcome of pending litigation and regulatory matters, nor potential liabilities associated with other loss contingencies, are likely to have such an effect. However, given the large and indeterminate amounts sought in certain litigation and the inherent unpredictability of all such matters, it is possible that an adverse outcome in certain of the Company’s litigation or regulatory matters, or liabilities arising from other loss contingencies, could, from time to time, have a material adverse effect upon the Company’s results of operations or cash flows in a particular quarterly or annual period. For some matters, the Company is able to estimate a possible range of loss. For such matters in which a loss is probable, an accrual has been made. For matters where the Company believes a loss is reasonably possible, but not probable, no accrual is required. For matters for which an accrual has been made, but there remains a reasonably possible range of loss in excess of the amounts accrued or for matters where no accrual is required, the Company develops an estimate of the unaccrued amounts of the reasonably possible range of losses. As of September 30, 2020, the Company estimates the aggregate range of reasonably possible losses, in excess of any amounts accrued for these matters as of such date, to be up to approximately $100 million. For other matters, the Company is currently not able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from plaintiffs and other parties, investigation of factual allegations, rulings by a court on motions or appeals, analysis by experts and the progress of settlement discussions. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation and regulatory contingencies and updates the Company’s accruals, disclosures and reasonably possible losses or ranges of loss based on such reviews. In August 2015, a lawsuit was filed in Connecticut Superior Court, Judicial Division of New Haven entitled Richard T. O’Donnell, on behalf of himself and all others similarly situated v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action on behalf of all persons who purchased variable annuities from Equitable Financial, which were subsequently subjected to the volatility management strategy and who suffered injury as a result thereof. Plaintiff asserts a claim for breach of contract alleging that Equitable Financial implemented the volatility management strategy in violation of applicable law. Plaintiff seeks an award of damages individually and on a classwide basis, and costs and disbursements, including attorneys’ fees, expert witness fees and other costs. In November 2015, the Connecticut Federal District Court transferred this action to the United States District Court for the Southern District of New York. In March 2017, the Southern District of New York granted Equitable Financial’s motion to dismiss the complaint. In April 2017, the plaintiff filed a notice of appeal. In April 2018, the United States Court of Appeals for the Second Circuit reversed the trial court’s decision with instructions to remand the case to Connecticut state court. In September 2018, the Second Circuit issued its mandate, following Equitable Financial’s notification to the court that it would not file a petition for writ of certiorari. The case was transferred in December 2018 to the Connecticut Superior Court, Judicial District of Stamford. In December 2018, Equitable Financial sought dismissal of the complaint by filing a motion to strike, which the court granted in August 2019. Plaintiff filed an Amended Class Action Complaint in September 2019. Equitable Financial filed a motion for entry of judgment in October 2019. On August 3, 2020, the court granted Equitable Financial’s motion for entry of judgment. In August 2020, Plaintiff filed a notice of appeal. We are vigorously defending this matter. In February 2016, a lawsuit was filed in the United States District Court for the Southern District of New York entitled Brach Family Foundation, Inc. v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action brought on behalf of all owners of universal life (“UL”) policies subject to Equitable Financial’s COI rate increase. In early 2016, Equitable Financial raised COI rates for certain UL policies issued between 2004 and 2007, which had both issue ages 70 and above and a current face value amount of $1 million and above. A second putative class action was filed in Arizona in 2017 and consolidated with the Brach matter. The current consolidated amended class action complaint alleges the following claims: breach of contract; misrepresentations by Equitable Financial in violation of Section 4226 of the New York Insurance Law; violations of New York General Business Law Section 349; and violations of the California Unfair Competition Law, and the California Elder Abuse Statute. Plaintiffs seek; (a) compensatory damages, costs, and, pre- and post-judgment interest; (b) with respect to their claim concerning Section 4226, a penalty in the amount of premiums paid by the plaintiffs and the putative class; and (c) injunctive relief and attorneys’ fees in connection with their statutory claims. In August 2020, the federal district court issued a decision granting in part Brach Plaintiffs’ motion for class certification. The court certified nationwide breach of contract and Section 4226 classes, and a New York State Section 349 class, and class notice has gone out. Equitable Financial filed a petition seeking permission to appeal the decision to certify the Section 4226 class and New York State Section 349 class. Five other federal actions challenging the COI rate increase are also pending against Equitable Financial and have been coordinated with the Brach action for the purposes of pre-trial activities. They contain allegations similar to those in the Brach action as well as additional allegations for violations of various states’ consumer protection statutes and common law fraud. Three actions are also pending against Equitable Financial in New York state court. Equitable Financial is vigorously defending each of these matters. Obligations under Funding Agreements Federal Home Loan Bank of New York As a member of the FHLB, Equitable Financial has access to collateralized borrowings. It also may issue funding agreements to the FHLBNY. Both the collateralized borrowings and funding agreements would require Equitable Financial to pledge qualified mortgage-backed assets and/or government securities as collateral. Equitable Financial issues short-term funding agreements to the FHLBNY and uses the funds for asset, liability, and cash management purposes. Equitable Financial issues long-term funding agreements to the FHLBNY and uses the funds for spread lending purposes. Entering into FHLB membership, borrowings and funding agreements requires the ownership of FHLB stock and the pledge of assets as collateral. Equitable Financial has purchased FHLB stock of $320 million and pledged collateral with a carrying value of $8.7 billion as of September 30, 2020. Funding agreements are reported in Policyholders’ account balances in the consolidated balance sheets. For other instruments used for asset/liability and cash management purposes, see “Derivative and offsetting assets and liabilities” included in Note 4. The table below summarizes the Company’s activity of funding agreements with the FHLB. Change in FHLB Funding Agreements during the Nine Months Ended September 30, 2020 Outstanding Balance at December 31, 2019 Issued During the Period Repaid During the Period Long-term Agreements Maturing Within One Year Long-term Agreements Maturing Within Five Years Outstanding Balance at September 30, 2020 (in millions) Short-term funding agreements: Due in one year or less $ 4,608 $ 34,298 $ 34,358 $ 490 $ — $ 5,038 Long-term funding agreements: Due in years two through five 1,646 — — (490) 112 1,268 Due in more than five years 646 — — — (112) 534 Total long-term funding agreements 2,292 — — (490) — 1,802 Total funding agreements (1) $ 6,900 $ 34,298 $ 34,358 $ — $ — $ 6,840 ____________ (1) The $8 million and $9 million difference between the funding agreements carrying value shown in fair value table for September 30, 2020 and December 31, 2019, respectively, reflects the remaining amortization of a hedge implemented and closed, which locked in the funding agreements borrowing rates. Funding Agreement-Backed Notes Program Under the FABN, Equitable Financial may issue funding agreements to a Delaware special purpose statutory trust (the “Trust”) in exchange for the proceeds from issuances of fixed and floating rate medium-term marketable notes issued by the Trust from time to time (the “Trust notes”). The funding agreements have matching interest and maturity payment terms to the applicable Trust notes. The maximum aggregate principal amount of Trust notes permitted to be outstanding at any one time is $5 billion. Funding agreements issued to the Trust are reported in policyholders’ account balances in the consolidated balance sheets. The table below summarizes the Company’s activity of funding agreements under the FABN. Change in FABN Funding Agreements during the Nine Months Ended September 30, 2020 Outstanding Balance at December 31, 2019 Issued During the Period Repaid During the Period Long-term Agreements Maturing Within One Year Long-term Agreements Maturing Within Five Years Outstanding Balance at September 30, 2020 (in millions) Short-term funding agreements: Due in one year or less — $ — $ — $ — $ — $ — Long-term funding agreements: Due in years two through five — 650 — — — 650 Due in more than five years — 500 — — — 500 Total long-term funding agreements — 1,150 — — — 1,150 Total funding agreements (1) $ — $ 1,150 $ — $ — $ — $ 1,150 _____________ (1) The $7 million difference between the funding agreements notional value shown and carrying value table at September 30, 2020, reflects the remaining amortization of the issuance cost of the funding agreements. Guarantees and Other Commitments The Company provides certain guarantees or commitments to affiliates and others. At September 30, 2020, these arrangements include commitments by the Company to provide equity financing of $1.2 billion (including $248 million with affiliates) to certain limited partnerships and real estate joint ventures under certain conditions. Management believes the Company will not incur material losses as a result of these commitments. The Company is the obligor under certain structured settlement agreements it had entered into with unaffiliated insurance companies and beneficiaries. To satisfy its obligations under these agreements, the Company owns single premium annuities issued by previously wholly-owned life insurance subsidiaries. The Company has directed payment under these annuities to be made directly to the beneficiaries under the structured settlement agreements. A contingent liability exists with respect to these agreements should the previously wholly-owned subsidiaries be unable to meet their obligations. Management believes the need for the Company to satisfy those obligations is remote. The Company had $17 million of undrawn letters of credit related to reinsurance at September 30, 2020. The Company had $469 million of commitments under existing mortgage loan agreements at September 30, 2020. Pursuant to certain assumption agreements (the “Assumption Agreements”), AXA Financial legally assumed primary liability from Equitable Financial for all current and future liabilities of Equitable Financial under certain employee benefit plans that provide participants with medical, life insurance and deferred compensation benefits as well as under the AXA Equitable Retirement plan, a frozen qualified pension plan. Equitable Financial remains secondarily liable for its obligations under these plans and would recognize such liabilities in the event AXA Financial does not perform under the terms of the Assumption Agreements. On October 1, 2018, AXA Financial merged with and into its direct parent, Holdings, with Holdings continuing as the surviving entity.

REVISION OF PRIOR PERIOD FINANC

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS	9 Months Ended
	Sep. 30, 2020
Accounting Changes and Error Corrections [Abstract]
REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS	REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS The Company identified certain errors primarily related to the calculations of actuarially determined insurance contract assets and liabilities that impacted previously issued consolidated financial statements. Management evaluated these adjustments and concluded they were not material to any previously reported quarterly or annual financial statements. In order to improve the consistency and comparability of the financial statements, management revised the financial statements and related disclosures to correct these errors as shown below. Management assessed the materiality of this change within prior period financial statements based upon SEC Staff Accounting Bulletin Number 99, Materiality, which is since codified in Accounting Standards Codification ("ASC") 250, Accounting Changes and Error Corrections. The prior period comparative financial statements that are presented herein have been revised. The following tables present line items for prior period financial statements that have been affected by the revision. For these line items, the tables detail the amounts as previously reported, the impact upon those line items due to the revision, and the amounts as currently revised within the financial statements. June 30, 2020 March 31, 2020 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Balance Sheets: ASSETS Other invested assets 1,962 — 1,962 1,595 12 1,607 Deferred policy acquisition costs 3,746 (70) 3,676 4,068 (85) 3,983 Total Assets $ 232,378 $ (70) $ 232,308 $ 218,841 $ (73) $ 218,768 LIABILITIES Future policy benefits and other policyholders’ liabilities 41,382 29 41,411 37,830 32 37,862 Current and deferred income taxes 1,020 (21) 999 1,637 (22) 1,615 Total Liabilities $ 217,176 $ 8 $ 217,184 $ 199,928 $ 10 $ 199,938 EQUITY Retained earnings 2,658 (78) 2,580 7,953 (83) 7,870 Total equity attributable to Equitable Financial 15,157 (78) 15,079 18,872 (83) 18,789 Total Equity 15,166 (78) 15,088 18,881 (83) 18,798 Total Liabilities, Redeemable Noncontrolling interest and Equity 232,378 (70) 232,308 $ 218,841 $ (73) $ 218,768 December 31, 2019 December 31, 2018 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Balance Sheets: ASSETS Investments: Deferred policy acquisition costs 4,337 (115) 4,222 5,011 (52) 4,959 Amounts due from reinsurers 3,001 1 3,002 3,124 — 3,124 GMIB reinsurance contract asset, at fair value 2,466 — 2,466 1,991 1 1,992 Current and deferred income taxes 224 25 249 438 35 473 Other assets 3,050 — 3,050 2,763 22 2,785 Total Assets $ 228,041 $ (89) $ 227,952 $ 199,952 $ 6 $ 199,958 LIABILITIES Future policy benefits and other policyholders’ liabilities 33,976 3 33,979 29,808 75 29,883 Other liabilities 1,768 1 1,769 1,460 — 1,460 Total Liabilities $ 216,344 $ 4 $ 216,348 $ 187,485 $ 75 $ 187,560 EQUITY Retained earnings 2,242 (97) 2,145 5,098 (59) 5,039 Accumulated other comprehensive income (loss) 1,592 4 1,596 (491) (10) (501) Total equity attributable to Equitable Financial 11,645 (93) 11,552 12,416 (69) 12,347 Total Equity 11,658 (93) 11,565 12,428 (69) 12,359 Total Liabilities, Redeemable Noncontrolling interest and Equity $ 228,041 $ (89) $ 227,952 $ 199,952 $ 6 $ 199,958 Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Income (Loss) REVENUES Policy charges and fee income $ 825 $ (1) $ 824 $ 1,729 $ — $ 1,729 Net derivative gains (losses) (5,903) (5) (5,908) 3,630 (6) 3,624 Net investment income (loss) 934 (13) 921 1,525 — 1,525 Other income 8 2 10 25 — 25 Total revenues (3,557) (17) (3,574) 8,031 (6) 8,025 BENEFITS AND OTHER DEDUCTIONS Policyholders' benefits 700 (9) 691 3,297 20 3,317 Amortization of deferred policy acquisition costs 164 (15) 149 1,222 (51) 1,171 Other operating costs and expenses 218 — 218 431 1 432 Total benefits and deductions 1,563 (24) 1,539 5,961 (30) 5,931 Income (loss) from continuing operations, before income taxes (5,120) 7 (5,113) 2,070 24 2,094 Income tax (expense) benefit from continuing operations 1,029 (2) 1,027 (425) (5) (430) Net income (loss) (4,091) 5 (4,086) 1,645 19 1,664 Net income (loss) attributable to Equitable Financial $ (4,095) $ 5 $ (4,090) $ 1,648 $ 19 $ 1,667 Three Months Ended March 31, 2020 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Income (Loss) REVENUES: Policy charges and fee income 904 1 905 Net derivative gains (losses) 9,533 (1) 9,532 Net investment income (loss) 591 13 604 Other income 17 (2) 15 Total revenues 11,588 11 11,599 BENEFITS AND OTHER DEDUCTIONS Policyholders' benefits 2,597 29 2,626 Interest credited to policyholders’ account balances 289 — 289 Amortization of deferred policy acquisition costs 1,058 (36) 1,022 Other operating costs and expenses 213 1 214 Total benefits and deductions 4,398 (6) 4,392 Income (loss) from continuing operations, before income taxes 7,190 17 7,207 Income tax (expense) benefit from continuing operations (1,454) (3) (1,457) Net income (loss) 5,736 14 5,750 Net income (loss) attributable to Equitable Financial $ 5,743 $ 14 $ 5,757 Year Ended December 31, 2019 Year Ended December 31, 2018 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Income (Loss) REVENUES Policy charges and fee income $ 3,450 $ 37 $ 3,487 $ 3,523 $ (8) $ 3,515 Net derivative gains (losses) (3,820) (11) (3,831) (1,010) (24) (1,034) Other income 56 — 56 65 (1) 64 Total revenues 5,148 26 5,174 6,951 (33) 6,918 BENEFITS AND OTHER DEDUCTIONS Policyholders' benefits 4,119 (31) 4,088 3,005 (45) 2,960 Interest credited to policyholders’ account balances 1,127 22 1,149 1,002 (23) 979 Commissions 629 — 629 620 5 625 Amortization of deferred policy acquisition costs 452 68 520 431 20 451 Other operating costs and expenses 912 — 912 2,918 1 2,919 Total benefits and deductions 7,578 59 7,637 8,432 (42) 8,390 Income (loss) from continuing operations, before income taxes (2,430) (33) (2,463) (1,481) 9 (1,472) Income tax (expense) benefit from continuing operations 584 (5) 579 446 10 456 Net income (loss) (1,846) (38) (1,884) (921) 19 (902) Net income (loss) attributable to Equitable Financial $ (1,851) $ (38) $ (1,889) $ (918) $ 19 $ (899) Three Months Ended September 30, 2019 Nine Months Ended September 30, 2019 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Income (Loss) REVENUES Policy charges and fee income $ 853 $ 46 $ 899 $ 2,577 $ 42 $ 2,619 Net derivative gains (losses) (342) (1) (343) (2,075) (5) (2,080) Other income — (1) (1) 40 (1) 39 Total revenues 1,946 44 1,990 4,707 36 4,743 BENEFITS AND OTHER DEDUCTIONS Policyholders' benefits 1,634 8 1,642 3,321 35 3,356 Interest credited to policyholders’ account balances 280 16 296 837 22 859 Amortization of deferred policy acquisition costs 32 22 54 341 4 345 Total benefits and deductions 2,383 46 2,429 5,816 61 5,877 Income (loss) from continuing operations, before income taxes (437) (2) (439) (1,109) (25) (1,134) Income tax (expense) benefit from continuing operations 175 — 175 284 5 289 Net income (loss) (262) (2) (264) (825) (20) (845) Net income (loss) attributable to Equitable Financial $ (262) $ (2) $ (264) $ (828) $ (20) $ (848) Three Months Ended June 30, 2019 Six Months Ended June 30, 2019 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Income (Loss) REVENUES Policy charges and fee income $ 865 $ (2) $ 863 $ 1,724 $ (4) $ 1,720 Net derivative gains (losses) (178) (1) (179) (1,733) (4) (1,737) Total revenues 2,071 (3) 2,068 2,761 (8) 2,753 BENEFITS AND OTHER DEDUCTIONS Policyholders' benefits 868 (7) 861 1,687 27 1,714 Interest credited to policyholders’ account balances 288 3 291 557 6 563 Amortization of deferred policy acquisition costs 144 (2) 142 309 (18) 291 Total benefits and deductions 1,753 (6) 1,747 3,433 15 3,448 Income (loss) from continuing operations, before income taxes 318 3 321 (672) (23) (695) Income tax (expense) benefit from continuing operations (53) — (53) 109 5 114 Net income (loss) 265 3 268 (563) (18) (581) Net income (loss) attributable to Equitable Financial $ 264 $ 3 $ 267 $ (566) $ (18) $ (584) Three Months Ended March 31, 2019 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Income (Loss) REVENUES: Policy charges and fee income 859 (2) 857 Net derivative gains (losses) (1,555) (3) (1,558) Net investment income (loss) 904 — 904 Other income 10 — 10 Total revenues 690 (5) 685 BENEFITS AND OTHER DEDUCTIONS Policyholders' benefits 819 34 853 Interest credited to policyholders’ account balances 269 3 272 Amortization of deferred policy acquisition costs 165 (16) 149 Other operating costs and expenses 184 — 184 Total benefits and deductions 1,680 21 1,701 Income (loss) from continuing operations, before income taxes (990) (26) (1,016) Income tax (expense) benefit from continuing operations 162 5 167 Net income (loss) (828) (21) (849) Net income (loss) attributable to Equitable Financial $ (830) $ (21) $ (851) Year Ended December 31, 2017 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Income (Loss) REVENUES: Policy charges and fee income 3,294 (5) 3,289 Net derivative gains (losses) 894 (16) 878 Total revenues 8,456 (21) 8,435 BENEFITS AND OTHER DEDUCTIONS Policyholders' benefits 3,473 8 3,481 Commissions 628 7 635 Amortization of deferred policy acquisition costs 900 25 925 Total benefits and deductions 6,907 40 6,947 Income (loss) from continuing operations, before income taxes 1,549 (61) 1,488 Income tax (expense) benefit from continuing operations 1,210 8 1,218 Net income (loss) from continuing operations 2,759 (53) 2,706 Net income (loss) 2,844 (53) 2,791 Net income (loss) attributable to Equitable Financial $ 2,843 $ (53) $ 2,790 Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Comprehensive Income (Loss) Net income (loss) $ (4,091) $ 5 $ (4,086) $ 1,645 $ 19 $ 1,664 Change in unrealized gains (losses), net of reclassification adjustment 1,569 — 1,569 3,083 (4) 3,079 Other comprehensive income 1,570 — 1,570 3,084 (4) 3,080 Comprehensive income (loss) (2,521) 5 (2,516) 4,729 15 4,744 Less: Comprehensive income (loss) attributable to noncontrolling interest (3) 7 4 (3) — (3) Comprehensive income (loss) attributable to Equitable Financial $ (2,518) $ (2) $ (2,520) $ 4,732 $ 15 $ 4,747 Three Months Ended March 31, 2020 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Comprehensive Income (Loss) Net income (loss) $ 5,736 $ 14 $ 5,750 Change in unrealized gains (losses), net of reclassification adjustment 1,514 (4) 1,510 Other comprehensive income 1,514 (4) 1,510 Comprehensive income (loss) 7,250 10 7,260 Comprehensive income (loss) attributable to Equitable Financial $ 7,257 $ 10 $ 7,267 Year Ended December 31, 2019 Year Ended December 31, 2018 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Comprehensive Income (Loss) Net income (loss) $ (1,846) $ (38) $ (1,884) $ (921) $ 19 $ (902) Change in unrealized gains (losses), net of reclassification adjustment 2,081 14 2,095 (1,230) 9 (1,221) Other comprehensive income 2,083 14 2,097 (1,234) 9 (1,225) Comprehensive income (loss) 237 (24) 213 (2,155) 28 (2,127) Less: Comprehensive income (loss) attributable to noncontrolling interest — 5 5 — (3) (3) Comprehensive income (loss) attributable to Equitable Financial $ 237 $ (29) $ 208 $ (2,155) $ 31 $ (2,124) Three Months Ended September 30, 2019 Nine Months Ended September 30, 2019 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Comprehensive Income (Loss) Net income (loss) $ (262) $ (2) $ (264) $ (825) $ (20) $ (845) Change in unrealized gains (losses), net of reclassification adjustment 574 156 730 2,629 92 2,721 Other comprehensive income 574 156 730 2,629 92 2,721 Comprehensive income (loss) 312 154 466 1,804 72 1,876 Less: Comprehensive income (loss) attributable to noncontrolling interest — — — — 3 3 Comprehensive income (loss) attributable to Equitable Financial $ 312 $ 154 $ 466 $ 1,804 $ 69 $ 1,873 Three Months Ended June 30, 2019 Six Months Ended June 30, 2019 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Comprehensive Income (Loss) Net income (loss) $ 265 $ 3 $ 268 $ (563) $ (18) $ (581) Change in unrealized gains (losses), net of reclassification adjustment 1,291 (65) 1,226 2,055 (64) 1,991 Other comprehensive income 1,291 (65) 1,226 2,055 (64) 1,991 Comprehensive income (loss) 1,556 (62) 1,494 1,492 (82) 1,410 Less: Comprehensive income (loss) attributable to noncontrolling interest — 1 1 — 3 3 Comprehensive income (loss) attributable to Equitable Financial $ 1,556 $ (63) $ 1,493 $ 1,492 $ (85) $ 1,407 Three Months Ended March 31, 2019 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Comprehensive Income (Loss) Net income (loss) $ (828) $ (21) $ (849) Change in unrealized gains (losses), net of reclassification adjustment 764 1 765 Other comprehensive income 764 1 765 Comprehensive income (loss) (64) (20) (84) Less: Comprehensive income (loss) attributable to noncontrolling interest — 2 2 Comprehensive income (loss) attributable to Equitable Financial $ (64) $ (22) $ (86) Year Ended December 31, 2017 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Comprehensive Income: Net income (loss) $ 2,844 $ (53) $ 2,791 Change in unrealized gains (losses), net of reclassification adjustment 584 (20) 564 Other comprehensive income 602 (20) 582 Comprehensive income (loss) 3,446 (73) 3,373 Less: Comprehensive income (loss) attributable to noncontrolling interest — 1 1 Comprehensive income (loss) attributable to Equitable Financial $ 3,446 $ (74) $ 3,372 Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Equity: Retained earnings, beginning of year $ 7,953 $ (83) $ 7,870 $ 2,242 $ (97) $ 2,145 Net income (loss) attributable to Equitable Financial (4,095) 5 (4,090) 1,648 19 1,667 Retained earnings, end of period $ 2,658 $ (78) $ 2,580 $ 2,658 $ (78) $ 2,580 Accumulated other comprehensive income (loss), beginning of year $ 3,106 $ — $ 3,106 $ 1,592 $ 4 $ 1,596 Other comprehensive income (loss) 1,570 — 1,570 3,084 (4) 3,080 Total Equitable Financial equity, end of period $ 15,157 $ (78) $ 15,079 $ 15,157 $ (78) $ 15,079 Total equity, end of period $ 15,166 $ (78) $ 15,088 $ 15,166 $ (78) $ 15,088 Three Months Ended March 31, 2020 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Equity: Retained earnings, beginning of year $ 2,242 $ (97) $ 2,145 Net income (loss) attributable to Equitable Financial 5,743 $ 14 5,757 Retained earnings, end of period $ 7,953 $ (83) $ 7,870 Accumulated other comprehensive income (loss), beginning of year $ 1,592 $ 4 $ 1,596 Other comprehensive income (loss) 1,514 (4) 1,510 Total Equitable Financial equity, end of period $ 18,872 $ (83) $ 18,789 Total equity, end of period $ 18,881 $ (83) $ 18,798 Year Ended December 31, 2019 Year Ended December 31, 2018 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Equity: Retained earnings, beginning of year $ 5,098 $ (59) $ 5,039 $ 8,938 $ (78) $ 8,860 Net income (loss) attributable to Equitable Financial (1,851) (38) (1,889) (918) 19 (899) Retained earnings, end of year $ 2,242 $ (97) $ 2,145 $ 5,098 $ (59) $ 5,039 Accumulated other comprehensive income (loss), beginning of year $ (491) $ (10) $ (501) $ 598 $ (19) $ 579 Other comprehensive income (loss) 2,083 14 2,097 (1,234) 9 (1,225) Accumulated other comprehensive income (loss), end of year $ 1,592 $ 4 $ 1,596 $ (491) $ (10) $ (501) Total Equitable Financial equity, end of year $ 11,645 $ (93) $ 11,552 $ 12,416 $ (69) $ 12,347 Total equity, end of year $ 11,658 $ (93) $ 11,565 $ 12,428 $ (69) $ 12,359 Three Months Ended September 30, 2019 Nine Months Ended September 30, 2019 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Equity: Retained earnings, beginning of year $ 4,532 $ (77) $ 4,455 $ 5,098 $ (59) $ 5,039 Net income (loss) attributable to Equitable Financial (262) (2) (264) (828) (20) (848) Retained earnings, end of period $ 3,270 $ (79) $ 3,191 $ 3,270 $ (79) $ 3,191 Accumulated other comprehensive income (loss), beginning of year $ 1,564 $ (74) $ 1,490 $ (491) $ (10) $ (501) Other comprehensive income (loss) 574 156 730 2,629 92 2,721 Accumulated other comprehensive income (loss), end of period $ 2,138 $ 82 $ 2,220 $ 2,138 $ 82 $ 2,220 Total Equitable Financial equity, end of period $ 13,239 $ 3 $ 13,242 $ 13,239 $ 3 $ 13,242 Total equity, end of period $ 13,251 $ 3 $ 13,254 $ 13,251 $ 3 $ 13,254 Three Months Ended June 30, 2019 Six Months Ended June 30, 2019 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Equity: Retained earnings, beginning of year $ 4,268 $ (80) $ 4,188 $ 5,098 $ (59) $ 5,039 Net income (loss) attributable to Equitable Financial 264 3 267 (566) (18) (584) Retained earnings, end of period $ 4,532 $ (77) $ 4,455 $ 4,532 $ (77) $ 4,455 Accumulated other comprehensive income (loss), beginning of year $ 273 $ (9) $ 264 $ (491) $ (10) $ (501) Other comprehensive income (loss) 1,291 (65) 1,226 2,055 (64) 1,991 Accumulated other comprehensive income (loss), end of period $ 1,564 $ (74) $ 1,490 $ 1,564 $ (74) $ 1,490 Total Equitable Financial equity, end of period $ 13,920 $ (151) $ 13,769 $ 13,920 $ (151) $ 13,769 Total equity, end of period $ 13,932 $ (151) $ 13,781 $ 13,932 $ (151) $ 13,781 Three Months Ended March 31, 2019 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Equity: Retained earnings, beginning of year $ 5,098 $ (59) $ 5,039 Net income (loss) attributable to Equitable Financial (830) $ (21) (851) Retained earnings, end of period $ 4,268 $ (80) $ 4,188 Accumulated other comprehensive income (loss), beginning of year $ (491) $ (10) $ (501) Other comprehensive income (loss) 764 1 765 Accumulated other comprehensive income (loss), end of period $ 273 $ (9) $ 264 Total Equitable Financial equity, end of period $ 12,358 $ (89) $ 12,269 Total equity, end of period $ 12,370 $ (89) $ 12,281 Year Ended December 31, 2017 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Equity: Retained earnings, beginning of year $ 6,095 $ (25) $ 6,070 Net income (loss) attributable to Equitable Financial 2,843 $ (53) 2,790 Retained earnings, end of period $ 8,938 $ (78) $ 8,860 Accumulated other comprehensive income (loss), beginning of year $ (4) $ 1 $ (3) Other comprehensive income (loss) 602 (20) 582 Accumulated other comprehensive income (loss), end of period $ 598 $ (19) $ 579 Total Equitable Financial equity, end of period $ 16,397 $ (97) $ 16,300 Total equity, end of period $ 19,492 $ (97) $ 19,395 June 30, 2020 March 31, 2020 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Cash Flows: Cash flow from operating activities: Net income (loss) $ 1,645 $ 19 $ 1,664 $ 5,736 $ 14 $ 5,750 Policy charges and fee income (1,729) — (1,729) (904) (1) (905) Net derivative (gains) losses (3,630) 6 (3,624) (9,533) 1 (9,532) Amortization and depreciation 1,181 (51) 1,130 1,025 (35) 990 Future policy benefits 1,666 20 1,686 1,817 29 1,846 Reinsurance recoverable (149) — (149) (97) 1 (96) Current and deferred income taxes 433 6 439 1,462 3 1,465 Net cash provided by (used in) operating activities $ (868) $ — $ (868) $ (621) $ 12 $ (609) Change in collateralized pledged assets 58 — 58 45 (1) 44 Change in collateralized pledged liabilities 247 — 247 667 (11) 656 Net cash provided by (used in) financing activities $ 2,308 $ — $ 2,308 $ 2,504 $ (12) $ 2,492 Cash and cash equivalents, end of period $ 4,318 $ — $ 4,318 $ 7,492 $ — $ 7,492 December 31, 2019 December 31, 2018 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Cash Flows: Cash flow from operating activities: Net income (loss) (1) $ (1,846) $ (38) $ (1,884) $ (358) $ 19 $ (339) Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities: Policy charges and fee income (3,450) (37) (3,487) (3,523) 8 (3,515) Interest credited to policyholders' account balances 1,127 22 1,149 1,002 (23) 979 Net derivative (gains) losses 3,820 11 3,831 1,010 24 1,034 Amortization and depreciation 323 68 391 340 20 360 Capitalization of DAC (648) — (648) (597) 5 (592) Future policy benefits 1,115 (31) 1,084 (284) (46) (330) Current and deferred income taxes (334) 5 (329) (556) (7) (563) Net cash provided by (used in) operating activities $ (606) $ — $ (606) $ 1,418 $ — $ 1,418 Cash and cash equivalents, end of period $ 1,492 $ — $ 1,492 $ 2,622 $ — $ 2,622 _____________ (1) December 31, 2018 Net Income (Loss) includes $563 million of discontinued operations that are not included in Net Income (Loss) in the Consolidated Statement of Income (Loss). September 30, 2019 June 30, 2019 As Previously Impact of Revisions As Revised As Previously Reported Impact of Revisions As Revised (in millions) Consolidated Statements of Cash Flows: Cash flow from operating activities: Net income (loss) $ (825) $ (20) $ (845) $ (563) $ (18) $ (581) Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities: Policy charges and fee income (2,577) (42) (2,619) (1,724) 4 (1,720) Interest credited to policyholders' account balances 837 22 859 557 6 563 Net derivative (gains) losses 2,075 5 2,080 1,733 4 1,737 Amortization and depreciation 267 4 271 268 (18) 250 Future policy benefits 1,035 40 1,075 91 27 118 Reinsurance recoverable (123) (4) (127) (59) — (59) Current and deferred income taxes (81) (5) (86) 99 (5) 94 Net cash provided by (used in) operating activities $ (712) $ — $ (712) $ (283) $ — $ (283) Cash and cash equivalents, end of period $ 1,553 $ — $ 1,553 $ 3,093 $ — $ 3,093 March 31, 2019 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Cash Flows: Cash flow from operating activities: Net income (loss) $ (828) $ (21) $ (849) Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities: Policy charges and fee income (859) 2 (857) Interest credited to policyholders' account balances 269 3 272 Net derivative (gains) losses 1,555 3 1,558 Amortization and depreciation 143 (16) 127 Future policy benefits 41 34 75 Current and deferred income taxes 54 (5) 49 Net cash provided by (used in) operating activities $ (148) $ — $ (148) Cash and cash equivalents, end of period 2,922 — 2,922 December 31, 2017 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Cash Flows: Cash flow from operating activities: Net income (loss) (1) $ 3,377 $ (54) $ 3,323 Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities: Policy charges and fee income (3,294) 5 (3,289) Net derivative (gains) losses (870) 16 (854) Amortization and depreciation 825 25 850 Future policy benefits 1,189 8 1,197 Net cash provided by (used in) operating activities $ (381) $ — $ (381) Cash and cash equivalents, end of period 3,409 — 3,409 _____________ (1) Net Income (Loss) includes $533 million of discontinued operations that are not included in Net Income (Loss) in the Consolidated Statement of Income (Loss).

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS On October 27, 2020, Holdings entered into a Master Transaction Agreement with Venerable Insurance and Annuity Company (“VIAC”), and Venerable Holdings, Inc., a Delaware corporation. VIAC will acquire all of the shares of the capital stock of Corporate Solutions Life Reinsurance Company (“CSLRC”), and, immediately following such sale, Equitable Financial will enter into a coinsurance and modified coinsurance agreement, pursuant to which Equitable Financial will cede to CSLRC, on a combined coinsurance and modified coinsurance basis, legacy variable annuity policies sold by Equitable Financial between 2006-2008 supported by general account assets of approximately $12 billion (the “Block”), comprised of non-New York “Accumulator” policies containing fixed rate Guaranteed Minimum Income Benefit and/or Guaranteed Minimum Death Benefit guarantees. Equitable Financial will reinsure the separate accounts relating to the Block on a modified coinsurance basis. Equitable Financial will also acquire a surplus note in aggregate principal amount of $50 million issued by VIAC in the transaction.

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The unaudited interim consolidated financial statements (the “consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP” or “GAAP”) on a basis consistent with reporting interim financial information in accordance with instructions to the Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments necessary for a fair statement of the financial position and results of operations have been made. All such adjustments are of a normal, recurring nature, with the exception of the Company’s update of its interest rate assumption and adoption of new economic scenario generator as further described below in Assumption Updates and Model Changes. Interim results are not necessarily indicative of the results that may be expected for the full year. These financial statements should be read in conjunction with the Company’s consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. The accompanying unaudited consolidated financial statements present the consolidated results of operations, financial condition and cash flows of the Company and its subsidiaries and those investment companies, partnerships and joint ventures in which the Company has control and a majority economic interest as well as those variable interest entities (“VIEs”) that meet the requirements for consolidation. All significant intercompany transactions and balances have been eliminated in consolidation. The terms “third quarter 2020” and “third quarter 2019” refer to the three months ended September 30, 2020 and 2019, respectively. The terms “first nine months of 2020” and “first nine months of 2019” refer to the nine months ended September 30, 2020 and 2019, respectively.
Adoption of New Accounting Pronouncements and Future Adoption of New Accounting Pronouncements	Adoption of New Accounting Pronouncements Description Effect on the Financial Statement or Other Significant Matters ASU 2016-13: Financial Instruments—Credit Losses (Topic 326), as clarified and amended by ASU 2018-19: Codification Improvements to Topic 326, Financial Instruments—Credit Losses, ASU 2019-04: Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments and ASU 2019-05: Financial Instruments—Credit Losses (Topic 326) Targeted Transition Relief, ASU 2019-11: Codification Improvements to Topic 326, Financial Instruments-Credit Losses ASU 2016-13 contains new guidance which introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. On January 1, 2020, the Company adopted the new standard and completed implementation of its updated current expected credit losses (“CECL”) models, processes and controls related to the identified financial assets that fall within the scope of the new standard. Upon adoption, the Company recorded a cumulative effect adjustment to reduce the opening retained earnings balance by approximately $40 million, on a pre-tax and pre-DAC basis. The adjustment is primarily attributable to an increase in the allowance for credit losses associated with the Company’s commercial and agricultural mortgage loan portfolios and reinsurance. ASU 2018-13 : Fair Value Measurement (Topic 820) This ASU improves the effectiveness of fair value disclosures in the notes to financial statements. Amendments in this ASU impact the disclosure requirements in Topic 820, including the removal, modification and addition to existing disclosure requirements. The Company elected to early adopt during 2019 the removal of disclosures relating to transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels and valuation processes for Level 3 fair value measurements. The Company adopted the additional disclosures related to Level 3 fair value information on January 1, 2020. ASU 2018-17: Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities This ASU provides guidance requiring that indirect interests held through related parties in common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. The Company adopted this new standard effective for January 1, 2020. Adoption of this standard did not materially impact the Company’s financial position or results of operations. Future Adoption of New Accounting Pronouncements Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-12 : Financial Services - Insurance (Topic 944); ASU 2019-09: Financial Services - Insurance (Topic 944): Effective Date This ASU provides targeted improvements to existing recognition, measurement, presentation, and disclosure requirements for long-duration contracts issued by an insurance entity. The ASU primarily impacts four key areas, including: In November 2019, ASU 2019-09 was issued which modified ASU 2018-12 to be effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021. Early adoption is permitted. On September 30, 2020, the FASB tentatively affirmed its decision to defer the effective date of the amendments in ASU 2018-12, for all insurance entities by one year. Early adoption would still be allowed. The Company is currently evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements, however the adoption of the ASU is expected to have a significant impact on the Company’s consolidated financial condition, results of operations, cash flows and required disclosures, as well as processes and controls. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters 2. Measurement of market risk benefits (“MRBs”). MRBs, as defined under the ASU, will encompass certain variable annuity guaranteed benefit (“GMxB”) features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in Other comprehensive income (“OCI”). For MRBs, the ASU should be applied retrospectively as of the beginning of the earliest period presented. ASU 2019-12: Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740, as well as clarifying and amending existing guidance. Effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the impact adopting the guidance will have on the Company’s consolidated financial statements, however the adoption is not expected to materially impact the Company’s financial position, results of operation, or cash flows. ASU2020-04: Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting The amendments in this ASU provide optional expedients and exceptions to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This ASU is effective as of March 12, 2020 through December 31, 2022. The Company will determine the applicability of the optional expedients and exceptions provided under the ASU as reference rate reform continues to develop.
Investments	Investments The carrying values of fixed maturities classified as available-for-sale (“AFS”) are reported at fair value. Changes in fair value are reported in OCI, net of allowance for credit losses, policy related amounts and deferred income taxes. With the adoption of the new Financial Instruments-Credit Losses standard, changes in credit losses are recognized in Investment gains (losses), net. The redeemable preferred stock investments that are reported in fixed maturities include real estate investment trusts (“REIT”), perpetual preferred stock and redeemable preferred stock. These securities may not have a stated maturity, may not be cumulative, and do not provide for mandatory redemption by the issuer. The Company determines the fair values of fixed maturities and equity securities based upon quoted prices in active markets, when available, or through the use of alternative approaches when market quotes are not readily accessible or available. These alternative approaches include matrix or model pricing and use of independent pricing services, each supported by reference to principal market trades or other observable market assumptions for similar securities. More specifically, the matrix pricing approach to fair value is a discounted cash flow methodology that incorporates market interest rates commensurate with the credit quality and duration of the investment. The Company’s management, with the assistance of its investment advisors, evaluates AFS debt securities that experienced a decline in fair value below amortized cost for credit losses which are evaluated in accordance with the new financial instruments credit losses guidance effective January 1, 2020. Integral to this review is an assessment made each quarter, on a security-by-security basis, by the Company’s Investments Under Surveillance (“IUS”) Committee, of various indicators of credit deterioration to determine whether the investment security has experienced a credit loss. This assessment includes, but is not limited to, consideration of the severity of the unrealized loss, failure, if any, of the issuer of the security to make scheduled payments, actions taken by rating agencies, adverse conditions specifically related to the security or sector, and the financial strength, liquidity and continued viability of the issuer. The Company recognizes an allowance for credit losses on AFS debt securities with a corresponding adjustment to earnings rather than a direct write down that reduces the cost basis of the investment, and credit losses are limited to the amount by which the security’s amortized cost basis exceeds its fair value. Any improvements in estimated credit losses on AFS debt securities are recognized immediately in earnings. Management does not use the length of time a security has been in an unrealized loss position as a factor, either by itself or in combination with other factors, to conclude that a credit loss does not exist, as they were permitted to do prior to January 1, 2020. When the Company determines that there is more than 50% likelihood that it is not going to recover the principal and interest cash flows related to an AFS debt security, the security is placed on nonaccrual status and the Company reverses accrued interest receivable against interest income. Since the nonaccrual policy results in a timely reversal of accrued interest receivable, the Company does not record an allowance for credit losses on accrued interest receivable. If there is no intent to sell or likely requirement to dispose of the fixed maturity security before its recovery, only the credit loss component of any resulting allowance is recognized in income (loss) and the remainder of the fair value loss is recognized in OCI. The amount of credit loss is the shortfall of the present value of the cash flows expected to be collected as compared to the amortized cost basis of the security. The present value is calculated by discounting management’s best estimate of projected future cash flows at the effective interest rate implicit in the debt security at the date of acquisition. Projections of future cash flows are based on assumptions regarding probability of default and estimates regarding the amount and timing of recoveries. These assumptions and estimates require use of management judgment and consider internal credit analyses as well as market observable data relevant to the collectability of the security. Write-offs of AFS debt securities are recorded when all or a portion of a financial asset is deemed uncollectible. Full or partial write-offs are recorded as reductions to the amortized cost basis of the AFS debt security and deducted from the allowance in the period in which the financial assets are deemed uncollectible. The Company elected to reverse accrued interest deemed uncollectible as a reversal of interest income. In instances where the Company collects cash that it has previously written off, the recovery will be recognized through earnings or as a reduction of the amortized cost basis for interest and principal, respectively. Real estate held for the production of income is stated at depreciated cost less allowance for credit losses. Depreciation of real estate held for production of income is computed using the straight-line method over the estimated useful lives of the properties, which generally range from 40 to 50 years. Policy loans represent funds loaned to policyholders up to the cash surrender value of the associated insurance policies and are carried at the unpaid principal balances due to the Company from the policyholders. Interest income on policy loans is recognized in net investment income at the contract interest rate when earned. Policy loans are fully collateralized by the cash surrender value of the associated insurance policies. Partnerships, investment companies and joint venture interests that the Company has control of and has an economic interest in or those that meet the requirements for consolidation under accounting guidance for consolidation of VIEs are consolidated. Those that the Company does not have control of and does not have a majority economic interest in and those that do not meet the VIE requirements for consolidation are reported on the equity method of accounting and are reported in other equity investments. The Company records its interests in certain of these partnerships on a month or one quarter lag. Trading securities, which include equity securities and fixed maturities, are carried at fair value based on quoted market prices, with realized and unrealized gains (losses) reported in net investment income (loss) in the consolidated statements of income (loss). Corporate owned life insurance (“COLI”) has been purchased by the Company and certain subsidiaries on the lives of certain key employees and the Company and these subsidiaries are named as beneficiaries under these policies. COLI is carried at the cash surrender value of the policies. At September 30, 2020 and December 31, 2019, the carrying value of COLI was $962 million and $942 million, respectively, and is reported in Other invested assets in the consolidated balance sheets. Cash and cash equivalents includes cash on hand, demand deposits, money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less. Due to the short-term nature of these investments, the recorded value is deemed to approximate fair value. All securities owned, including U.S. government and agency securities, mortgage-backed securities, futures and forwards transactions, are reported in the consolidated financial statements on a trade-date basis. Mortgage Loans on Real Estate Mortgage loans are stated at unpaid principal balances, net of unamortized discounts and the allowance for credit losses. The Company calculates the allowance for credit losses in accordance with the CECL model in order to provide for the risk of credit losses in the lending process. Expected credit losses for loans with similar risk characteristics are estimated on a collective (i.e., pool) basis in order to meet CECL’s risk of loss concept which requires the Company to consider possibilities of loss, even if remote. For collectively evaluated mortgages, the Company estimates the allowance for credit losses based on the amortized cost basis of its mortgages over their expected life using a probability of default (“PD”) / loss given default (“LGD”) model. The PD/LGD model incorporates the Company’s reasonable and supportable forecast of macroeconomic information over a specified period. The length of the reasonable and supportable forecast period is reassessed on a quarterly basis and may be adjusted as appropriate over time to be consistent with macroeconomic conditions and the environment as of the reporting date. For periods beyond the reasonable and supportable forecast period, the model reverts to historical loss information. The PD and LGD are estimated at the loan-level based on loans’ current and forecasted risk characteristics as well as macroeconomic forecasts. The PD is estimated using both macroeconomic conditions as well as individual loan risk characteristics including LTV ratios, DSC ratios, seasoning, collateral type, geography, and underlying credit. The LGD is driven primarily by the type and value of collateral, and secondarily by expected liquidation costs and time to recovery. The CECL model is configured to the Company’s specifications and takes into consideration the detailed risk attributes of each discrete loan in the mortgage portfolio which include, but are not limited to the following: • Loan-to-value (“LTV”) ratio - Derived from current loan balance divided by the fair market value of the property. An LTV ratio in excess of 100% indicates an underwater mortgage. • Debt service coverage (“DSC”) ratio - Derived from actual operating earnings divided by annual debt service. If the ratio is below 1.0x, then the income from the property does not support the debt. • Occupancy - Criteria varies by property type but low or below market occupancy is an indicator of sub-par property performance. • Lease expirations - The percentage of leases expiring in the upcoming 12 to 36 months are monitored as a decline in rent and/or occupancy may negatively impact the debt service coverage ratio. In the case of single-tenant properties or properties with large tenant exposure, the lease expiration is a material risk factor. • Other - Any other factors such as maturity, borrower/tenant related issues, payment status, property condition, or current economic conditions may call into question the performance of the loan. Mortgage loans that do not share similar risk characteristics with other loans in the portfolio are individually evaluated quarterly by the Company’s IUS Committee. The allowance for credit losses on these individually evaluated mortgages is a loan-specific reserve as a result of the loan review process that is recorded based on the present value of expected future cash flows discounted at the loan’s effective interest rate or based on the fair value of the collateral. The individually assessed allowance for mortgage loans can increase or decrease from period to period based on such factors. Individually assessed loans may include, but are not limited to, mortgages that have deteriorated in credit quality such as troubled debt restructurings (“TDR”) and reasonably expected TDRs, mortgages for which foreclosure is probable, and mortgages which have been classified as “potential problem” or “problem” loans within the Company’s IUS Committee processes as described below. Within the IUS process, Commercial mortgages 60 days or more past due and agricultural mortgages 90 days or more past due, as well as all mortgages in the process of foreclosure, are identified as problem loans. Based on its monthly monitoring of mortgages, a class of potential problem loans are also identified, consisting of mortgage loans not currently classified as problem loans but for which management has doubts as to the ability of the borrower to comply with the present loan payment terms and which may result in the loan becoming a problem or being modified. The decision whether to classify a performing mortgage loan as a potential problem involves judgments by management as to likely future industry conditions and developments with respect to the borrower or the individual mortgaged property. Individually assessed mortgage loans without provision for losses are mortgage loans where the fair value of the collateral or the net present value of the expected future cash flows related to the loan equals or exceeds the recorded investment. Interest income earned on mortgage loans where the collateral value is used to measure impairment is recorded on a cash basis. Interest income on mortgage loans where the present value method is used to measure impairment is accrued on the net carrying value amount of the loan at the interest rate used to discount the cash flows. Mortgage loans are placed on nonaccrual status once management believes the collection of accrued interest is not probable. Once mortgage loans are classified as nonaccrual mortgage loans, interest income is recognized under the cash basis of accounting and the resumption of the interest accrual would commence only after all past due interest has been collected or the mortgage loan has been restructured to where the collection of interest is considered likely. The Company charges off loan balances and accrued interest that are deemed uncollectible. The components of amortized cost for mortgage loans on the consolidated balance sheets excludes accrued interest amounts because the Company presents accrued interest receivables within Other assets. Once mortgage loans are placed on nonaccrual status, the Company reverses accrued interest receivable against interest income. Since the nonaccrual policy results in the timely reversal of accrued interest receivable, the Company does not record an allowance for credit losses on accrued interest receivable. Troubled Debt Restructuring The Company invests in commercial and agricultural mortgage loans included in the balance sheet as Mortgage loans on real estate and privately negotiated fixed maturities included in the balance sheet as Fixed maturities AFS. Under certain circumstances, modifications are granted to these contracts. Each modification is evaluated as to whether a troubled debt restructuring has occurred. A modification is a troubled debt restructuring when the borrower is in financial difficulty and the creditor makes concessions. Generally, the types of concessions may include reducing the face amount or maturity amount of the debt as originally stated, reducing the contractual interest rate, extending the maturity date at an interest rate lower than current market interest rates and/or reducing accrued interest. The Company considers the amount, timing and extent of the concession granted in determining any impairment or changes in the specific credit allowance recorded in connection with the troubled debt restructuring. A credit allowance may have been recorded prior to the quarter when the loan is modified in a troubled debt restructuring. Accordingly, the carrying value (net of the allowance) before and after modification through a troubled debt restructuring may not change significantly, or may increase if the expected recovery is higher than the pre-modification recovery assessment. Net Investment Income (Loss), Investment Gains (Losses), Net, and Unrealized Investment Gains (Losses) Realized investment gains (losses) are determined by identification with the specific asset and are presented as a component of revenue. Changes in the allowance for credit losses are included in Investment gains (losses), net. Realized and unrealized holding gains (losses) on trading and equity securities are reflected in Net investment income (loss). Unrealized investment gains (losses) on fixed maturities designated as AFS held by the Company are accounted for as a separate component of AOCI, net of related deferred income taxes, as are amounts attributable to certain pension operations, Closed Block’s policyholders’ dividend obligation, insurance liability loss recognition, DAC related to UL policies, investment-type products and participating traditional life policies. Changes in unrealized gains (losses) reflect changes in fair value of only those fixed maturities classified as AFS and do not reflect any change in fair value of policyholders’ account balances and future policy benefits.
Accounting and Consolidation of VIEs	Accounting and Consolidation of VIEs For all new investment products and entities developed by the Company (other than Collateralized Debt Obligations (“CDOs”)), the Company first determines whether the entity is a VIE, which involves determining an entity’s variability and variable interests, identifying the holders of the equity investment at risk and assessing the five characteristics of a VIE. Once an entity has been determined to be a VIE, the Company then identifies the primary beneficiary of the VIE. If the Company is deemed to be the primary beneficiary of the VIE, then the Company consolidates the entity. Management of the Company reviews quarterly its investment management agreements and its investments in, and other financial arrangements with, certain entities that hold client assets under management (“AUM”) to determine the entities that the Company is required to consolidate under this guidance. These entities include certain mutual fund products, hedge funds, structured products, group trusts, collective investment trusts and limited partnerships. The analysis performed to identify variable interests held, determine whether entities are VIEs or voting interest entities (“VOEs”), and evaluate whether the Company has a controlling financial interest in such entities requires the exercise of judgment and is updated on a continuous basis as circumstances change or new entities are developed. The primary beneficiary evaluation generally is performed qualitatively based on all facts and circumstances, including consideration of economic interests in the VIE held directly and indirectly through related parties and entities under common control, as well as quantitatively, as appropriate. Consolidated VIEs At September 30, 2020 and December 31, 2019, the Company consolidated one real estate joint venture for which it was identified as the primary beneficiary under the VIE model. The consolidated entity is jointly owned by Equitable Financial and AXA France and holds an investment in a real estate venture. Included in Other invested assets in the Company’s consolidated balance sheets at September 30, 2020 and December 31, 2019 are total assets of $31 million an d $32 million, respectively related to this VIE, primarily resulting from the consolidated presentation of this real estate joint venture as real estate held for sale. Redeemable noncontrolling interests are presented in mezzanine equity and non-redeemable noncontrolling interests are presented within permanent equity. Non-Consolidated VIEs At September 30, 2020 and December 31, 2019, respectively, the Company held approximately $1.2 billion and $1.1 billion of investment assets in the form of equity interests issued by non-corporate legal entities determined under the guidance to be VIEs, such as limited partnerships and limited liability companies, including hedge funds, private equity funds and real estate-related funds. Additionally, as of September 30, 2020, Equitable Financial holds $18 million of equity interests in a newly formed Special Purpose Entity (“SPE”) established to purchase loans from the market in anticipation of a Collateralized Loan Obligation (“CLO”) transaction. As an equity investor, the Company is considered to have a variable interest in each of these VIEs as a result of its participation in the risks and/or rewards these funds were designed to create by their defined portfolio objectives and strategies. Primarily through qualitative assessment, including consideration of related party interests or other financial arrangements, if any, the Company was not identified as primary beneficiary of any of these VIEs, largely due to its inability to direct the activities that most significantly impact their economic performance. Consequently, the Company continues to reflect these equity interests in the consolidated balance sheets as Other equity investments and applies the equity method of accounting for these positions. The net assets of these non-consolidated VIEs are approximately $156.6 billion and $160.2 billion at September 30, 2020 and December 31, 2019, respectively. The Company’s maximum exposure to loss from its direct involvement with these VIEs is the carrying value of its investment of $1.2 billion and $1.1 billion and approximately $1.2 billion and $1.1 billion of unfunded commitments at September 30, 2020 and December 31, 2019, respectively. The Company has no further economic interest in these VIEs in the form of guarantees, derivatives, credit enhancements or similar instruments and obligations.
Fair Value Measurement	U.S. GAAP establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value, and identifies three levels of inputs that may be used to measure fair value: Level 1 Unadjusted quoted prices for identical instruments in active markets. Level 1 fair values generally are supported by market transactions that occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar instruments, quoted prices in markets that are not active, and inputs to model-derived valuations that are directly observable or can be corroborated by observable market data. Level 3 Unobservable inputs supported by little or no market activity and often requiring significant management judgment or estimation, such as an entity’s own assumptions about the cash flows or other significant components of value that market participants would use in pricing the asset or liability. The Company uses unadjusted quoted market prices to measure fair value for those instruments that are actively traded in financial markets. In cases where quoted market prices are not available, fair values are measured using present value or other valuation techniques. The fair value determinations are made at a specific point in time, based on available market information and judgments about the financial instrument, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such adjustments do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value cannot be substantiated by direct comparison to independent markets, nor can the disclosed value be realized in immediate settlement of the instrument. Management is responsible for the determination of the value of investments carried at fair value and the supporting methodologies and assumptions. Under the terms of various service agreements, the Company often utilizes independent valuation service providers to gather, analyze, and interpret market information and derive fair values based upon relevant methodologies and assumptions for individual securities. These independent valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of widely accepted valuation models, provide a single fair value measurement for individual securities for which a fair value has been requested. As further described below with respect to specific asset classes, these inputs include, but are not limited to, market prices for recent trades and transactions in comparable securities, benchmark yields, interest rate yield curves, credit spreads, quoted prices for similar securities, and other market-observable information, as applicable. Specific attributes of the security being valued also are considered, including its term, interest rate, credit rating, industry sector, and when applicable, collateral quality and other security- or issuer-specific information. When insufficient market observable information is available upon which to measure fair value, the Company either will request brokers knowledgeable about these securities to provide a non-binding quote or will employ internal valuation models. Fair values received from independent valuation service providers and brokers and those internally modeled or otherwise estimated are assessed for reasonableness.

SIGNIFICANT ACCOUNTING POLICI_3

SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Schedule of New Accounting Pronouncements and Changes in Accounting Principles	Adoption of New Accounting Pronouncements Description Effect on the Financial Statement or Other Significant Matters ASU 2016-13: Financial Instruments—Credit Losses (Topic 326), as clarified and amended by ASU 2018-19: Codification Improvements to Topic 326, Financial Instruments—Credit Losses, ASU 2019-04: Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments and ASU 2019-05: Financial Instruments—Credit Losses (Topic 326) Targeted Transition Relief, ASU 2019-11: Codification Improvements to Topic 326, Financial Instruments-Credit Losses ASU 2016-13 contains new guidance which introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. On January 1, 2020, the Company adopted the new standard and completed implementation of its updated current expected credit losses (“CECL”) models, processes and controls related to the identified financial assets that fall within the scope of the new standard. Upon adoption, the Company recorded a cumulative effect adjustment to reduce the opening retained earnings balance by approximately $40 million, on a pre-tax and pre-DAC basis. The adjustment is primarily attributable to an increase in the allowance for credit losses associated with the Company’s commercial and agricultural mortgage loan portfolios and reinsurance. ASU 2018-13 : Fair Value Measurement (Topic 820) This ASU improves the effectiveness of fair value disclosures in the notes to financial statements. Amendments in this ASU impact the disclosure requirements in Topic 820, including the removal, modification and addition to existing disclosure requirements. The Company elected to early adopt during 2019 the removal of disclosures relating to transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels and valuation processes for Level 3 fair value measurements. The Company adopted the additional disclosures related to Level 3 fair value information on January 1, 2020. ASU 2018-17: Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities This ASU provides guidance requiring that indirect interests held through related parties in common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. The Company adopted this new standard effective for January 1, 2020. Adoption of this standard did not materially impact the Company’s financial position or results of operations. Future Adoption of New Accounting Pronouncements Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-12 : Financial Services - Insurance (Topic 944); ASU 2019-09: Financial Services - Insurance (Topic 944): Effective Date This ASU provides targeted improvements to existing recognition, measurement, presentation, and disclosure requirements for long-duration contracts issued by an insurance entity. The ASU primarily impacts four key areas, including: In November 2019, ASU 2019-09 was issued which modified ASU 2018-12 to be effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021. Early adoption is permitted. On September 30, 2020, the FASB tentatively affirmed its decision to defer the effective date of the amendments in ASU 2018-12, for all insurance entities by one year. Early adoption would still be allowed. The Company is currently evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements, however the adoption of the ASU is expected to have a significant impact on the Company’s consolidated financial condition, results of operations, cash flows and required disclosures, as well as processes and controls. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters 2. Measurement of market risk benefits (“MRBs”). MRBs, as defined under the ASU, will encompass certain variable annuity guaranteed benefit (“GMxB”) features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in Other comprehensive income (“OCI”). For MRBs, the ASU should be applied retrospectively as of the beginning of the earliest period presented. ASU 2019-12: Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740, as well as clarifying and amending existing guidance. Effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the impact adopting the guidance will have on the Company’s consolidated financial statements, however the adoption is not expected to materially impact the Company’s financial position, results of operation, or cash flows. ASU2020-04: Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting The amendments in this ASU provide optional expedients and exceptions to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This ASU is effective as of March 12, 2020 through December 31, 2022. The Company will determine the applicability of the optional expedients and exceptions provided under the ASU as reference rate reform continues to develop.

INVESTMENTS (Tables)

INVESTMENTS (Tables)	9 Months Ended
	Sep. 30, 2020
Investments, Debt and Equity Securities [Abstract]
Available-for-Sale Fixed Maturities by Classification	The following tables provide information relating to the Company’s fixed maturities classified as AFS. AFS Fixed Maturities by Classification Amortized Allowance for Credit Losses (4) Gross Gross Fair Value (in millions) September 30, 2020: Fixed Maturities: Corporate (1) $ 47,421 $ 13 $ 4,281 $ 170 $ 51,519 U.S. Treasury, government and agency 13,126 — 4,158 — 17,284 States and political subdivisions 706 — 109 — 815 Foreign governments 828 — 80 6 902 Residential mortgage-backed (2) 132 — 13 — 145 Asset-backed (3) 2,584 — 25 18 2,591 Commercial mortgage-backed 1,067 — 50 — 1,117 Redeemable preferred stock 413 — 31 3 441 Total at September 30, 2020 $ 66,277 $ 13 $ 8,747 $ 197 $ 74,814 December 31, 2019: Fixed Maturities: Corporate (1) $ 42,347 $ — $ 2,178 $ 61 $ 44,464 U.S. Treasury, government and agency 14,385 — 1,151 305 15,231 States and political subdivisions 584 — 68 3 649 Foreign governments 460 — 35 5 490 Residential mortgage-backed (2) 161 — 12 — 173 Asset-backed (3) 843 — 3 2 844 Redeemable preferred stock 498 — 18 5 511 Total at December 31, 2019 $ 59,278 $ — $ 3,465 $ 381 $ 62,362 ______________ (1) Corporate fixed maturities include both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (4) Amounts represent the allowance for credit losses for 2020 - (see Note 2 Significant Accounting Policies - Investments).
Contractual Maturities of Available-for-Sale Fixed Maturities	The contractual maturities of AFS fixed maturities at September 30, 2020 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Contractual Maturities of AFS Fixed Maturities Amortized Cost (Less Allowance for Credit Losses) Fair Value (in millions) September 30, 2020: Contractual maturities: Due in one year or less $ 4,094 $ 4,126 Due in years two through five 14,862 15,722 Due in years six through ten 16,872 18,691 Due after ten years 26,240 31,981 Subtotal 62,068 70,520 Residential mortgage-backed 132 145 Asset-backed 2,584 2,591 Commercial mortgage-backed 1,067 1,117 Redeemable preferred stock 413 441 Total at September 30, 2020 $ 66,264 $ 74,814
Proceeds and Gains (Losses) on Sales for Available-for-Sale Fixed Maturities	The following table shows proceeds from sales, gross gains (losses) from sales and credit losses for AFS fixed maturities for the three and nine months ended September 30, 2020 and 2019: Proceeds from Sales, Gross Gains (Losses) from Sales and Credit Losses for AFS Fixed Maturities Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (in millions) Proceeds from sales $ 1,399 $ 3,839 $ 5,985 $ 6,756 Gross gains on sales $ 23 $ 207 $ 297 $ 224 Gross losses on sales $ (5) $ (4) $ (32) $ (25) Credit losses (1) $ — $ — $ (13) $ — ______________
AFS Fixed Maturities - Credit Loss Impairments	The following table sets forth the amount of credit loss impairments on AFS fixed maturities held by the Company at the dates indicated and the corresponding changes in such amounts. AFS Fixed Maturities - Credit Loss Impairments Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (in millions) Balance, beginning of period $ 28 $ 18 $ 15 $ 46 Previously recognized impairments on securities that matured, paid, prepaid or sold — (3) — (31) Recognized impairments on securities impaired to fair value this period (1) — — — — Credit losses recognized this period on securities for which credit losses were not previously recognized (2) — 7 — Additional credit losses this period on securities previously impaired 2 — 6 — Increases due to passage of time on previously recorded credit losses — — — — Accretion of previously recognized impairments due to increases in expected cash flows (for OTTI securities 2019 and prior) — — — — Balance at September 30, $ 28 $ 15 $ 28 $ 15 ______________ (1) Represents circumstances where the Company determined in the current period that it intends to sell the security, or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost.
Net Unrealized Gains (Losses) on Available-for-Sale Fixed Maturities	The tables that follow below present a roll-forward of net unrealized investment gains (losses) recognized in AOCI, split between amounts related to fixed maturities on which a credit loss has been recognized, and all other. Net Unrealized Gains (Losses) on AFS Fixed Maturities Net Unrealized Gains (Losses) on Investments DAC Policyholders’ Liabilities Deferred Income Tax Asset (Liability) AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) (in millions) Balance, July 1, 2020 $ 8,207 $ (494) $ (1,801) $ (1,242) $ 4,670 Net investment gains (losses) arising during the period 345 — — — 345 Reclassification adjustment: — Included in Net income (loss) (18) — — — (18) Excluded from Net income (loss) — — — — — Impact of net unrealized investment gains (losses) — 54 (6) (79) (31) Net unrealized investment gains (losses) excluding credit losses 8,534 (440) (1,807) (1,321) 4,966 Net unrealized investment gains (losses) with credit losses 3 — (1) — 2 Balance, September 30, 2020 $ 8,537 $ (440) $ (1,808) $ (1,321) $ 4,968 Balance, July 1, 2019 $ 2,622 $ (616) $ (98) $ (420) $ 1,488 Net investment gains (losses) arising during the period 1,548 — — — 1,548 Reclassification adjustment: — Included in Net income (loss) (201) — — — (201) Excluded from Net income (loss) — — — — — Impact of net unrealized investment gains (losses) — (324) (122) (156) (602) Net unrealized investment gains (losses) excluding credit losses 3,969 (940) (220) (576) 2,233 Net unrealized investment gains (losses) with credit losses (1) 1 — — — 1 Balance, September 30, 2019 $ 3,970 $ (940) $ (220) $ (576) $ 2,234 Net Unrealized Gains (Losses) on Investments DAC Policyholders’ Liabilities Deferred Income Tax Asset (Liability) AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) (in millions) Balance, January 1, 2020 $ 3,084 $ (826) $ (192) $ (433) $ 1,633 Net investment gains (losses) arising during the period 5,707 — — — 5,707 Reclassification adjustment: — Included in Net income (loss) (248) — — — (248) Excluded from Net income (loss) — — — — — Impact of net unrealized investment gains (losses) — 386 (1,617) (889) (2,120) Net unrealized investment gains (losses) excluding credit losses 8,543 (440) (1,809) (1,322) 4,972 Net unrealized investment gains (losses) with credit losses (6) — 1 1 (4) Balance, September 30, 2020 $ 8,537 $ (440) $ (1,808) $ (1,321) $ 4,968 Balance, January 1, 2019 $ (577) $ 37 $ (69) $ 125 $ (484) Net investment gains (losses) arising during the period 4,754 — — — 4,754 Reclassification adjustment: Included in Net income (loss) (208) — — — (208) Excluded from Net income (loss) — — — — — Impact of net unrealized investment gains (losses) — (977) (151) (701) (1,829) Net unrealized investment gains (losses) excluding credit losses 3,969 (940) (220) (576) 2,233 Net unrealized investment gains (losses) with credit losses (1) 1 — — — 1 Balance, September 30, 2019 $ 3,970 $ (940) $ (220) $ (576) $ 2,234 ______________ (1) Credit losses for 2019 were OTTI losses.
Continuous Gross Unrealized Losses for Available-for-Sale Fixed Maturities	The following tables disclose the fair values and gross unrealized losses of the 709 issues at September 30, 2020 and the 390 issues at December 31, 2019 that are not deemed to have credit losses, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated: AFS Fixed Maturities in an Unrealized Loss Position for Which No Allowance Is Recorded Less Than 12 Months 12 Months or Longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses (in millions) September 30, 2020: Fixed Maturities: Corporate $ 4,063 $ 116 $ 365 $ 49 $ 4,428 $ 165 Foreign governments 88 1 31 5 119 6 Asset-backed 1,324 16 74 2 1,398 18 Redeemable preferred stock 59 1 11 2 70 3 Total at September 30, 2020 $ 5,534 $ 134 $ 481 $ 58 $ 6,015 $ 192 December 31, 2019: (1) Less Than 12 Months 12 Months or Longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses (in millions) Fixed Maturities: Corporate $ 2,669 $ 41 $ 366 $ 20 $ 3,035 $ 61 U.S. Treasury, government and agency 4,245 305 2 — 4,247 305 States and political subdivisions 123 3 — — 123 3 Foreign governments 11 — 47 5 58 5 Asset-backed 319 — 201 2 520 2 Redeemable preferred stock 29 — 49 5 78 5 Total at December 31, 2019 $ 7,396 $ 349 $ 665 $ 32 $ 8,061 $ 381 ______________ (1) Amounts represents fixed maturities in an unrealized loss position that are not deemed to be OTTI for 2019.
Financing Receivable, Allowance for Credit Loss	The change in the allowance for credit losses for commercial mortgage loans and agricultural mortgage loans during the three and nine months ended September 30, 2020 was as follows: Three Months Ended September 30, 2020 Nine Months Ended September 30, 2020 (in millions) Allowance for credit losses on mortgage loans (1): Commercial mortgages: Balance, beginning of period $ 62 $ 33 Current-period provision for expected credit losses 4 33 Write-offs charged against the allowance — — Recoveries of amounts previously written off — — Net change in allowance 4 33 Ending Balance, September 30, $ 66 $ 66 Agricultural mortgages: Balance, beginning of period $ 4 $ 3 Current-period provision for expected credit losses — 1 Write-offs charged against the allowance — — Recoveries of amounts previously written off — — Net change in allowance — 1 Ending Balance, September 30, $ 4 $ 4 Total allowance for credit losses $ 70 $ 70 ____________ (1) See Note 2 for discussion of the allowance of credit losses transition balance, which is included in the Balance, beginning of period.
Financing Receivable Credit Quality Indicators	The following tables summarize the Company’s mortgage loans segregated by risk rating exposure at September 30, 2020. LTV Ratios (1) At September 30, 2020 Amortized Cost Basis by Origination Year 2020 2019 2018 2017 2016 Prior Total (in millions) Mortgage loans: Commercial: 0% - 50% $ — $ — $ — $ 324 $ 170 $ 650 $ 1,144 50% - 70% 935 411 885 760 2,432 1,608 7,031 70% - 90% 90 394 368 115 153 574 1,694 90% plus — — 12 5 — 216 233 Total commercial $ 1,025 $ 805 $ 1,265 $ 1,204 $ 2,755 $ 3,048 $ 10,102 At September 30, 2020 Amortized Cost Basis by Origination Year 2020 2019 2018 2017 2016 Prior Total (in millions) Agricultural: 0% - 50% $ 181 $ 137 $ 168 $ 161 $ 232 $ 679 $ 1,558 50% - 70% 253 131 172 110 136 372 1,174 70% - 90% — — 3 — — 18 21 90% plus — — — — — — — Total agricultural $ 434 $ 268 $ 343 $ 271 $ 368 $ 1,069 $ 2,753 Total mortgage loans: 0% - 50% $ 181 $ 137 $ 168 $ 485 $ 402 $ 1,329 $ 2,702 50% - 70% 1,188 542 1,057 870 2,568 1,980 8,205 70% - 90% 90 394 371 115 153 592 1,715 90% plus — — 12 5 — 216 233 Total mortgage loans $ 1,459 $ 1,073 $ 1,608 $ 1,475 $ 3,123 $ 4,117 $ 12,855 Debt Service Coverage Ratios (2) At September 30, 2020 Amortized Cost Basis by Origination Year 2020 2019 2018 2017 2016 Prior Total (in millions) Mortgage loans: Commercial: Greater than 2.0x $ 749 $ 492 $ 772 $ 268 $ 2,036 $ 1,268 $ 5,585 1.8x to 2.0x 227 77 118 378 184 524 1,508 1.5x to 1.8x 49 138 186 480 437 569 1,859 1.2x to 1.5x — 56 154 78 97 533 918 1.0x to 1.2x — 42 35 — 1 82 160 Less than 1.0x — — — — — 72 72 Total commercial $ 1,025 $ 805 $ 1,265 $ 1,204 $ 2,755 $ 3,048 $ 10,102 Agricultural Greater than 2.0x $ 52 $ 27 $ 39 $ 38 $ 73 $ 158 $ 387 1.8x to 2.0x 33 36 14 15 21 90 209 1.5x to 1.8x 103 38 45 41 52 212 491 1.2x to 1.5x 165 118 146 105 147 327 1,008 1.0x to 1.2x 77 39 91 71 57 265 600 Less than 1.0x 4 10 8 1 18 17 58 Total agricultural $ 434 $ 268 $ 343 $ 271 $ 368 $ 1,069 $ 2,753 Total mortgage loans Greater than 2.0x $ 801 $ 519 $ 811 $ 306 $ 2,109 $ 1,426 $ 5,972 1.8x to 2.0x 260 113 132 393 205 614 1,717 1.5x to 1.8x 152 176 231 521 489 781 2,350 1.2x to 1.5x 165 174 300 183 244 860 1,926 1.0x to 1.2x 77 81 126 71 58 347 760 Less than 1.0x 4 10 8 1 18 89 130 Total mortgage loans $ 1,459 $ 1,073 $ 1,608 $ 1,475 $ 3,123 $ 4,117 $ 12,855 _____________ (1) The LTV ratio is derived from current loan balance divided by the fair value of the property. The fair value of the underlying commercial properties is updated annually for each mortgage loan. (2) The DSC ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service. The following tables provide information relating to the LTV and DSC ratios for commercial and agricultural mortgage loans at September 30, 2020 and December 31, 2019. The values used in these ratio calculations were developed as part of the periodic review of the commercial and agricultural mortgage loan portfolio, which includes an evaluation of the underlying collateral value. Mortgage Loans by LTV and DSC Ratios DSC Ratio (2) (3) LTV Ratio (1) (3): Greater than 2.0x 1.8x to 2.0x 1.5x to 1.8x 1.2x to 1.5x 1.0x to 1.2x Less than 1.0x Total (in millions) September 30, 2020: Mortgage loans: Commercial: 0% - 50% $ 935 $ — $ 185 $ 24 $ — $ — $ 1,144 50% - 70% 3,992 1,160 1,342 511 26 — 7,031 70% - 90% 574 348 332 306 134 — 1,694 90% plus 84 — — 77 — 72 233 Total commercial $ 5,585 $ 1,508 $ 1,859 $ 918 $ 160 $ 72 $ 10,102 Agricultural: 0% - 50% $ 283 $ 107 $ 271 $ 529 $ 335 $ 33 $ 1,558 50% - 70% 104 100 220 460 265 25 1,174 70% - 90% — 2 — 19 — — 21 90% plus — — — — — — — Total agricultural $ 387 $ 209 $ 491 $ 1,008 $ 600 $ 58 $ 2,753 Total mortgage loans: 0% - 50% $ 1,218 $ 107 $ 456 $ 553 $ 335 $ 33 $ 2,702 50% - 70% 4,096 1,260 1,562 971 291 25 8,205 70% - 90% 574 350 332 325 134 — 1,715 90% plus 84 — — 77 — 72 233 Total mortgage loans $ 5,972 $ 1,717 $ 2,350 $ 1,926 $ 760 $ 130 $ 12,855 December 31, 2019: Mortgage loans: Commercial: 0% - 50% $ 887 $ 38 $ 214 $ 24 $ — $ — $ 1,163 50% - 70% 4,097 1,195 1,118 795 242 — 7,447 70% - 90% 251 98 214 154 46 — 763 90% plus — — — — — — — Total commercial $ 5,235 $ 1,331 $ 1,546 $ 973 $ 288 $ — $ 9,373 DSC Ratio (2) (3) LTV Ratio (1) (3): Greater than 2.0x 1.8x to 2.0x 1.5x to 1.8x 1.2x to 1.5x 1.0x to 1.2x Less than 1.0x Total (in millions) Agricultural: 0% - 50% $ 322 $ 104 $ 241 $ 545 $ 321 $ 50 $ 1,583 50% - 70% 82 87 236 426 251 33 1,115 70% - 90% — — — 19 — — 19 90% plus — — — — — — — Total agricultural $ 404 $ 191 $ 477 $ 990 $ 572 $ 83 $ 2,717 Total mortgage loans: 0% - 50% $ 1,209 $ 142 $ 455 $ 569 $ 321 $ 50 $ 2,746 50% - 70% 4,179 1,282 1,354 1,221 493 33 8,562 70% - 90% 251 98 214 173 46 — 782 90% plus — — — — — — — Total mortgage loans $ 5,639 $ 1,522 $ 2,023 $ 1,963 $ 860 $ 83 $ 12,090 ______________ (1) The LTV ratio is derived from current loan balance divided by the fair value of the property. The fair value of the underlying commercial properties is updated annually for each mortgage loan. (2) The DSC ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service. (3) Amounts presented at amortized cost basis.
Age Analysis Of Past Due Mortgage Loans	The following table provides information relating to the aging analysis of past-due mortgage loans at September 30, 2020 and December 31, 2019, respectively: Age Analysis of Past Due Mortgage Loans (1) Accruing Loans Non-accruing Loans Total Loans Non-accruing Loans with No Allowance Interest Income on Non-accruing Loans(2) Past Due Current Total 30-59 Days 60-89 Days 90 Days or More Total (in millions) September 30, 2020: Mortgage loans: Commercial $ — $ — $ — $ — $ 10,102 $ 10,102 $ — $ 10,102 $ — $ — Agricultural 24 6 135 165 2,588 2,753 — 2,753 — — Total $ 24 $ 6 $ 135 $ 165 $ 12,690 $ 12,855 $ — $ 12,855 $ — $ — December 31, 2019: Mortgage loans: Commercial $ — $ — $ — $ — $ 9,373 $ 9,373 $ — $ 9,373 $ — $ — Agricultural 57 1 66 124 2,593 2,717 — 2,717 — — Total $ 57 $ 1 $ 66 $ 124 $ 11,966 $ 12,090 $ — $ 12,090 $ — $ — _______________ (1) Amounts presented at amortized cost basis. (2) Amounts for 2020 represent results for both the three and nine months ended September 30, 2020.
Net Investment Income (Loss) from Trading Securities	The table below shows a breakdown of Net investment income (loss) from trading securities during the three and nine months ended September 30, 2020 and 2019: Net Investment Income (Loss) from Trading Securities Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (in millions) Net investment gains (losses) recognized during the period on securities held at the end of the period $ (1) $ 7 $ 86 $ 431 Net investment gains (losses) recognized on securities sold during the period (5) 13 12 (10) Unrealized and realized gains (losses) on trading securities (6) 20 98 421 Interest and dividend income from trading securities 58 59 152 220 Net investment income (loss) from trading securities $ 52 $ 79 $ 250 $ 641

DERIVATIVES (Tables)

DERIVATIVES (Tables)	9 Months Ended
	Sep. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments by Category	The tables below present quantitative disclosures about the Company’s derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments: Derivative Instruments by Category At September 30, 2020 Nine Months Ended September 30, 2020 Fair Value Notional Derivative Assets Derivative Liabilities Net Derivative Gains (Losses) (2) (in millions) Derivative instruments: Freestanding derivatives (1): Equity contracts: Futures $ 3,739 $ — $ — $ (347) Swaps 20,667 27 18 (594) Options 31,679 5,543 2,791 (480) Interest rate contracts: Swaps 23,952 1,696 338 3,588 Futures 19,484 — — 2,058 Swaptions — — — 9 Credit contracts: Credit default swaps 1,252 9 4 (4) Other freestanding contracts: Foreign currency contracts 347 — — (3) Margin — 40 125 — Collateral — 14 4,959 — Embedded derivatives: GMIB reinsurance contracts (3) — 3,247 — 849 GMxB derivative features liability (4) — — 11,985 (3,382) SCS, SIO, MSO and IUL indexed features (5) — — 2,502 410 Total derivative instruments $ 101,120 $ 10,576 $ 22,722 Net derivative gains (losses) (6) $ 2,104 ______________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Net derivative gains (losses) in the consolidated statements of income (loss). (3) Reported in GMIB reinsurance contract asset in the consolidated balance sheets. (4) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (5) Reported in Policyholders’ account balances in the consolidated balance sheets. (6) Investment fees of $9 million are reported in Net derivative gains (losses) in the consolidated statements of income (loss). Derivative Instruments by Category At December 31, 2019 Nine Months Ended September 30, 2019 Fair Value Notional Derivative Assets Derivative Liabilities Net Derivative Gains (Losses) (2) (in millions) Derivative instruments: Freestanding derivatives (1): Equity contracts: Futures $ 3,510 $ — $ — $ (967) Swaps 17,064 9 279 (1,263) Options 47,766 5,080 1,749 1,241 Interest rate contracts: Swaps 23,700 467 523 2,844 Futures 20,424 — — 183 Swaptions 3,201 16 — 146 Credit contracts: Credit default swaps 1,232 18 — 13 Other freestanding contracts: Foreign currency contracts 501 3 — (13) Margin — 140 — — Collateral — 72 3,001 — Embedded derivatives: GMIB reinsurance contracts (3) — 2,466 — 881 GMxB derivative features liability (4) — — 8,316 (3,656) SCS, SIO, MSO and IUL indexed features (5) — — 3,150 (1,489) Total derivative instruments $ 117,398 $ 8,271 $ 17,018 Net derivative gains (losses) $ (2,080) ______________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Net derivative gains (losses) in the consolidated statements of income (loss). (3) Reported in GMIB reinsurance contract asset in the consolidated balance sheets. (4) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (5) Reported in Policyholders’ account balances in the consolidated balance sheets.
Offsetting Financial Assets and Liabilities and Derivative Instruments	The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at September 30, 2020: Offsetting of Financial Assets and Liabilities and Derivative Instruments At September 30, 2020 Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets Gross Amount not Offset in the Balance Sheets (1) Net Amount (in millions) Assets: Derivative assets $ 7,330 $ 7,241 $ 89 $ (54) $ 35 Other financial assets 1,434 — 1,434 — 1,434 Other invested assets $ 8,764 $ 7,241 $ 1,523 $ (54) $ 1,469 Liabilities: Derivative liabilities $ 8,181 $ 7,241 $ 940 $ — $ 940 Other financial liabilities 1,579 — 1,579 — 1,579 Other liabilities $ 9,760 $ 7,241 $ 2,519 $ — $ 2,519 ______________ (1) Financial instruments sent (held). The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at December 31, 2019. Offsetting of Financial Assets and Liabilities and Derivative Instruments At December 31, 2019 Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets Gross Amount not Offset in the Balance Sheets (1) Net Amount (in millions) Assets: Derivative assets $ 5,804 $ 5,429 $ 375 $ (77) $ 298 Other financial instruments 1,781 — 1,781 — 1,781 Other invested assets $ 7,585 $ 5,429 $ 2,156 $ (77) $ 2,079 Liabilities: Derivative liabilities $ 5,474 $ 5,429 $ 45 $ — $ 45 Other financial liabilities 1,724 — 1,724 — 1,724 Other liabilities $ 7,198 $ 5,429 $ 1,769 $ — $ 1,769 ______________ (1) Financial instruments sent (held).

CLOSED BLOCK (Tables)

CLOSED BLOCK (Tables)	9 Months Ended
	Sep. 30, 2020
Closed Block Disclosure [Abstract]
Schedule of Closed Block Assets and Liabilities	Summarized financial information for the Company’s Closed Block is as follows: September 30, 2020 December 31, 2019 (in millions) Closed Block Liabilities: Future policy benefits, policyholders’ account balances and other $ 6,260 $ 6,478 Policyholder dividend obligation 149 2 Other liabilities 58 38 Total Closed Block liabilities 6,467 6,518 Assets Designated to the Closed Block: Fixed maturities available-for-sale, at fair value (amortized cost of $3,440 and $3,558) (allowance for credit losses of $0 at September 30, 2020) 3,788 3,754 Mortgage loans on real estate (net of allowance for credit losses of $6 at September 30, 2020) 1,782 1,759 Policy loans 656 706 Cash and other invested assets 3 82 Other assets 172 145 Total assets designated to the Closed Block 6,401 6,446 Excess of Closed Block liabilities over assets designated to the Closed Block 66 72 Amounts included in accumulated other comprehensive income (loss): Net unrealized investment gains (losses), net of policyholders’ dividend obligation: $149 and $2; and net of income tax: $42 and $41 168 164 Maximum future earnings to be recognized from Closed Block assets and liabilities $ 234 $ 236
Closed Block Operations, Net Results	The Company’s Closed Block revenues and expenses were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (in millions) Revenues: Premiums and other income $ 36 $ 42 $ 118 $ 136 Net investment income (loss) 61 69 190 208 Investment gains (losses), net 1 — (1) (1) Total revenues 98 111 307 343 Benefits and Other Deductions: Policyholders’ benefits and dividends 96 108 302 343 Other operating costs and expenses — — 1 1 Total benefits and other deductions 96 108 303 344 Net income (loss), before income taxes 2 3 4 (1) Income tax (expense) benefit (1) — (2) (2) Net income (loss) $ 1 $ 3 $ 2 $ (3)

INSURANCE LIABILITIES (Tables)

INSURANCE LIABILITIES (Tables)	9 Months Ended
	Sep. 30, 2020
Insurance [Abstract]
GMDB and GMIB Liabilities and Other Policyholder's Liabilities	Change in Liability for Variable Annuity Contracts with GMDB and GMIB Features and No NLG Feature For the Three and Nine Months Ended September 30, 2020 and 2019 GMDB GMIB Direct Ceded Direct Ceded (in millions) Balance at July 1, 2020 $ 4,998 $ (99) $ 6,121 $ (3,433) Paid guarantee benefits (121) 3 (110) 21 Other changes in reserve 235 9 113 165 Balance at September 30, 2020 $ 5,112 $ (87) $ 6,124 $ (3,247) Balance at July 1, 2019 $ 4,709 $ (100) $ 3,757 $ (2,197) Paid guarantee benefits (102) 3 (70) 20 Other changes in reserve 155 (4) 979 (676) Balance at September 30, 2019 $ 4,762 $ (101) $ 4,666 $ (2,853) GMDB GMIB Direct Ceded Direct Ceded (in millions) Balance at January 1, 2020 $ 4,775 $ (99) $ 4,671 $ (2,466) Paid guarantee benefits (372) 12 (287) 58 Other changes in reserve 709 — 1,740 (839) Balance at September 30, 2020 $ 5,112 $ (87) $ 6,124 $ (3,247) Balance at January 1, 2019 $ 4,657 $ (107) $ 3,744 $ (1,993) Paid guarantee benefits (328) 11 (182) 55 Other changes in reserve 433 (5) 1,104 (915) Balance at September 30, 2019 $ 4,762 $ (101) $ 4,666 $ (2,853)
Variable Annuity Contracts with GMDB and GMIB Features	Account Values and Net Amount at Risk (“NAR”) for direct variable annuity contracts in force with GMDB and GMIB features as of September 30, 2020 are presented in the following tables by guarantee type. For contracts with the GMDB feature, the NAR in the event of death is the amount by which the GMDB feature exceeds the related Account Values. For contracts with the GMIB feature, the NAR in the event of annuitization is the amount by which the present value of the GMIB benefits exceed the related Account Values, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. Since variable annuity contracts with GMDB features may also offer GMIB guarantees in the same contract, the GMDB and GMIB amounts listed are not mutually exclusive. Direct Variable Annuity Contracts with GMDB and GMIB Features at September 30, 2020 Guarantee Type Return of Premium Ratchet Roll-Up Combo Total (in millions, except age and interest rate) Variable annuity contracts with GMDB features Account Values invested in: General Account $ 15,155 $ 89 $ 57 $ 171 $ 15,472 Separate Accounts 48,407 8,812 3,021 31,083 91,323 Total Account Values $ 63,562 $ 8,901 $ 3,078 $ 31,254 $ 106,795 Net Amount at Risk, gross $ 125 $ 94 $ 1,864 $ 19,561 $ 21,644 Net Amount at Risk, net of amounts reinsured $ 125 $ 91 $ 1,319 $ 19,561 $ 21,096 Average attained age of policyholders (in years) 51.3 68.1 74.7 70.0 55.3 Percentage of policyholders over age 70 11.0 % 47.7 % 69.8 % 53.3 % 20.0 % Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5% Variable annuity contracts with GMIB features Account Values invested in: General Account $ — $ — $ 17 $ 220 $ 237 Separate Accounts — — 23,124 33,217 56,341 Total Account Values $ — $ — $ 23,141 $ 33,437 $ 56,578 Net Amount at Risk, gross $ — $ — $ 1,100 $ 14,461 $ 15,561 Net Amount at Risk, net of amounts reinsured $ — $ — $ 349 $ 13,066 $ 13,415 Average attained age of policyholders (in years) N/A N/A 64.0 70.0 67.8 Weighted average years remaining until annuitization N/A N/A 5.7 0.7 2.5 Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5%
Investment in Variable Insurance Trust Mutual Funds	The following table presents the aggregate fair value of assets, by major investment category, held by Separate Accounts that support variable annuity contracts with GMDB and GMIB features. The investment performance of the assets impacts the related Account Values and, consequently, the NAR associated with the GMDB and GMIB benefits and guarantees. Because the Company’s variable annuity contracts offer both GMDB and GMIB features, GMDB and GMIB amounts are not mutually exclusive. Investment in Variable Insurance Trust Mutual Funds September 30, 2020 December 31, 2019 Mutual Fund Type GMDB GMIB GMDB GMIB (in millions) Equity $ 41,259 $ 16,739 $ 42,489 $ 17,941 Fixed income 5,371 2,679 5,263 2,699 Balanced 43,685 36,656 45,872 38,445 Other 1,008 267 865 263 Total $ 91,323 $ 56,341 $ 94,489 $ 59,348
No Lapse Guarantee Liabilities	The change in the NLG liabilities, reflected in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets, is summarized in the table below. 2020 2019 Direct Liability Reinsurance Ceded Net Direct Liability Reinsurance Ceded Net (in millions) 2020 2019 Direct Liability Reinsurance Ceded Net Direct Liability Reinsurance Ceded Net Balance at July 1, $ 941 $ (841) $ 100 $ 821 $ (756) $ 65 Paid guarantee benefits (6) — (6) (7) — (7) Other changes in reserves 61 (31) 30 54 (31) 23 Balance at September 30, $ 996 $ (872) $ 124 $ 868 $ (787) $ 81 Balance at January 1, $ 894 $ (808) $ 86 $ 788 $ (734) $ 54 Paid guarantee benefits (32) — (32) (16) — (16) Other changes in reserves 134 (64) 70 96 (53) 43 Balance at September 30, $ 996 $ (872) $ 124 $ 868 $ (787) $ 81

FAIR VALUE DISCLOSURES (Tables)

FAIR VALUE DISCLOSURES (Tables)	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Assets and Liabilities Measured at Fair Value on Recurring Basis	Assets and liabilities measured at fair value on a recurring basis are summarized below. At September 30, 2020 and December 31, 2019, no assets were required to be measured at fair value on a non-recurring basis. Fair value measurements are required on a non-recurring basis for certain assets, including goodwill and mortgage loans on real estate, only when an impairment or other event occurs. When such fair value measurements are recorded, they must be classified and disclosed within the fair value hierarchy. Fair Value Measurements at September 30, 2020 Level 1 Level 2 Level 3 Total (in millions) Assets: Investments: Fixed maturities, AFS: Corporate (1) $ — $ 50,040 $ 1,479 $ 51,519 U.S. Treasury, government and agency — 17,284 — 17,284 States and political subdivisions — 776 39 815 Foreign governments — 902 — 902 Residential mortgage-backed (2) — 145 — 145 Asset-backed (3) — 2,578 13 2,591 Commercial mortgage-backed — 1,117 — 1,117 Redeemable preferred stock 367 74 — 441 Total fixed maturities, AFS 367 72,916 1,531 74,814 Other equity investments 20 — 4 24 Trading securities 258 5,529 — 5,787 Other invested assets: Short-term investments — 106 — 106 Assets of consolidated VIEs/VOEs — — 12 12 Swaps — 1,367 — 1,367 Credit default swaps — 5 — 5 Options — 2,752 — 2,752 Total other invested assets — 4,230 12 4,242 Cash equivalents 2,488 1,031 — 3,519 GMIB reinsurance contracts asset — — 3,247 3,247 Separate Accounts assets (4) 118,085 2,424 — 120,509 Total Assets $ 121,218 $ 86,130 $ 4,794 $ 212,142 Liabilities: GMxB derivative features’ liability $ — $ — $ 11,985 $ 11,985 SCS, SIO, MSO and IUL indexed features’ liability — 2,502 — 2,502 Total Liabilities $ — $ 2,502 $ 11,985 $ 14,487 ______________ (1) Corporate fixed maturities includes both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (4) Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate and commercial mortgages. At September 30, 2020 the fair value of such investments was $356 million. Fair Value Measurements at December 31, 2019 Level 1 Level 2 Level 3 Total (in millions) Assets: Investments: Fixed maturities, AFS: Corporate (1) $ — $ 43,218 $ 1,246 $ 44,464 U.S. Treasury, government and agency — 15,231 — 15,231 States and political subdivisions — 610 39 649 Foreign governments — 490 — 490 Residential mortgage-backed (2) — 173 — 173 Asset-backed (3) — 744 100 844 Redeemable preferred stock 237 274 — 511 Total fixed maturities, AFS 237 60,740 1,385 62,362 Other equity investments 13 — — 13 Trading securities 321 6,277 — 6,598 Other invested assets: Short-term investments — 468 — 468 Assets of consolidated VIEs/VOEs — — 16 16 Swaps — (326) — (326) Credit default swaps — 18 — 18 Options — 3,331 — 3,331 Total other invested assets — 3,491 16 3,507 Cash equivalents 1,155 — — 1,155 GMIB reinsurance contracts asset — — 2,466 2,466 Separate Accounts assets (4) 121,184 2,878 — 124,062 Total Assets $ 122,910 $ 73,386 $ 3,867 $ 200,163 Liabilities: GMxB derivative features’ liability $ — $ — $ 8,316 $ 8,316 SCS, SIO, MSO and IUL indexed features’ liability — 3,150 — 3,150 Total Liabilities $ — $ 3,150 $ 8,316 $ 11,466 ______________ (1) Corporate fixed maturities includes both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans.
Reconciliation of Assets and Liabilities at Level 3	The tables below present reconciliations for all Level 3 assets and liabilities for the three and nine months ended September 30, 2020 and 2019, respectively. Level 3 Instruments - Fair Value Measurements Corporate State and Political Subdivisions Asset-backed (in millions) Balance, July 1, 2020 $ 1,652 $ 40 $ — Total gains and (losses), realized and unrealized, included in: Net income (loss) as: Net investment income (loss) — — — Investment gains (losses), net (1) — — Subtotal (1) — — Other comprehensive income (loss) 18 (1) — Purchases (138) — 13 Sales (22) — — Transfers into Level 3 (1) (30) — — Transfers out of Level 3 (1) — — — Balance, September 30, 2020 $ 1,479 $ 39 $ 13 Balance, July 1, 2019 $ 1,290 $ 39 $ 534 Total gains and (losses), realized and unrealized, included in: Net income (loss) as: Net investment income (loss) — — — Investment gains (losses), net — — — Subtotal — — — Other comprehensive income (loss) (7) 1 — Purchases (2) — 71 Sales (42) (1) (73) Transfers into Level 3 (1) — — — Transfers out of Level 3 (1) (31) — — Balance, September 30, 2019 $ 1,208 $ 39 $ 532 ______________ (1) Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values. Corporate State and Political Subdivisions Asset-backed (in millions) Balance, January 1, 2020 $ 1,246 $ 39 $ 100 Total gains and (losses), realized and unrealized, included in: Net income (loss) as: Net investment income (loss) 2 — — Investment gains (losses), net (14) — — Subtotal (12) — — Corporate State and Political Subdivisions Asset-backed (in millions) Other comprehensive income (loss) (36) 1 — Purchases 207 — 13 Sales (112) (1) — Transfers into Level 3 (1) 189 — — Transfers out of Level 3 (1) (3) — (100) Balance, September 30, 2020 $ 1,479 $ 39 $ 13 Balance, January 1, 2019 $ 1,174 $ 38 $ 519 Total gains and (losses), realized and unrealized, included in: Net income (loss) as: Net investment income (loss) 3 — — Investment gains (losses), net — — — Subtotal 3 — — Other comprehensive income (loss) 3 3 5 Purchases 219 — 81 Sales (101) (2) (73) Transfers into Level 3 (1) 14 — — Transfers out of Level 3 (1) (104) — — Balance, September 30, 2019 $ 1,208 $ 39 $ 532 ______________ (1) Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values. Other Equity Investments GMIB Reinsurance Contract Asset Separate Accounts Assets GMxB Derivative Features Liability (in millions) Balance, July 1, 2020 $ 16 $ 3,433 $ — $ (12,458) Realized and unrealized gains (losses), included in Net income (loss) as: Investment gains (losses), net — — — — Net derivative gains (losses) (1) — (177) — 570 Total realized and unrealized gains (losses) — (177) — 570 Other comprehensive income (loss) — — — — Purchases (2) 3 11 — (113) Sales (3) — (21) — 16 Change in estimate (4) — 1 — — Activity related to consolidated VIEs/VOEs (3) — — — Transfers into Level 3 (5) — — — — Transfers out of Level 3 (5) — — — — Balance, September 30, 2020 $ 16 $ 3,247 $ — $ (11,985) Balance, July 1, 2019 $ 16 $ 2,198 $ 25 $ (6,813) Realized and unrealized gains (losses), included in Net income (loss) as: Investment gains (losses), net — — — — Net derivative gains (losses) — 664 — (2,535) Total realized and unrealized gains (losses) — 664 — (2,535) Other comprehensive income (loss) — — — — Purchases (2) — 11 (5) (100) Sales (3) — (20) (1) 12 Settlements — — (1) — Activity related to consolidated VIEs/VOEs — — — — Transfers into Level 3 (5) — — — — Transfers out of Level 3 (5) — — (11) — Balance, September 30, 2019 $ 16 $ 2,853 $ 7 $ (9,436) ______________ (1) The Company’s nonperformance risk impact of ($458) million for the GMxB derivative features liability and $6 million for the GMIB reinsurance contract asset the three months ended September 2020, respectively, is recorded through Net derivative gains (losses). (2) For the GMIB reinsurance contract asset and GMxB derivative features liability, represents attributed fee. (3) For the GMIB reinsurance contract asset, represents recoveries from reinsurers and for GMxB derivative features liability, represents benefits paid. (4) For the GMIB reinsurance contract asset, represents a transfer from amounts due from reinsurers. (5) Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values. Other Equity Investments GMIB Reinsurance Contract Asset Separate Accounts Assets GMxB Derivative Features Liability (in millions) Balance, January 1, 2020 $ 16 $ 2,466 $ — $ (8,316) Realized and unrealized gains (losses), included in Net income (loss) as: Investment gains (losses), net — — — — Net derivative gains (losses) (1) — 849 — (3,382) Total realized and unrealized gains (losses) — 849 — (3,382) Other comprehensive income (loss) — Purchases (2) 4 34 — (328) Sales (3) — (58) — 41 Settlements — — — — Change in estimate (4) — (44) — — Activity related to consolidated VIEs/VOEs (4) — — — Transfers into Level 3 (5) — — — — Transfers out of Level 3 (5) — — — — Balance, September 30, 2020 $ 16 $ 3,247 $ — $ (11,985) Balance, January 1, 2019 $ 48 $ 1,993 $ 21 $ (5,491) Realized and unrealized gains (losses), included in Net income (loss) as: Investment gains (losses), net — — — — Net derivative gains (losses) — 881 — (3,656) Total realized and unrealized gains (losses) — 881 — (3,656) Other comprehensive income (loss) — — — — Purchases (2) — 34 3 (309) Sales (3) — (55) (1) 20 Settlements — — (4) — Activity related to consolidated VIEs/VOEs (3) — — — Transfers into Level 3 (5) — — — — Transfers out of Level 3 (5) (29) — (12) — Balance, September 30, 2019 $ 16 $ 2,853 $ 7 $ (9,436) ______________ (1) The Company’s nonperformance risk impact of $35 million for the GMxB derivative features liability and ($50) million for the GMIB reinsurance contract asset the nine months ended September 2020, respectively, is recorded through Net derivative gains (losses). (2) For the GMIB reinsurance contract asset and GMxB derivative features liability, represents attributed fee. (3) For the GMIB reinsurance contract asset, represents recoveries from reinsurers and for GMxB derivative features liability, represents benefits paid. (4) For the GMIB reinsurance contract asset, represents a transfer from amounts due from reinsurers. (5) Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values. The table below details changes in unrealized gains (losses) for the nine months ended September 30, 2020 and 2019 by category for Level 3 assets and liabilities still held at September 30, 2020 and 2019, respectively. Change in Unrealized Gains (Losses) for Level 3 Instruments Net Income (Loss) Investment Gains (Losses), Net Net Derivative Gains (Losses) OCI (in millions) Held at September 30, 2020: Change in unrealized gains (losses): Fixed maturities, AFS: Corporate $ — $ — $ (37) State and political subdivisions — — 2 Total fixed maturities, AFS — — (35) GMIB reinsurance contracts — 849 — GMxB derivative features liability — (3,382) — Total $ — $ (2,533) $ (35) Held at September 30, 2019: Change in unrealized gains (losses): Fixed maturities, AFS: Corporate $ — $ — $ 3 State and political subdivisions — — 3 Asset-backed — — 4 Total fixed maturities, AFS — — 10 GMIB reinsurance contracts — 881 — Separate Account assets (14) — — GMxB derivative features liability — (3,656) — Total $ (14) $ (2,775) $ 10
Quantitative Information About Level 3 Fair Value Measurement	The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities at September 30, 2020 and December 31, 2019, respectively. Quantitative Information about Level 3 Fair Value Measurements at September 30, 2020 Fair Value Valuation Technique Significant Unobservable Input Range Weighted Average (2) (in millions) Assets: Investments: Fixed maturities, AFS: Corporate $ 25 Matrix pricing Spread over Benchmark 270 - 610 bps 288 bps 1,105 Market EBITDA multiples 3.5x-31.8x 14.4x Fair Value Valuation Technique Significant Unobservable Input Range Weighted Average (2) (in millions) Other equity investments 4 Market comparable companies Revenue multiple 3.5x - 18.0x 9.5x GMIB reinsurance contract asset 3,247 Discounted cash flow Non-performance risk 60 - 125 bps 72 bps Liabilities: GMIBNLG 11,682 Discounted cash flow Non-performance risk 141.0 bps GWBL/GMWB 220 Discounted cash flow Non-performance risk 141.0 bps GIB 77 Discounted cash flow Non-performance risk 141.0 bps GMAB 6 Discounted cash flow Non-performance risk 141.0 bps ______________ (1) Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives. (2) For Lapses, Withdrawals, and Utilizations the rates were weighted by counts, for Mortality weighted average rates are shown for all ages combined and for Withdrawals the weighted averages were based on an estimated split of partial withdrawal and dollar-for-dollar withdrawals. Quantitative Information about Level 3 Fair Value Measurements at December 31, 2019 Fair Value Valuation Technique Significant Unobservable Input Range Weighted Average (in millions) Assets: Investments: Fixed maturities, AFS: Corporate $ 51 Matrix pricing model Spread over benchmark 65 - 580 bps 186 bps 1,025 Market comparable companies EBITDA multiples 3.3x - 56.7x 14.3x GMIB reinsurance contract asset 2,466 Discounted cash flow Non-performance risk 55 - 109 bps Liabilities: GMIBNLG 8,135 Discounted cash flow Non-performance risk 124 bps GWBL/GMWB 172 Discounted cash flow Non-performance risk 124 bps GIB 5 Discounted cash flow Non-performance risk 124 bps GMAB 4 Discounted cash flow Lapse rates 1.0% - 10.0% ______________ (1) Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives.
Fair Value Disclosure Financial Instruments Not Carried At Fair Value	The carrying values and fair values at September 30, 2020 and December 31, 2019 for financial instruments not otherwise disclosed in Note 3 and Note 4 are presented in the table below. Carrying Values and Fair Values for Financial Instruments Not Otherwise Disclosed Carrying Value Fair Value Level 1 Level 2 Level 3 Total (in millions) September 30, 2020: Mortgage loans on real estate $ 12,785 $ — $ — $ 13,032 $ 13,032 Policy loans $ 3,647 $ — $ — $ 4,726 $ 4,726 Loans to affiliates $ 1,200 $ — $ 1,241 $ — $ 1,241 Policyholders’ liabilities: Investment contracts $ 2,063 $ — $ — $ 2,280 $ 2,280 FHLB funding agreements (1) $ 6,848 $ — $ 6,940 $ — $ 6,940 FABN funding agreements (2) $ 1,143 $ — $ 1,168 $ — $ 1,168 Separate Accounts liabilities $ 9,000 $ — $ — $ 9,000 $ 9,000 December 31, 2019: Mortgage loans on real estate $ 12,090 $ — $ — $ 12,317 $ 12,317 Policy loans $ 3,270 $ — $ — $ 4,199 $ 4,199 Loans to affiliates $ 1,200 $ — $ 1,224 $ — $ 1,224 Policyholders’ liabilities: Investment contracts $ 1,922 $ — $ — $ 2,029 $ 2,029 FHLB funding agreements (1) $ 6,909 $ — $ 6,957 $ — $ 6,957 Separate Accounts liabilities $ 9,041 $ — $ — $ 9,041 $ 9,041 _____________ (1) Federal Home Loan Bank of New York (“FHLB”) (2) Funding Agreement Backed Notes Program (“FABN”) (3) Excludes amounts reclassified as Held-for-Sale.

EQUITY (Tables)

EQUITY (Tables)	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	AOCI represents cumulative gains (losses) on items that are not reflected in Net income (loss). The balances as of September 30, 2020 and 2019 follow: September 30, 2020 2019 (in millions) Unrealized gains (losses) on investments $ 4,927 $ 2,226 Defined benefit pension plans (4) (7) Accumulated other comprehensive income (loss) attributable to Equitable Financial $ 4,923 $ 2,220
Components of Accumulated Other Comprehensive Income (Loss), Net of Taxes	The components of OCI, net of taxes for the three and nine months ended September 30, 2020 and 2019, follow: Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (in millions) Change in net unrealized gains (losses) on investments: Net unrealized gains (losses) arising during the period $ 295 $ 1,224 $ 4,524 $ 3,750 (Gains) losses reclassified into net income (loss) during the period (1) (23) (159) (205) (157) Net unrealized gains (losses) on investments 271 1,065 4,318 3,593 Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other (24) (335) (992) (872) Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of 66, $194, $884 and $718) 247 730 3,327 2,721 Other comprehensive income (loss), attributable to Equitable Financial $ 247 $ 730 $ 3,327 $ 2,721 ____________ (1) See “Reclassification adjustments” in Note 3. Reclassification amounts presented net of income tax expense (benefit) of $(6) million, $(42) million, $(55) million and $(42) million for the three and nine months ended September 30, 2020 and 2019, respectively.

REDEEMABLE NONCONTROLLING INT_2

REDEEMABLE NONCONTROLLING INTEREST (Tables)	9 Months Ended
	Sep. 30, 2020
Noncontrolling Interest [Abstract]
Redeemable Noncontrolling Interest	The changes in the components of redeemable noncontrolling interests are presented in the table that follows: Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (in millions) Balance, beginning of period $ 36 $ 42 $ 39 $ 39 Net earnings (loss) attributable to redeemable noncontrolling interests 3 — — 3 Purchase/change of redeemable noncontrolling interests (1) 4 (1) 4 Balance, end of period $ 38 $ 46 $ 38 $ 46

COMMITMENTS AND CONTINGENT LI_2

COMMITMENTS AND CONTINGENT LIABILITIES (Tables)	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Activity of Funding Agreements	Change in FHLB Funding Agreements during the Nine Months Ended September 30, 2020 Outstanding Balance at December 31, 2019 Issued During the Period Repaid During the Period Long-term Agreements Maturing Within One Year Long-term Agreements Maturing Within Five Years Outstanding Balance at September 30, 2020 (in millions) Short-term funding agreements: Due in one year or less $ 4,608 $ 34,298 $ 34,358 $ 490 $ — $ 5,038 Long-term funding agreements: Due in years two through five 1,646 — — (490) 112 1,268 Due in more than five years 646 — — — (112) 534 Total long-term funding agreements 2,292 — — (490) — 1,802 Total funding agreements (1) $ 6,900 $ 34,298 $ 34,358 $ — $ — $ 6,840 ____________ (1) The $8 million and $9 million difference between the funding agreements carrying value shown in fair value table for September 30, 2020 and December 31, 2019, respectively, reflects the remaining amortization of a hedge implemented and closed, which locked in the funding agreements borrowing rates. Change in FABN Funding Agreements during the Nine Months Ended September 30, 2020 Outstanding Balance at December 31, 2019 Issued During the Period Repaid During the Period Long-term Agreements Maturing Within One Year Long-term Agreements Maturing Within Five Years Outstanding Balance at September 30, 2020 (in millions) Short-term funding agreements: Due in one year or less — $ — $ — $ — $ — $ — Long-term funding agreements: Due in years two through five — 650 — — — 650 Due in more than five years — 500 — — — 500 Total long-term funding agreements — 1,150 — — — 1,150 Total funding agreements (1) $ — $ 1,150 $ — $ — $ — $ 1,150 _____________ (1) The $7 million difference between the funding agreements notional value shown and carrying value table at September 30,

REVISION OF PRIOR PERIOD FINA_2

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS (Tables)	9 Months Ended
	Sep. 30, 2020
Accounting Changes and Error Corrections [Abstract]
Financial Information Affected by Revisions and Change in Accounting Principle	The following tables present line items for prior period financial statements that have been affected by the revision. For these line items, the tables detail the amounts as previously reported, the impact upon those line items due to the revision, and the amounts as currently revised within the financial statements. June 30, 2020 March 31, 2020 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Balance Sheets: ASSETS Other invested assets 1,962 — 1,962 1,595 12 1,607 Deferred policy acquisition costs 3,746 (70) 3,676 4,068 (85) 3,983 Total Assets $ 232,378 $ (70) $ 232,308 $ 218,841 $ (73) $ 218,768 LIABILITIES Future policy benefits and other policyholders’ liabilities 41,382 29 41,411 37,830 32 37,862 Current and deferred income taxes 1,020 (21) 999 1,637 (22) 1,615 Total Liabilities $ 217,176 $ 8 $ 217,184 $ 199,928 $ 10 $ 199,938 EQUITY Retained earnings 2,658 (78) 2,580 7,953 (83) 7,870 Total equity attributable to Equitable Financial 15,157 (78) 15,079 18,872 (83) 18,789 Total Equity 15,166 (78) 15,088 18,881 (83) 18,798 Total Liabilities, Redeemable Noncontrolling interest and Equity 232,378 (70) 232,308 $ 218,841 $ (73) $ 218,768 December 31, 2019 December 31, 2018 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Balance Sheets: ASSETS Investments: Deferred policy acquisition costs 4,337 (115) 4,222 5,011 (52) 4,959 Amounts due from reinsurers 3,001 1 3,002 3,124 — 3,124 GMIB reinsurance contract asset, at fair value 2,466 — 2,466 1,991 1 1,992 Current and deferred income taxes 224 25 249 438 35 473 Other assets 3,050 — 3,050 2,763 22 2,785 Total Assets $ 228,041 $ (89) $ 227,952 $ 199,952 $ 6 $ 199,958 LIABILITIES Future policy benefits and other policyholders’ liabilities 33,976 3 33,979 29,808 75 29,883 Other liabilities 1,768 1 1,769 1,460 — 1,460 Total Liabilities $ 216,344 $ 4 $ 216,348 $ 187,485 $ 75 $ 187,560 EQUITY Retained earnings 2,242 (97) 2,145 5,098 (59) 5,039 Accumulated other comprehensive income (loss) 1,592 4 1,596 (491) (10) (501) Total equity attributable to Equitable Financial 11,645 (93) 11,552 12,416 (69) 12,347 Total Equity 11,658 (93) 11,565 12,428 (69) 12,359 Total Liabilities, Redeemable Noncontrolling interest and Equity $ 228,041 $ (89) $ 227,952 $ 199,952 $ 6 $ 199,958 Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Income (Loss) REVENUES Policy charges and fee income $ 825 $ (1) $ 824 $ 1,729 $ — $ 1,729 Net derivative gains (losses) (5,903) (5) (5,908) 3,630 (6) 3,624 Net investment income (loss) 934 (13) 921 1,525 — 1,525 Other income 8 2 10 25 — 25 Total revenues (3,557) (17) (3,574) 8,031 (6) 8,025 BENEFITS AND OTHER DEDUCTIONS Policyholders' benefits 700 (9) 691 3,297 20 3,317 Amortization of deferred policy acquisition costs 164 (15) 149 1,222 (51) 1,171 Other operating costs and expenses 218 — 218 431 1 432 Total benefits and deductions 1,563 (24) 1,539 5,961 (30) 5,931 Income (loss) from continuing operations, before income taxes (5,120) 7 (5,113) 2,070 24 2,094 Income tax (expense) benefit from continuing operations 1,029 (2) 1,027 (425) (5) (430) Net income (loss) (4,091) 5 (4,086) 1,645 19 1,664 Net income (loss) attributable to Equitable Financial $ (4,095) $ 5 $ (4,090) $ 1,648 $ 19 $ 1,667 Three Months Ended March 31, 2020 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Income (Loss) REVENUES: Policy charges and fee income 904 1 905 Net derivative gains (losses) 9,533 (1) 9,532 Net investment income (loss) 591 13 604 Other income 17 (2) 15 Total revenues 11,588 11 11,599 BENEFITS AND OTHER DEDUCTIONS Policyholders' benefits 2,597 29 2,626 Interest credited to policyholders’ account balances 289 — 289 Amortization of deferred policy acquisition costs 1,058 (36) 1,022 Other operating costs and expenses 213 1 214 Total benefits and deductions 4,398 (6) 4,392 Income (loss) from continuing operations, before income taxes 7,190 17 7,207 Income tax (expense) benefit from continuing operations (1,454) (3) (1,457) Net income (loss) 5,736 14 5,750 Net income (loss) attributable to Equitable Financial $ 5,743 $ 14 $ 5,757 Year Ended December 31, 2019 Year Ended December 31, 2018 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Income (Loss) REVENUES Policy charges and fee income $ 3,450 $ 37 $ 3,487 $ 3,523 $ (8) $ 3,515 Net derivative gains (losses) (3,820) (11) (3,831) (1,010) (24) (1,034) Other income 56 — 56 65 (1) 64 Total revenues 5,148 26 5,174 6,951 (33) 6,918 BENEFITS AND OTHER DEDUCTIONS Policyholders' benefits 4,119 (31) 4,088 3,005 (45) 2,960 Interest credited to policyholders’ account balances 1,127 22 1,149 1,002 (23) 979 Commissions 629 — 629 620 5 625 Amortization of deferred policy acquisition costs 452 68 520 431 20 451 Other operating costs and expenses 912 — 912 2,918 1 2,919 Total benefits and deductions 7,578 59 7,637 8,432 (42) 8,390 Income (loss) from continuing operations, before income taxes (2,430) (33) (2,463) (1,481) 9 (1,472) Income tax (expense) benefit from continuing operations 584 (5) 579 446 10 456 Net income (loss) (1,846) (38) (1,884) (921) 19 (902) Net income (loss) attributable to Equitable Financial $ (1,851) $ (38) $ (1,889) $ (918) $ 19 $ (899) Three Months Ended September 30, 2019 Nine Months Ended September 30, 2019 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Income (Loss) REVENUES Policy charges and fee income $ 853 $ 46 $ 899 $ 2,577 $ 42 $ 2,619 Net derivative gains (losses) (342) (1) (343) (2,075) (5) (2,080) Other income — (1) (1) 40 (1) 39 Total revenues 1,946 44 1,990 4,707 36 4,743 BENEFITS AND OTHER DEDUCTIONS Policyholders' benefits 1,634 8 1,642 3,321 35 3,356 Interest credited to policyholders’ account balances 280 16 296 837 22 859 Amortization of deferred policy acquisition costs 32 22 54 341 4 345 Total benefits and deductions 2,383 46 2,429 5,816 61 5,877 Income (loss) from continuing operations, before income taxes (437) (2) (439) (1,109) (25) (1,134) Income tax (expense) benefit from continuing operations 175 — 175 284 5 289 Net income (loss) (262) (2) (264) (825) (20) (845) Net income (loss) attributable to Equitable Financial $ (262) $ (2) $ (264) $ (828) $ (20) $ (848) Three Months Ended June 30, 2019 Six Months Ended June 30, 2019 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Income (Loss) REVENUES Policy charges and fee income $ 865 $ (2) $ 863 $ 1,724 $ (4) $ 1,720 Net derivative gains (losses) (178) (1) (179) (1,733) (4) (1,737) Total revenues 2,071 (3) 2,068 2,761 (8) 2,753 BENEFITS AND OTHER DEDUCTIONS Policyholders' benefits 868 (7) 861 1,687 27 1,714 Interest credited to policyholders’ account balances 288 3 291 557 6 563 Amortization of deferred policy acquisition costs 144 (2) 142 309 (18) 291 Total benefits and deductions 1,753 (6) 1,747 3,433 15 3,448 Income (loss) from continuing operations, before income taxes 318 3 321 (672) (23) (695) Income tax (expense) benefit from continuing operations (53) — (53) 109 5 114 Net income (loss) 265 3 268 (563) (18) (581) Net income (loss) attributable to Equitable Financial $ 264 $ 3 $ 267 $ (566) $ (18) $ (584) Three Months Ended March 31, 2019 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Income (Loss) REVENUES: Policy charges and fee income 859 (2) 857 Net derivative gains (losses) (1,555) (3) (1,558) Net investment income (loss) 904 — 904 Other income 10 — 10 Total revenues 690 (5) 685 BENEFITS AND OTHER DEDUCTIONS Policyholders' benefits 819 34 853 Interest credited to policyholders’ account balances 269 3 272 Amortization of deferred policy acquisition costs 165 (16) 149 Other operating costs and expenses 184 — 184 Total benefits and deductions 1,680 21 1,701 Income (loss) from continuing operations, before income taxes (990) (26) (1,016) Income tax (expense) benefit from continuing operations 162 5 167 Net income (loss) (828) (21) (849) Net income (loss) attributable to Equitable Financial $ (830) $ (21) $ (851) Year Ended December 31, 2017 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Income (Loss) REVENUES: Policy charges and fee income 3,294 (5) 3,289 Net derivative gains (losses) 894 (16) 878 Total revenues 8,456 (21) 8,435 BENEFITS AND OTHER DEDUCTIONS Policyholders' benefits 3,473 8 3,481 Commissions 628 7 635 Amortization of deferred policy acquisition costs 900 25 925 Total benefits and deductions 6,907 40 6,947 Income (loss) from continuing operations, before income taxes 1,549 (61) 1,488 Income tax (expense) benefit from continuing operations 1,210 8 1,218 Net income (loss) from continuing operations 2,759 (53) 2,706 Net income (loss) 2,844 (53) 2,791 Net income (loss) attributable to Equitable Financial $ 2,843 $ (53) $ 2,790 Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Comprehensive Income (Loss) Net income (loss) $ (4,091) $ 5 $ (4,086) $ 1,645 $ 19 $ 1,664 Change in unrealized gains (losses), net of reclassification adjustment 1,569 — 1,569 3,083 (4) 3,079 Other comprehensive income 1,570 — 1,570 3,084 (4) 3,080 Comprehensive income (loss) (2,521) 5 (2,516) 4,729 15 4,744 Less: Comprehensive income (loss) attributable to noncontrolling interest (3) 7 4 (3) — (3) Comprehensive income (loss) attributable to Equitable Financial $ (2,518) $ (2) $ (2,520) $ 4,732 $ 15 $ 4,747 Three Months Ended March 31, 2020 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Comprehensive Income (Loss) Net income (loss) $ 5,736 $ 14 $ 5,750 Change in unrealized gains (losses), net of reclassification adjustment 1,514 (4) 1,510 Other comprehensive income 1,514 (4) 1,510 Comprehensive income (loss) 7,250 10 7,260 Comprehensive income (loss) attributable to Equitable Financial $ 7,257 $ 10 $ 7,267 Year Ended December 31, 2019 Year Ended December 31, 2018 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Comprehensive Income (Loss) Net income (loss) $ (1,846) $ (38) $ (1,884) $ (921) $ 19 $ (902) Change in unrealized gains (losses), net of reclassification adjustment 2,081 14 2,095 (1,230) 9 (1,221) Other comprehensive income 2,083 14 2,097 (1,234) 9 (1,225) Comprehensive income (loss) 237 (24) 213 (2,155) 28 (2,127) Less: Comprehensive income (loss) attributable to noncontrolling interest — 5 5 — (3) (3) Comprehensive income (loss) attributable to Equitable Financial $ 237 $ (29) $ 208 $ (2,155) $ 31 $ (2,124) Three Months Ended September 30, 2019 Nine Months Ended September 30, 2019 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Comprehensive Income (Loss) Net income (loss) $ (262) $ (2) $ (264) $ (825) $ (20) $ (845) Change in unrealized gains (losses), net of reclassification adjustment 574 156 730 2,629 92 2,721 Other comprehensive income 574 156 730 2,629 92 2,721 Comprehensive income (loss) 312 154 466 1,804 72 1,876 Less: Comprehensive income (loss) attributable to noncontrolling interest — — — — 3 3 Comprehensive income (loss) attributable to Equitable Financial $ 312 $ 154 $ 466 $ 1,804 $ 69 $ 1,873 Three Months Ended June 30, 2019 Six Months Ended June 30, 2019 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Comprehensive Income (Loss) Net income (loss) $ 265 $ 3 $ 268 $ (563) $ (18) $ (581) Change in unrealized gains (losses), net of reclassification adjustment 1,291 (65) 1,226 2,055 (64) 1,991 Other comprehensive income 1,291 (65) 1,226 2,055 (64) 1,991 Comprehensive income (loss) 1,556 (62) 1,494 1,492 (82) 1,410 Less: Comprehensive income (loss) attributable to noncontrolling interest — 1 1 — 3 3 Comprehensive income (loss) attributable to Equitable Financial $ 1,556 $ (63) $ 1,493 $ 1,492 $ (85) $ 1,407 Three Months Ended March 31, 2019 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Comprehensive Income (Loss) Net income (loss) $ (828) $ (21) $ (849) Change in unrealized gains (losses), net of reclassification adjustment 764 1 765 Other comprehensive income 764 1 765 Comprehensive income (loss) (64) (20) (84) Less: Comprehensive income (loss) attributable to noncontrolling interest — 2 2 Comprehensive income (loss) attributable to Equitable Financial $ (64) $ (22) $ (86) Year Ended December 31, 2017 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Comprehensive Income: Net income (loss) $ 2,844 $ (53) $ 2,791 Change in unrealized gains (losses), net of reclassification adjustment 584 (20) 564 Other comprehensive income 602 (20) 582 Comprehensive income (loss) 3,446 (73) 3,373 Less: Comprehensive income (loss) attributable to noncontrolling interest — 1 1 Comprehensive income (loss) attributable to Equitable Financial $ 3,446 $ (74) $ 3,372 Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Equity: Retained earnings, beginning of year $ 7,953 $ (83) $ 7,870 $ 2,242 $ (97) $ 2,145 Net income (loss) attributable to Equitable Financial (4,095) 5 (4,090) 1,648 19 1,667 Retained earnings, end of period $ 2,658 $ (78) $ 2,580 $ 2,658 $ (78) $ 2,580 Accumulated other comprehensive income (loss), beginning of year $ 3,106 $ — $ 3,106 $ 1,592 $ 4 $ 1,596 Other comprehensive income (loss) 1,570 — 1,570 3,084 (4) 3,080 Total Equitable Financial equity, end of period $ 15,157 $ (78) $ 15,079 $ 15,157 $ (78) $ 15,079 Total equity, end of period $ 15,166 $ (78) $ 15,088 $ 15,166 $ (78) $ 15,088 Three Months Ended March 31, 2020 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Equity: Retained earnings, beginning of year $ 2,242 $ (97) $ 2,145 Net income (loss) attributable to Equitable Financial 5,743 $ 14 5,757 Retained earnings, end of period $ 7,953 $ (83) $ 7,870 Accumulated other comprehensive income (loss), beginning of year $ 1,592 $ 4 $ 1,596 Other comprehensive income (loss) 1,514 (4) 1,510 Total Equitable Financial equity, end of period $ 18,872 $ (83) $ 18,789 Total equity, end of period $ 18,881 $ (83) $ 18,798 Year Ended December 31, 2019 Year Ended December 31, 2018 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Equity: Retained earnings, beginning of year $ 5,098 $ (59) $ 5,039 $ 8,938 $ (78) $ 8,860 Net income (loss) attributable to Equitable Financial (1,851) (38) (1,889) (918) 19 (899) Retained earnings, end of year $ 2,242 $ (97) $ 2,145 $ 5,098 $ (59) $ 5,039 Accumulated other comprehensive income (loss), beginning of year $ (491) $ (10) $ (501) $ 598 $ (19) $ 579 Other comprehensive income (loss) 2,083 14 2,097 (1,234) 9 (1,225) Accumulated other comprehensive income (loss), end of year $ 1,592 $ 4 $ 1,596 $ (491) $ (10) $ (501) Total Equitable Financial equity, end of year $ 11,645 $ (93) $ 11,552 $ 12,416 $ (69) $ 12,347 Total equity, end of year $ 11,658 $ (93) $ 11,565 $ 12,428 $ (69) $ 12,359 Three Months Ended September 30, 2019 Nine Months Ended September 30, 2019 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Equity: Retained earnings, beginning of year $ 4,532 $ (77) $ 4,455 $ 5,098 $ (59) $ 5,039 Net income (loss) attributable to Equitable Financial (262) (2) (264) (828) (20) (848) Retained earnings, end of period $ 3,270 $ (79) $ 3,191 $ 3,270 $ (79) $ 3,191 Accumulated other comprehensive income (loss), beginning of year $ 1,564 $ (74) $ 1,490 $ (491) $ (10) $ (501) Other comprehensive income (loss) 574 156 730 2,629 92 2,721 Accumulated other comprehensive income (loss), end of period $ 2,138 $ 82 $ 2,220 $ 2,138 $ 82 $ 2,220 Total Equitable Financial equity, end of period $ 13,239 $ 3 $ 13,242 $ 13,239 $ 3 $ 13,242 Total equity, end of period $ 13,251 $ 3 $ 13,254 $ 13,251 $ 3 $ 13,254 Three Months Ended June 30, 2019 Six Months Ended June 30, 2019 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Equity: Retained earnings, beginning of year $ 4,268 $ (80) $ 4,188 $ 5,098 $ (59) $ 5,039 Net income (loss) attributable to Equitable Financial 264 3 267 (566) (18) (584) Retained earnings, end of period $ 4,532 $ (77) $ 4,455 $ 4,532 $ (77) $ 4,455 Accumulated other comprehensive income (loss), beginning of year $ 273 $ (9) $ 264 $ (491) $ (10) $ (501) Other comprehensive income (loss) 1,291 (65) 1,226 2,055 (64) 1,991 Accumulated other comprehensive income (loss), end of period $ 1,564 $ (74) $ 1,490 $ 1,564 $ (74) $ 1,490 Total Equitable Financial equity, end of period $ 13,920 $ (151) $ 13,769 $ 13,920 $ (151) $ 13,769 Total equity, end of period $ 13,932 $ (151) $ 13,781 $ 13,932 $ (151) $ 13,781 Three Months Ended March 31, 2019 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Equity: Retained earnings, beginning of year $ 5,098 $ (59) $ 5,039 Net income (loss) attributable to Equitable Financial (830) $ (21) (851) Retained earnings, end of period $ 4,268 $ (80) $ 4,188 Accumulated other comprehensive income (loss), beginning of year $ (491) $ (10) $ (501) Other comprehensive income (loss) 764 1 765 Accumulated other comprehensive income (loss), end of period $ 273 $ (9) $ 264 Total Equitable Financial equity, end of period $ 12,358 $ (89) $ 12,269 Total equity, end of period $ 12,370 $ (89) $ 12,281 Year Ended December 31, 2017 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Equity: Retained earnings, beginning of year $ 6,095 $ (25) $ 6,070 Net income (loss) attributable to Equitable Financial 2,843 $ (53) 2,790 Retained earnings, end of period $ 8,938 $ (78) $ 8,860 Accumulated other comprehensive income (loss), beginning of year $ (4) $ 1 $ (3) Other comprehensive income (loss) 602 (20) 582 Accumulated other comprehensive income (loss), end of period $ 598 $ (19) $ 579 Total Equitable Financial equity, end of period $ 16,397 $ (97) $ 16,300 Total equity, end of period $ 19,492 $ (97) $ 19,395 June 30, 2020 March 31, 2020 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Cash Flows: Cash flow from operating activities: Net income (loss) $ 1,645 $ 19 $ 1,664 $ 5,736 $ 14 $ 5,750 Policy charges and fee income (1,729) — (1,729) (904) (1) (905) Net derivative (gains) losses (3,630) 6 (3,624) (9,533) 1 (9,532) Amortization and depreciation 1,181 (51) 1,130 1,025 (35) 990 Future policy benefits 1,666 20 1,686 1,817 29 1,846 Reinsurance recoverable (149) — (149) (97) 1 (96) Current and deferred income taxes 433 6 439 1,462 3 1,465 Net cash provided by (used in) operating activities $ (868) $ — $ (868) $ (621) $ 12 $ (609) Change in collateralized pledged assets 58 — 58 45 (1) 44 Change in collateralized pledged liabilities 247 — 247 667 (11) 656 Net cash provided by (used in) financing activities $ 2,308 $ — $ 2,308 $ 2,504 $ (12) $ 2,492 Cash and cash equivalents, end of period $ 4,318 $ — $ 4,318 $ 7,492 $ — $ 7,492 December 31, 2019 December 31, 2018 As Previously Impact of Revisions As Revised As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Cash Flows: Cash flow from operating activities: Net income (loss) (1) $ (1,846) $ (38) $ (1,884) $ (358) $ 19 $ (339) Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities: Policy charges and fee income (3,450) (37) (3,487) (3,523) 8 (3,515) Interest credited to policyholders' account balances 1,127 22 1,149 1,002 (23) 979 Net derivative (gains) losses 3,820 11 3,831 1,010 24 1,034 Amortization and depreciation 323 68 391 340 20 360 Capitalization of DAC (648) — (648) (597) 5 (592) Future policy benefits 1,115 (31) 1,084 (284) (46) (330) Current and deferred income taxes (334) 5 (329) (556) (7) (563) Net cash provided by (used in) operating activities $ (606) $ — $ (606) $ 1,418 $ — $ 1,418 Cash and cash equivalents, end of period $ 1,492 $ — $ 1,492 $ 2,622 $ — $ 2,622 _____________ (1) December 31, 2018 Net Income (Loss) includes $563 million of discontinued operations that are not included in Net Income (Loss) in the Consolidated Statement of Income (Loss). September 30, 2019 June 30, 2019 As Previously Impact of Revisions As Revised As Previously Reported Impact of Revisions As Revised (in millions) Consolidated Statements of Cash Flows: Cash flow from operating activities: Net income (loss) $ (825) $ (20) $ (845) $ (563) $ (18) $ (581) Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities: Policy charges and fee income (2,577) (42) (2,619) (1,724) 4 (1,720) Interest credited to policyholders' account balances 837 22 859 557 6 563 Net derivative (gains) losses 2,075 5 2,080 1,733 4 1,737 Amortization and depreciation 267 4 271 268 (18) 250 Future policy benefits 1,035 40 1,075 91 27 118 Reinsurance recoverable (123) (4) (127) (59) — (59) Current and deferred income taxes (81) (5) (86) 99 (5) 94 Net cash provided by (used in) operating activities $ (712) $ — $ (712) $ (283) $ — $ (283) Cash and cash equivalents, end of period $ 1,553 $ — $ 1,553 $ 3,093 $ — $ 3,093 March 31, 2019 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Cash Flows: Cash flow from operating activities: Net income (loss) $ (828) $ (21) $ (849) Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities: Policy charges and fee income (859) 2 (857) Interest credited to policyholders' account balances 269 3 272 Net derivative (gains) losses 1,555 3 1,558 Amortization and depreciation 143 (16) 127 Future policy benefits 41 34 75 Current and deferred income taxes 54 (5) 49 Net cash provided by (used in) operating activities $ (148) $ — $ (148) Cash and cash equivalents, end of period 2,922 — 2,922 December 31, 2017 As Previously Impact of Revisions As Revised (in millions) Consolidated Statements of Cash Flows: Cash flow from operating activities: Net income (loss) (1) $ 3,377 $ (54) $ 3,323 Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities: Policy charges and fee income (3,294) 5 (3,289) Net derivative (gains) losses (870) 16 (854) Amortization and depreciation 825 25 850 Future policy benefits 1,189 8 1,197 Net cash provided by (used in) operating activities $ (381) $ — $ (381) Cash and cash equivalents, end of period 3,409 — 3,409 _____________ (1) Net Income (Loss) includes $533 million of discontinued operations that are not included in Net Income (Loss) in the Consolidated Statement of Income (Loss).

ORGANIZATION - Narrative (Detai

ORGANIZATION - Narrative (Details)	9 Months Ended
	Sep. 30, 2020principalSubsidiary
Organization [Abstract]
Number of principal subsidiaries	2

SIGNIFICANT ACCOUNTING POLICI_4

SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details) - USD ($) $ in Millions	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Jan. 01, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' equity	$ 14,399	$ 15,088	$ 18,798		$ 11,565	$ 13,254	$ 13,781	$ 12,281	$ 12,359	$ 19,395
Retained Earnings
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' equity	$ 1,634	$ 2,580	$ 7,870		2,145	$ 3,191	$ 4,455	$ 4,188	$ 5,039	$ 8,860	$ 6,070
Cumulative effect of period of adoption, adjusted balance
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' equity					(32)
Cumulative effect of period of adoption, adjusted balance | Retained Earnings
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' equity					$ (32)
Accounting Standards Update 2016-13 | Cumulative effect of period of adoption, adjusted balance | Retained Earnings
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' equity				$ (40)

SIGNIFICANT ACCOUNTING POLICI_5

SIGNIFICANT ACCOUNTING POLICIES - Investments and Commercial and Agricultural Mortgage Loans on Real Estate (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Mortgage Loans on Real Estate, Write-down or Reserve, Management Judgment Factor [Line Items]
Carrying value of COLI	$ 962	$ 942
Real estate held for the production of income | Minimum
Mortgage Loans on Real Estate, Write-down or Reserve, Management Judgment Factor [Line Items]
Real estate held for the production of income, useful lives	40 years
Real estate held for the production of income | Maximum
Mortgage Loans on Real Estate, Write-down or Reserve, Management Judgment Factor [Line Items]
Real estate held for the production of income, useful lives	50 years

SIGNIFICANT ACCOUNTING POLICI_6

SIGNIFICANT ACCOUNTING POLICIES - Accounting and Consolidation of Variable Interest Entities (VIEs) (Details) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2020USD ($)joint_venture	Dec. 31, 2019USD ($)joint_venture	Jun. 30, 2020USD ($)	Mar. 31, 2020USD ($)	Dec. 31, 2018USD ($)
Variable Interest Entity [Line Items]
Assets	$ 239,945	$ 227,952	$ 232,308	$ 218,768	$ 199,958
Consolidated Variable Interest Entities
Variable Interest Entity [Line Items]
Number of consolidated real estate joint ventures | joint_venture	1	1
Assets	$ 31	$ 32
Non-consolidated Vairable Interest Entities
Variable Interest Entity [Line Items]
Assets	156,600	160,200
Investment assets	1,200	1,100
Variable interest, maximum loss exposure	1,200	1,100
Unfunded commitments	1,200	1,100
Operating income (loss)	$ (4)	$ (5)
Number of non-consolidated real estate joint ventures | joint_venture	1	1
Special Purpose Entity
Variable Interest Entity [Line Items]
Investment assets	$ 18

SIGNIFICANT ACCOUNTING POLICI_7

SIGNIFICANT ACCOUNTING POLICIES - Assumption Updates and Model Changes (Details) - USD ($)	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Change in Accounting Estimate [Line Items]
Policy charges and fee income	$ 853,000,000	$ 824,000,000	$ 905,000,000	$ 899,000,000	$ 863,000,000	$ 857,000,000	$ 1,729,000,000	$ 1,720,000,000	$ 2,582,000,000	$ 2,619,000,000	$ 3,487,000,000	$ 3,515,000,000	$ 3,289,000,000
Policyholders’ benefits	950,000,000	691,000,000	2,626,000,000	1,642,000,000	861,000,000	853,000,000	3,317,000,000	1,714,000,000	4,267,000,000	3,356,000,000	4,088,000,000	2,960,000,000	3,481,000,000
Interest credited to policyholders’ account balances	277,000,000		289,000,000	296,000,000	291,000,000	272,000,000		563,000,000	845,000,000	859,000,000	1,149,000,000	979,000,000
Net derivative gains (losses)		(5,908,000,000)	9,532,000,000	(343,000,000)	(179,000,000)	(1,558,000,000)	3,624,000,000	(1,737,000,000)	2,097,000,000	(2,080,000,000)	(3,831,000,000)	(1,034,000,000)	854,000,000
Income (loss) from operations, before income taxes	(1,193,000,000)	(5,113,000,000)	7,207,000,000	(439,000,000)	321,000,000	(1,016,000,000)	2,094,000,000	(695,000,000)	901,000,000	(1,134,000,000)	(2,463,000,000)	(1,472,000,000)	1,488,000,000
Net income (loss)	(944,000,000)	$ (4,086,000,000)	5,750,000,000	(264,000,000)	$ 268,000,000	$ (849,000,000)	$ 1,664,000,000	$ (581,000,000)	720,000,000	$ (845,000,000)	$ (1,884,000,000)	$ (902,000,000)	$ 2,791,000,000
Long-term Lapses Partial Withdrawal Rates And Election Assumptions Updates
Change in Accounting Estimate [Line Items]
Policy charges and fee income	(21,000,000)		54,000,000	(11,000,000)
Policyholders’ benefits	175,000,000		1,300,000,000	886,000,000
Interest credited to policyholders’ account balances	(8,000,000)		(6,000,000)	(14,000,000)
Net derivative gains (losses)	106,000,000			(548,000,000)
Amortization of deferred policy acquisition costs, net	26,000,000		840,000,000	(77,000,000)
Income (loss) from operations, before income taxes	(124,000,000)		(2,100,000,000)	(1,400,000,000)
Net income (loss)	(98,000,000)		(1,700,000,000)	$ (1,100,000,000)
Economic Scenario Generator
Change in Accounting Estimate [Line Items]
Income (loss) from operations, before income taxes									165,000,000
Net income (loss)									$ 130,000,000
Credit Risk Adjustment, Fair Value Scenario Calibration
Change in Accounting Estimate [Line Items]
Gain (loss) on assumption updates and model changes, pre tax	$ 421,000,000
5-year Historical Average Over A 10-year Period
Change in Accounting Estimate [Line Items]
Interest rate assumptions			$ 0.0225

INVESTMENTS - Narrative (Detail

INVESTMENTS - Narrative (Details)	3 Months Ended	9 Months Ended
	Sep. 30, 2020USD ($)security	Sep. 30, 2020USD ($)numberOfLoansecurity	Dec. 31, 2019USD ($)security	Sep. 30, 2019USD ($)
Net Investment Income [Line Items]
Number of unrealized loss positions | security	709	709	390
Debt securities exposure in single issuer greater than stated percentage of total investments	0.60%	0.60%
Amortized cost	$ 66,264,000,000	$ 66,264,000,000
Unrealized loss on available for sale securities	81,000,000	81,000,000	$ 21,000,000
Gross unrealized losses	58,000,000	58,000,000	32,000,000
Allowance for credit loss	70,000,000	70,000,000
Separate account equity investment carrying value	37,000,000	37,000,000	58,000,000
Corporate
Net Investment Income [Line Items]
Debt securities exposure in single issuer of total investments	$ 321,000,000	$ 321,000,000	$ 279,000,000
Debt securities exposure in single issuer of total investments, percent	2.20%	2.20%	2.40%
Gross unrealized losses	$ 49,000,000	$ 49,000,000	$ 20,000,000
Fixed maturities
Net Investment Income [Line Items]
Accrued investment income receivable	510,000,000	510,000,000
Accrued interest, written off	0	0
Amortized cost	66,277,000,000	66,277,000,000	59,278,000,000
Commercial Mortgage Loans
Net Investment Income [Line Items]
Accrued investment income receivable	29,000,000	29,000,000
Accrued interest, written off	$ 0	$ 0
Number of troubled debt restructuring | numberOfLoan		1
Troubled debt restructuring, premodification		$ 75,000,000
Troubled debt restructuring, postmodification		$ 75,000,000
Troubled debt restructuring, percentage of total invested assets	0.07%	0.07%
Agricultural Mortgage Loans
Net Investment Income [Line Items]
Accrued investment income receivable				$ 32,000,000
Accrued interest, written off	$ 0	$ 0
Individually Assessed Mortgage Loans
Net Investment Income [Line Items]
Mortgage loans foreclosure probable	0	0
Allowance for credit loss	$ 0	$ 0
Privately Negotiated Fixed Maturity
Net Investment Income [Line Items]
Number of troubled debt restructuring | numberOfLoan		6
Troubled debt restructuring, premodification		$ 50,000,000
Troubled debt restructuring, postmodification		$ 44,000,000
Troubled debt restructuring, percentage of total invested assets	0.04%	0.04%
Fair Value, Recurring
Net Investment Income [Line Items]
Trading securities, at fair value	$ 5,787,000,000	$ 5,787,000,000	6,598,000,000
Other Than Investment Grade | External Credit Rating, Non Investment Grade | Fixed maturities
Net Investment Income [Line Items]
Available-for-sale securities, amortized cost	$ 2,000,000,000	$ 2,000,000,000	$ 1,400,000,000
Percentage of available for sale securities	3.00%	3.00%	2.30%

INVESTMENTS - Available-for-sal

INVESTMENTS - Available-for-sale Securities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 66,277		$ 66,277		$ 59,278
Allowance for Credit Losses	13		13		0
Gross Unrealized Gains	8,747		8,747		3,465
Gross Unrealized Losses	197		197		381
Fair Value	74,814		74,814		62,362
Amortized Cost
Due in one year or less, Amortized Cost	4,094		4,094
Due in years two through five, Amortized Cost	14,862		14,862
Due in years six through ten, Amortized Cost	16,872		16,872
Due after ten years, Amortized Cost	26,240		26,240
Subtotal	62,068		62,068
Amortized cost	66,264		66,264
Fair Value
Due in one year or less, Fair Value	4,126		4,126
Due in years two through five, Fair Value	15,722		15,722
Due in years six through ten, Fair Value	18,691		18,691
Due after ten years, Fair Value	31,981		31,981
Subtotal	70,520		70,520
Fair Value	74,814		74,814
Available For Sale Fixed Maturities Proceeds Gross Gains And Gross Losses From Sales And Other Than Temporary Impairments [Abstract]
Proceeds from sales	1,399	$ 3,839	5,985	$ 6,756
Gross gains on sales	23	207	297	224
Gross losses on sales	(5)	(4)	(32)	(25)
Credit losses	0	0	(13)	0
Fixed Maturities - Credit Loss Impairments
Balances, beginning of period	28	18	15	46
Previously recognized impairments on securities that matured, paid, prepaid or sold	0	(3)	0	(31)
Recognized impairments on securities impaired to fair value this period	0	0	0	0
Credit losses recognized this period on securities for which credit losses were not previously recognized	(2)	0	7	0
Additional credit losses this period on securities previously impaired	2	0	6	0
Increases due to passage of time on previously recorded credit losses	0	0	0	0
Accretion of previously recognized impairments due to increases in expected cash flows	0	0	0	0
Balances, ending of period	28	$ 15	28	$ 15
Corporate
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	47,421		47,421		42,347
Allowance for Credit Losses	13		13		0
Gross Unrealized Gains	4,281		4,281		2,178
Gross Unrealized Losses	170		170		61
Fair Value	51,519		51,519		44,464
U.S. Treasury, government and agency
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	13,126		13,126		14,385
Allowance for Credit Losses	0		0		0
Gross Unrealized Gains	4,158		4,158		1,151
Gross Unrealized Losses	0		0		305
Fair Value	17,284		17,284		15,231
States and political subdivisions
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	706		706		584
Allowance for Credit Losses	0		0		0
Gross Unrealized Gains	109		109		68
Gross Unrealized Losses	0		0		3
Fair Value	815		815		649
Foreign governments
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	828		828		460
Allowance for Credit Losses	0		0		0
Gross Unrealized Gains	80		80		35
Gross Unrealized Losses	6		6		5
Fair Value	902		902		490
Residential mortgage-backed
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	132		132		161
Allowance for Credit Losses	0		0		0
Gross Unrealized Gains	13		13		12
Gross Unrealized Losses	0		0		0
Fair Value	145		145		173
Amortized Cost
Amortized Cost Basis, without Single Maturity Date	132		132
Fair Value
Without single maturity date	145		145
Asset-backed
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	2,584		2,584		843
Allowance for Credit Losses	0		0		0
Gross Unrealized Gains	25		25		3
Gross Unrealized Losses	18		18		2
Fair Value	2,591		2,591		844
Amortized Cost
Amortized Cost Basis, without Single Maturity Date	2,584		2,584
Fair Value
Without single maturity date	2,591		2,591
Commercial mortgage-backed
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	1,067		1,067
Allowance for Credit Losses	0		0
Gross Unrealized Gains	50		50
Gross Unrealized Losses	0		0
Fair Value	1,117		1,117
Amortized Cost
Amortized Cost Basis, without Single Maturity Date	1,067		1,067
Fair Value
Without single maturity date	1,117		1,117
Redeemable preferred stock
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	413		413		498
Allowance for Credit Losses	0		0		0
Gross Unrealized Gains	31		31		18
Gross Unrealized Losses	3		3		5
Fair Value	441		441		$ 511
Amortized Cost
Amortized Cost Basis, without Single Maturity Date	413		413
Fair Value
Without single maturity date	$ 441		$ 441

INVESTMENTS - Net Unrealized In

INVESTMENTS - Net Unrealized Investment (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 15,088	$ 13,781	$ 11,565	$ 12,359
Ending balance	14,399	13,254	14,399	13,254
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | Unrealized Investment Gains Losses All Other | Net Unrealized Gains (Losses) on Investments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	8,207	2,622	3,084	(577)
Net investment gains (losses) arising during the period	345	1,548	5,707	4,754
Included in Net income (loss)	(18)	(201)	(248)	(208)
Excluded from Net income (loss)	0	0	0	0
Impact of net unrealized investment gains (losses)	0	0	0	0
Net unrealized investment gains (losses) excluding OTTI losses	8,534	3,969	8,543	3,969
Net unrealized investment gains (losses) with OTTI losses	3	1	(6)	1
Ending balance	8,537	3,970	8,537	3,970
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | Unrealized Investment Gains Losses All Other | DAC
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(494)	(616)	(826)	37
Impact of net unrealized investment gains (losses)	54	(324)	386	(977)
Net unrealized investment gains (losses) excluding OTTI losses	(440)	(940)	(440)	(940)
Ending balance	(440)	(940)	(440)	(940)
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | Unrealized Investment Gains Losses All Other | Policyholders’ Liabilities
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(1,801)	(98)	(192)	(69)
Impact of net unrealized investment gains (losses)	(6)	(122)	(1,617)	(151)
Net unrealized investment gains (losses) excluding OTTI losses	(1,807)	(220)	(1,809)	(220)
Ending balance	(1,808)	(220)	(1,808)	(220)
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | Unrealized Investment Gains Losses All Other | Deferred Income Tax Asset (Liability)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(1,242)	(420)	(433)	125
Impact of net unrealized investment gains (losses)	(79)	(156)	(889)	(701)
Net unrealized investment gains (losses) excluding OTTI losses	(1,321)	(576)	(1,322)	(576)
Ending balance	(1,321)	(576)	(1,321)	(576)
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | Unrealized Investment Gains Losses All Other | AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	4,670	1,488	1,633	(484)
Net investment gains (losses) arising during the period	345	1,548	5,707	4,754
Included in Net income (loss)	(18)	(201)	(248)	(208)
Excluded from Net income (loss)	0	0	0	0
Impact of net unrealized investment gains (losses)	(31)	(602)	(2,120)	(1,829)
Net unrealized investment gains (losses) excluding OTTI losses	4,966	2,233	4,972	2,233
Net unrealized investment gains (losses) with OTTI losses	2	1	(4)	1
Ending balance	4,968	2,234	4,968	2,234
Fixed Maturities | AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | Unrealized Investment Gains Losses All Other | DAC
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Net unrealized investment gains (losses) with OTTI losses	0	0	0	0
Fixed Maturities | AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | Unrealized Investment Gains Losses All Other | Policyholders’ Liabilities
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Net unrealized investment gains (losses) with OTTI losses	(1)	0	1	0
Fixed Maturities | AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | Unrealized Investment Gains Losses All Other | Deferred Income Tax Asset (Liability)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Net unrealized investment gains (losses) with OTTI losses	$ 0	$ 0	$ 1	$ 0

INVESTMENTS - Fixed Maturities

INVESTMENTS - Fixed Maturities Available-for-sale (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, fair value	$ 5,534	$ 7,396
Less than 12 months, gross unrealized losses	134	349
12 months or longer, fair value	481	665
12 Months or Longer, Gross unrealized Losses	58	32
Fair value	6,015	8,061
Gross unrealized losses	192	381
Corporate
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, fair value	4,063	2,669
Less than 12 months, gross unrealized losses	116	41
12 months or longer, fair value	365	366
12 Months or Longer, Gross unrealized Losses	49	20
Fair value	4,428	3,035
Gross unrealized losses	165	61
U.S. Treasury, government and agency
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, fair value		4,245
Less than 12 months, gross unrealized losses		305
12 months or longer, fair value		2
12 Months or Longer, Gross unrealized Losses		0
Fair value		4,247
Gross unrealized losses		305
States and political subdivisions
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, fair value		123
Less than 12 months, gross unrealized losses		3
12 months or longer, fair value		0
12 Months or Longer, Gross unrealized Losses		0
Fair value		123
Gross unrealized losses		3
Foreign governments
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, fair value	88	11
Less than 12 months, gross unrealized losses	1	0
12 months or longer, fair value	31	47
12 Months or Longer, Gross unrealized Losses	5	5
Fair value	119	58
Gross unrealized losses	6	5
Asset-backed
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, fair value	1,324	319
Less than 12 months, gross unrealized losses	16	0
12 months or longer, fair value	74	201
12 Months or Longer, Gross unrealized Losses	2	2
Fair value	1,398	520
Gross unrealized losses	18	2
Redeemable preferred stock
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, fair value	59	29
Less than 12 months, gross unrealized losses	1	0
12 months or longer, fair value	11	49
12 Months or Longer, Gross unrealized Losses	2	5
Fair value	70	78
Gross unrealized losses	$ 3	$ 5

INVESTMENTS - Mortgage Loans (D

INVESTMENTS - Mortgage Loans (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Ending balance	$ 70	$ 70
Commercial Mortgage Loans
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	62	33
Current-period provision for expected credit losses	4	33
Write-offs charged against the allowance	0	0
Recoveries of amounts previously written off	0	0
Net change in allowance	4	33
Ending balance	66	66
Agricultural Mortgage Loans
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	4	3
Current-period provision for expected credit losses	0	1
Write-offs charged against the allowance	0	0
Recoveries of amounts previously written off	0	0
Net change in allowance	0	1
Ending balance	$ 4	$ 4

INVESTMENTS - Credit Quality (D

INVESTMENTS - Credit Quality (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Commercial Mortgage Loans
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	$ 1,025
2019	805
2018	1,265
2017	1,204
2016	2,755
Prior	3,048
Total	10,102	$ 9,373
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	0	0
Current	10,102	9,373
Total	10,102	9,373
Non-accruing Loans	0	0
Total	10,102	9,373
Non-accruing Loans with No allowance	0	0
Interest Income on Non-accruing Loans	0	0
Commercial Mortgage Loans | 30-59 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	0	0
Commercial Mortgage Loans | 60-89 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	0	0
Commercial Mortgage Loans | 90 Days Or Greater
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	0	0
Commercial Mortgage Loans | Greater than 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	749
2019	492
2018	772
2017	268
2016	2,036
Prior	1,268
Total	5,585	5,235
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	5,585	5,235
Commercial Mortgage Loans | 1.8x to 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	227
2019	77
2018	118
2017	378
2016	184
Prior	524
Total	1,508	1,331
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	1,508	1,331
Commercial Mortgage Loans | 1.5x to 1.8x
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	49
2019	138
2018	186
2017	480
2016	437
Prior	569
Total	1,859	1,546
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	1,859	1,546
Commercial Mortgage Loans | 1.2x to 1.5x
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	0
2019	56
2018	154
2017	78
2016	97
Prior	533
Total	918	973
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	918	973
Commercial Mortgage Loans | 1.0x to 1.2x
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	0
2019	42
2018	35
2017	0
2016	1
Prior	82
Total	160	288
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	160	288
Commercial Mortgage Loans | Less than 1.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	0
2019	0
2018	0
2017	0
2016	0
Prior	72
Total	72	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	72	0
Commercial Mortgage Loans | 0% - 50%
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	0
2019	0
2018	0
2017	324
2016	170
Prior	650
Total	1,144	1,163
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	1,144	1,163
Commercial Mortgage Loans | 0% - 50% | Greater than 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	935	887
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	935	887
Commercial Mortgage Loans | 0% - 50% | 1.8x to 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	38
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	38
Commercial Mortgage Loans | 0% - 50% | 1.5x to 1.8x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	185	214
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	185	214
Commercial Mortgage Loans | 0% - 50% | 1.2x to 1.5x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	24	24
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	24	24
Commercial Mortgage Loans | 0% - 50% | 1.0x to 1.2x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Commercial Mortgage Loans | 0% - 50% | Less than 1.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Commercial Mortgage Loans | 50% - 70%
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	935
2019	411
2018	885
2017	760
2016	2,432
Prior	1,608
Total	7,031	7,447
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	7,031	7,447
Commercial Mortgage Loans | 50% - 70% | Greater than 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	3,992	4,097
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	3,992	4,097
Commercial Mortgage Loans | 50% - 70% | 1.8x to 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	1,160	1,195
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	1,160	1,195
Commercial Mortgage Loans | 50% - 70% | 1.5x to 1.8x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	1,342	1,118
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	1,342	1,118
Commercial Mortgage Loans | 50% - 70% | 1.2x to 1.5x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	511	795
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	511	795
Commercial Mortgage Loans | 50% - 70% | 1.0x to 1.2x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	26	242
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	26	242
Commercial Mortgage Loans | 50% - 70% | Less than 1.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Commercial Mortgage Loans | 70% - 90%
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	90
2019	394
2018	368
2017	115
2016	153
Prior	574
Total	1,694	763
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	1,694	763
Commercial Mortgage Loans | 70% - 90% | Greater than 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	574	251
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	574	251
Commercial Mortgage Loans | 70% - 90% | 1.8x to 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	348	98
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	348	98
Commercial Mortgage Loans | 70% - 90% | 1.5x to 1.8x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	332	214
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	332	214
Commercial Mortgage Loans | 70% - 90% | 1.2x to 1.5x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	306	154
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	306	154
Commercial Mortgage Loans | 70% - 90% | 1.0x to 1.2x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	134	46
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	134	46
Commercial Mortgage Loans | 70% - 90% | Less than 1.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Commercial Mortgage Loans | 90% plus
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	0
2019	0
2018	12
2017	5
2016	0
Prior	216
Total	233	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	233	0
Commercial Mortgage Loans | 90% plus | Greater than 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	84	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	84	0
Commercial Mortgage Loans | 90% plus | 1.8x to 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Commercial Mortgage Loans | 90% plus | 1.5x to 1.8x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Commercial Mortgage Loans | 90% plus | 1.2x to 1.5x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	77	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	77	0
Commercial Mortgage Loans | 90% plus | 1.0x to 1.2x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Commercial Mortgage Loans | 90% plus | Less than 1.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	72	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	72	0
Agricultural Mortgage Loans
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	434
2019	268
2018	343
2017	271
2016	368
Prior	1,069
Total	2,753	2,717
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	165	124
Current	2,588	2,593
Total	2,753	2,717
Non-accruing Loans	0	0
Total	2,753	2,717
Non-accruing Loans with No allowance	0	0
Interest Income on Non-accruing Loans	0	0
Agricultural Mortgage Loans | 30-59 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	24	57
Agricultural Mortgage Loans | 60-89 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	6	1
Agricultural Mortgage Loans | 90 Days Or Greater
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	135	66
Agricultural Mortgage Loans | Greater than 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	52
2019	27
2018	39
2017	38
2016	73
Prior	158
Total	387	404
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	387	404
Agricultural Mortgage Loans | 1.8x to 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	33
2019	36
2018	14
2017	15
2016	21
Prior	90
Total	209	191
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	209	191
Agricultural Mortgage Loans | 1.5x to 1.8x
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	103
2019	38
2018	45
2017	41
2016	52
Prior	212
Total	491	477
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	491	477
Agricultural Mortgage Loans | 1.2x to 1.5x
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	165
2019	118
2018	146
2017	105
2016	147
Prior	327
Total	1,008	990
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	1,008	990
Agricultural Mortgage Loans | 1.0x to 1.2x
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	77
2019	39
2018	91
2017	71
2016	57
Prior	265
Total	600	572
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	600	572
Agricultural Mortgage Loans | Less than 1.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	4
2019	10
2018	8
2017	1
2016	18
Prior	17
Total	58	83
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	58	83
Agricultural Mortgage Loans | 0% - 50%
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	181
2019	137
2018	168
2017	161
2016	232
Prior	679
Total	1,558	1,583
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	1,558	1,583
Agricultural Mortgage Loans | 0% - 50% | Greater than 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	283	322
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	283	322
Agricultural Mortgage Loans | 0% - 50% | 1.8x to 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	107	104
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	107	104
Agricultural Mortgage Loans | 0% - 50% | 1.5x to 1.8x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	271	241
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	271	241
Agricultural Mortgage Loans | 0% - 50% | 1.2x to 1.5x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	529	545
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	529	545
Agricultural Mortgage Loans | 0% - 50% | 1.0x to 1.2x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	335	321
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	335	321
Agricultural Mortgage Loans | 0% - 50% | Less than 1.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	33	50
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	33	50
Agricultural Mortgage Loans | 50% - 70%
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	253
2019	131
2018	172
2017	110
2016	136
Prior	372
Total	1,174	1,115
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	1,174	1,115
Agricultural Mortgage Loans | 50% - 70% | Greater than 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	104	82
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	104	82
Agricultural Mortgage Loans | 50% - 70% | 1.8x to 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	100	87
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	100	87
Agricultural Mortgage Loans | 50% - 70% | 1.5x to 1.8x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	220	236
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	220	236
Agricultural Mortgage Loans | 50% - 70% | 1.2x to 1.5x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	460	426
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	460	426
Agricultural Mortgage Loans | 50% - 70% | 1.0x to 1.2x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	265	251
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	265	251
Agricultural Mortgage Loans | 50% - 70% | Less than 1.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	25	33
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	25	33
Agricultural Mortgage Loans | 70% - 90%
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	0
2019	0
2018	3
2017	0
2016	0
Prior	18
Total	21	19
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	21	19
Agricultural Mortgage Loans | 70% - 90% | Greater than 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Agricultural Mortgage Loans | 70% - 90% | 1.8x to 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	2	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	2	0
Agricultural Mortgage Loans | 70% - 90% | 1.5x to 1.8x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Agricultural Mortgage Loans | 70% - 90% | 1.2x to 1.5x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	19	19
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	19	19
Agricultural Mortgage Loans | 70% - 90% | 1.0x to 1.2x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Agricultural Mortgage Loans | 70% - 90% | Less than 1.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Agricultural Mortgage Loans | 90% plus
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	0
2019	0
2018	0
2017	0
2016	0
Prior	0
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Agricultural Mortgage Loans | 90% plus | Greater than 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Agricultural Mortgage Loans | 90% plus | 1.8x to 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Agricultural Mortgage Loans | 90% plus | 1.5x to 1.8x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Agricultural Mortgage Loans | 90% plus | 1.2x to 1.5x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Agricultural Mortgage Loans | 90% plus | 1.0x to 1.2x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Agricultural Mortgage Loans | 90% plus | Less than 1.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Total Mortgages Loan
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	1,459
2019	1,073
2018	1,608
2017	1,475
2016	3,123
Prior	4,117
Total	12,855	12,090
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	165	124
Current	12,690	11,966
Total	12,855	12,090
Non-accruing Loans	0	0
Total	12,855	12,090
Non-accruing Loans with No allowance	0	0
Interest Income on Non-accruing Loans	0	0
Total Mortgages Loan | 30-59 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	24	57
Total Mortgages Loan | 60-89 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	6	1
Total Mortgages Loan | 90 Days Or Greater
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	135	66
Total Mortgages Loan | Greater than 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	801
2019	519
2018	811
2017	306
2016	2,109
Prior	1,426
Total	5,972	5,639
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	5,972	5,639
Total Mortgages Loan | 1.8x to 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	260
2019	113
2018	132
2017	393
2016	205
Prior	614
Total	1,717	1,522
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	1,717	1,522
Total Mortgages Loan | 1.5x to 1.8x
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	152
2019	176
2018	231
2017	521
2016	489
Prior	781
Total	2,350	2,023
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	2,350	2,023
Total Mortgages Loan | 1.2x to 1.5x
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	165
2019	174
2018	300
2017	183
2016	244
Prior	860
Total	1,926	1,963
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	1,926	1,963
Total Mortgages Loan | 1.0x to 1.2x
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	77
2019	81
2018	126
2017	71
2016	58
Prior	347
Total	760	860
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	760	860
Total Mortgages Loan | Less than 1.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	4
2019	10
2018	8
2017	1
2016	18
Prior	89
Total	130	83
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	130	83
Total Mortgages Loan | 0% - 50%
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	181
2019	137
2018	168
2017	485
2016	402
Prior	1,329
Total	2,702	2,746
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	2,702	2,746
Total Mortgages Loan | 0% - 50% | Greater than 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	1,218	1,209
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	1,218	1,209
Total Mortgages Loan | 0% - 50% | 1.8x to 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	107	142
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	107	142
Total Mortgages Loan | 0% - 50% | 1.5x to 1.8x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	456	455
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	456	455
Total Mortgages Loan | 0% - 50% | 1.2x to 1.5x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	553	569
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	553	569
Total Mortgages Loan | 0% - 50% | 1.0x to 1.2x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	335	321
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	335	321
Total Mortgages Loan | 0% - 50% | Less than 1.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	33	50
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	33	50
Total Mortgages Loan | 50% - 70%
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	1,188
2019	542
2018	1,057
2017	870
2016	2,568
Prior	1,980
Total	8,205	8,562
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	8,205	8,562
Total Mortgages Loan | 50% - 70% | Greater than 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	4,096	4,179
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	4,096	4,179
Total Mortgages Loan | 50% - 70% | 1.8x to 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	1,260	1,282
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	1,260	1,282
Total Mortgages Loan | 50% - 70% | 1.5x to 1.8x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	1,562	1,354
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	1,562	1,354
Total Mortgages Loan | 50% - 70% | 1.2x to 1.5x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	971	1,221
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	971	1,221
Total Mortgages Loan | 50% - 70% | 1.0x to 1.2x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	291	493
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	291	493
Total Mortgages Loan | 50% - 70% | Less than 1.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	25	33
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	25	33
Total Mortgages Loan | 70% - 90%
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	90
2019	394
2018	371
2017	115
2016	153
Prior	592
Total	1,715	782
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	1,715	782
Total Mortgages Loan | 70% - 90% | Greater than 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	574	251
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	574	251
Total Mortgages Loan | 70% - 90% | 1.8x to 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	350	98
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	350	98
Total Mortgages Loan | 70% - 90% | 1.5x to 1.8x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	332	214
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	332	214
Total Mortgages Loan | 70% - 90% | 1.2x to 1.5x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	325	173
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	325	173
Total Mortgages Loan | 70% - 90% | 1.0x to 1.2x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	134	46
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	134	46
Total Mortgages Loan | 70% - 90% | Less than 1.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Total Mortgages Loan | 90% plus
Financing Receivable, before Allowance for Credit Loss [Abstract]
2020	0
2019	0
2018	12
2017	5
2016	0
Prior	216
Total	233	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	233	0
Total Mortgages Loan | 90% plus | Greater than 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	84	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	84	0
Total Mortgages Loan | 90% plus | 1.8x to 2.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Total Mortgages Loan | 90% plus | 1.5x to 1.8x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Total Mortgages Loan | 90% plus | 1.2x to 1.5x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	77	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	77	0
Total Mortgages Loan | 90% plus | 1.0x to 1.2x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	0	0
Total Mortgages Loan | 90% plus | Less than 1.0x
Financing Receivable, before Allowance for Credit Loss [Abstract]
Total	72	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total	$ 72	$ 0

INVESTMENTS - Trading Securitie

INVESTMENTS - Trading Securities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Investments, Debt and Equity Securities [Abstract]
Net investment gains (losses) recognized during the period on securities held at the end of the period	$ (1)	$ 7	$ 86	$ 431
Net investment gains (losses) recognized on securities sold during the period	(5)	13	12	(10)
Unrealized and realized gains (losses) on trading securities	(6)	20	98	421
Interest and dividend income from trading securities	58	59	152	220
Net investment income (loss) from trading securities	$ 52	$ 79	$ 250	$ 641

DERIVATIVES - Derivatives by Ca

DERIVATIVES - Derivatives by Category (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Derivatives, Fair Value [Line Items]
Notional Amount	$ 101,120		$ 117,398
Derivative Assets	10,576		8,271
Derivative Liabilities	22,722		17,018
Net Derivative Gains (Losses)	2,104	$ (2,080)
Futures
Derivatives, Fair Value [Line Items]
Notional Amount	3,739		3,510
Derivative Assets	0		0
Derivative Liabilities	0		0
Net Derivative Gains (Losses)	(347)	(967)
Swaps
Derivatives, Fair Value [Line Items]
Notional Amount	20,667		17,064
Derivative Assets	27		9
Derivative Liabilities	18		279
Net Derivative Gains (Losses)	(594)	(1,263)
Equity Option
Derivatives, Fair Value [Line Items]
Notional Amount	31,679		47,766
Derivative Assets	5,543		5,080
Derivative Liabilities	2,791		1,749
Net Derivative Gains (Losses)	(480)	1,241
Swaps
Derivatives, Fair Value [Line Items]
Notional Amount	23,952		23,700
Derivative Assets	1,696		467
Derivative Liabilities	338		523
Net Derivative Gains (Losses)	3,588	2,844
Futures
Derivatives, Fair Value [Line Items]
Notional Amount	19,484		20,424
Derivative Assets	0		0
Derivative Liabilities	0		0
Net Derivative Gains (Losses)	2,058	183
Swaptions
Derivatives, Fair Value [Line Items]
Notional Amount	0		3,201
Derivative Assets	0		16
Derivative Liabilities	0		0
Net Derivative Gains (Losses)	9	146
Credit default swaps
Derivatives, Fair Value [Line Items]
Notional Amount	1,252		1,232
Derivative Assets	9		18
Derivative Liabilities	4		0
Net Derivative Gains (Losses)	(4)	13
Foreign Currency Contracts
Derivatives, Fair Value [Line Items]
Notional Amount	347		501
Derivative Assets	0		3
Derivative Liabilities	0		0
Net Derivative Gains (Losses)	(3)	(13)
Margin
Derivatives, Fair Value [Line Items]
Notional Amount	0		0
Derivative Assets	40		140
Derivative Liabilities	125		0
Net Derivative Gains (Losses)	0	0
Collateral
Derivatives, Fair Value [Line Items]
Notional Amount	0		0
Derivative Assets	14		72
Derivative Liabilities	4,959		3,001
Net Derivative Gains (Losses)	0	0
GMIB Reinsurance Contracts
Derivatives, Fair Value [Line Items]
Notional Amount	0		0
Derivative Assets	3,247		2,466
Derivative Liabilities	0		0
Net Derivative Gains (Losses)	849	881
GMxB Derivative Features’ Liability
Derivatives, Fair Value [Line Items]
Notional Amount	0		0
Derivative Assets	0		0
Derivative Liabilities	11,985		8,316
Net Derivative Gains (Losses)	(3,382)	(3,656)
SCS, SIO, MSO and IUL Indexed Features
Derivatives, Fair Value [Line Items]
Notional Amount	0		0
Derivative Assets	0		0
Derivative Liabilities	2,502		$ 3,150
Net Derivative Gains (Losses)	410	$ (1,489)
Investment fees	$ 9

DERIVATIVES - Narrative (Detail

DERIVATIVES - Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Derivative [Line Items]
Cash and securities collateral for derivative contract	$ 5,000	$ 3,000
Cash and securities collateral	14	72
S&P 500, Russell 1000, NASDAQ 100 and Emerging Market Indices
Derivative [Line Items]
Initial margin requirements	205	58
Us Treasury Notes Ultra Long Bonds And Euro Dollar
Derivative [Line Items]
Initial margin requirements	314	165
Euro Stoxx, FTSE100, Topix, ASX200 and EAFE Indices
Derivative [Line Items]
Initial margin requirements	$ 40	$ 60

DERIVATIVES - Offsetting of Fin

DERIVATIVES - Offsetting of Financial Assets and Liabilities and Derivative Instruments (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Total derivatives
Assets
Gross Amount Recognized	$ 7,330	$ 5,804
Gross Amount Offset in the Balance Sheets	7,241	5,429
Net Amount Presented in the Balance Sheets	89	375
Gross Amount not Offset in the Balance Sheets	(54)	(77)
Net Amount	35	298
Liabilities
Gross Amount Recognized	8,181	5,474
Gross Amount Offset in the Balance Sheets	7,241	5,429
Net Amount Presented in the Balance Sheets	940	45
Gross Amount not Offset in the Balance Sheets	0	0
Net Amount	940	45
Other financial instruments
Assets
Gross Amount Recognized	1,434	1,781
Gross Amount Offset in the Balance Sheets	0	0
Net Amount Presented in the Balance Sheets	1,434	1,781
Gross Amount not Offset in the Balance Sheets	0	0
Net Amount	1,434	1,781
Other invested assets
Assets
Gross Amount Recognized	8,764	7,585
Gross Amount Offset in the Balance Sheets	7,241	5,429
Net Amount Presented in the Balance Sheets	1,523	2,156
Gross Amount not Offset in the Balance Sheets	(54)	(77)
Net Amount	1,469	2,079
Other financial liabilities
Liabilities
Gross Amount Recognized	1,579	1,724
Gross Amount Offset in the Balance Sheets	0	0
Net Amount Presented in the Balance Sheets	1,579	1,724
Gross Amount not Offset in the Balance Sheets	0	0
Net Amount	1,579	1,724
Other liabilities
Liabilities
Gross Amount Recognized	9,760	7,198
Gross Amount Offset in the Balance Sheets	7,241	5,429
Net Amount Presented in the Balance Sheets	2,519	1,769
Gross Amount not Offset in the Balance Sheets	0	0
Net Amount	$ 2,519	$ 1,769

CLOSED BLOCK - Summarized Finan

CLOSED BLOCK - Summarized Financial Information for Closed Block (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Closed Block Liabilities:
Future policy benefits, policyholders’ account balances and other	$ 6,260	$ 6,478
Policyholder dividend obligation	149	2
Other liabilities	58	38
Total Closed Block liabilities	6,467	6,518
Assets Designated to the Closed Block:
Fixed maturities available-for-sale, at fair value (amortized cost of $3,4400 and $3,558) (allowance for credit losses of $0 at September 30, 2020)	3,788	3,754
Mortgage loans on real estate (net of allowance for credit losses of $6 at September 30, 2020)	1,782	1,759
Policy loans	656	706
Cash and other invested assets	3	82
Other assets	172	145
Total assets designated to the Closed Block	6,401	6,446
Excess of Closed Block liabilities over assets designated to the Closed Block	66	72
Amounts included in accumulated other comprehensive income (loss):
Net unrealized investment gains (losses), net of policyholders’ dividend obligation: $149 and $2; and net of income tax: $42 and $41	168	164
Maximum future earnings to be recognized from Closed Block assets and liabilities	234	236
Fixed maturities, available for sale, amortized cost	3,440	3,558
Fixed maturities available-for-sale, allowance for credit losses	0
Mortgage loans, credit losses	(6)
Policyholder dividend obligation	149	2
Closed block operations, income taxes	$ (42)	$ (41)

CLOSED BLOCK - Revenues and Exp

CLOSED BLOCK - Revenues and Expenses (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenues:
Premiums and other income	$ 36	$ 42	$ 118	$ 136
Net investment income (loss)	61	69	190	208
Investment gains (losses), net	1	0	(1)	(1)
Total revenues	98	111	307	343
Benefits and Other Deductions:
Policyholders’ benefits and dividends	96	108	302	343
Other operating costs and expenses	0	0	1	1
Total benefits and other deductions	96	108	303	344
Net income (loss), before income taxes	2	3	4	(1)
Income tax (expense) benefit	(1)	0	(2)	(2)
Net income (loss)	$ 1	$ 3	$ 2	$ (3)

INSURANCE LIABILITIES - Rollfor

INSURANCE LIABILITIES - Rollforward of Liability and Reinsurance Ceded (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
GMDB Direct
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross
Balance, beginning of period	$ 4,998	$ 4,709	$ 4,775	$ 4,657
Paid guarantee benefits	(121)	(102)	(372)	(328)
Other changes in reserves	235	155	709	433
Balance, end of period	5,112	4,762	5,112	4,762
GMDB Ceded
Guaranteed Minimum Death Benefit Reinsurance Ceded [Roll Forward]
Balance, beginning of period	(99)	(100)	(99)	(107)
Paid guarantee benefits	3	3	12	11
Other changes in reserves	9	(4)	0	(5)
Balance, end of period	(87)	(101)	(87)	(101)
GMIB Direct
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross
Balance, beginning of period	6,121	3,757	4,671	3,744
Paid guarantee benefits	(110)	(70)	(287)	(182)
Other changes in reserves	113	979	1,740	1,104
Balance, end of period	6,124	4,666	6,124	4,666
GMIB Ceded
Guaranteed Minimum Death Benefit Reinsurance Ceded [Roll Forward]
Balance, beginning of period	(3,433)	(2,197)	(2,466)	(1,993)
Paid guarantee benefits	21	20	58	55
Other changes in reserves	165	(676)	(839)	(915)
Balance, end of period	$ (3,247)	$ (2,853)	$ (3,247)	$ (2,853)

INSURANCE LIABILITIES - Variabl

INSURANCE LIABILITIES - Variable Annuity Contracts with GMDB and GMIB Features (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
GMDB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 15,472
Separate Accounts	91,323	$ 94,489
Net Amount At Risk By Product And Guarantee, Account Value	106,795
Net Amount at Risk, gross	21,644
Net Amount at Risk, net of amounts reinsured	$ 21,096
Percentage of policyholders over age 70	20.00%
GMDB | Return of Premium
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 15,155
Separate Accounts	48,407
Net Amount At Risk By Product And Guarantee, Account Value	63,562
Net Amount at Risk, gross	125
Net Amount at Risk, net of amounts reinsured	$ 125
Percentage of policyholders over age 70	11.00%
GMDB | Ratchet
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 89
Separate Accounts	8,812
Net Amount At Risk By Product And Guarantee, Account Value	8,901
Net Amount at Risk, gross	94
Net Amount at Risk, net of amounts reinsured	$ 91
Percentage of policyholders over age 70	47.70%
GMDB | Roll-Up
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 57
Separate Accounts	3,021
Net Amount At Risk By Product And Guarantee, Account Value	3,078
Net Amount at Risk, gross	1,864
Net Amount at Risk, net of amounts reinsured	$ 1,319
Percentage of policyholders over age 70	69.80%
GMDB | Combo
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 171
Separate Accounts	31,083
Net Amount At Risk By Product And Guarantee, Account Value	31,254
Net Amount at Risk, gross	19,561
Net Amount at Risk, net of amounts reinsured	$ 19,561
Percentage of policyholders over age 70	53.30%
GMIB
Net Amount at Risk by Product and Guarantee [Line Items]
Separate Accounts	$ 56,341	$ 59,348
Immediate Variable Annuity | GMDB
Net Amount at Risk by Product and Guarantee [Line Items]
Average attained age of policyholders (in years)	55 years 3 months 18 days
Immediate Variable Annuity | GMDB | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	3.00%
Immediate Variable Annuity | GMDB | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	6.50%
Immediate Variable Annuity | GMDB | Return of Premium
Net Amount at Risk by Product and Guarantee [Line Items]
Average attained age of policyholders (in years)	51 years 3 months 18 days
Immediate Variable Annuity | GMDB | Ratchet
Net Amount at Risk by Product and Guarantee [Line Items]
Average attained age of policyholders (in years)	68 years 1 month 6 days
Immediate Variable Annuity | GMDB | Roll-Up
Net Amount at Risk by Product and Guarantee [Line Items]
Average attained age of policyholders (in years)	74 years 8 months 12 days
Immediate Variable Annuity | GMDB | Roll-Up | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	3.00%
Immediate Variable Annuity | GMDB | Roll-Up | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	6.00%
Immediate Variable Annuity | GMDB | Combo
Net Amount at Risk by Product and Guarantee [Line Items]
Average attained age of policyholders (in years)	70 years
Immediate Variable Annuity | GMDB | Combo | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	3.00%
Immediate Variable Annuity | GMDB | Combo | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	6.50%
Immediate Variable Annuity | GMIB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 237
Separate Accounts	56,341
Net Amount At Risk By Product And Guarantee, Account Value	56,578
Net Amount at Risk, gross	15,561
Net Amount at Risk, net of amounts reinsured	$ 13,415
Average attained age of policyholders (in years)	67 years 9 months 18 days
Weighted average years remaining until annuitization (in years)	2 years 6 months
Immediate Variable Annuity | GMIB | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	3.00%
Immediate Variable Annuity | GMIB | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	6.50%
Immediate Variable Annuity | GMIB | Return of Premium
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 0
Separate Accounts	0
Net Amount At Risk By Product And Guarantee, Account Value	0
Net Amount at Risk, gross	0
Net Amount at Risk, net of amounts reinsured	0
Immediate Variable Annuity | GMIB | Ratchet
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	0
Separate Accounts	0
Net Amount At Risk By Product And Guarantee, Account Value	0
Net Amount at Risk, gross	0
Net Amount at Risk, net of amounts reinsured	0
Immediate Variable Annuity | GMIB | Roll-Up
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	17
Separate Accounts	23,124
Net Amount At Risk By Product And Guarantee, Account Value	23,141
Net Amount at Risk, gross	1,100
Net Amount at Risk, net of amounts reinsured	$ 349
Average attained age of policyholders (in years)	64 years
Weighted average years remaining until annuitization (in years)	5 years 8 months 12 days
Immediate Variable Annuity | GMIB | Roll-Up | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	3.00%
Immediate Variable Annuity | GMIB | Roll-Up | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	6.00%
Immediate Variable Annuity | GMIB | Combo
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 220
Separate Accounts	33,217
Net Amount At Risk By Product And Guarantee, Account Value	33,437
Net Amount at Risk, gross	14,461
Net Amount at Risk, net of amounts reinsured	$ 13,066
Average attained age of policyholders (in years)	70 years
Weighted average years remaining until annuitization (in years)	8 months 12 days
Immediate Variable Annuity | GMIB | Combo | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	3.00%
Immediate Variable Annuity | GMIB | Combo | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates	6.50%

INSURANCE LIABILITIES - Separat

INSURANCE LIABILITIES - Separate Account Investments, Hedging Programs and Variable and Interest-Sensitive Live Insurance Policies (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Direct Liability
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross
Balance, beginning of period	$ 941	$ 821	$ 894	$ 788
Paid guaranteed benefits	(6)	(7)	(32)	(16)
Other changes in reserves	61	54	134	96
Balance, end of period	996	868	996	868
Reinsurance Ceded
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross
Balance, beginning of period	(841)	(756)	(808)	(734)
Paid guaranteed benefits	0	0	0	0
Other changes in reserves	(31)	(31)	(64)	(53)
Balance, end of period	(872)	(787)	(872)	(787)
Net
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross
Balance, beginning of period	100	65	86	54
Paid guaranteed benefits	(6)	(7)	(32)	(16)
Other changes in reserves	30	23	70	43
Balance, end of period	124	81	124	81
GMDB
Fair Value, Separate Account Investment [Line Items]
Separate Accounts	91,323		91,323		$ 94,489
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross
Balance, beginning of period	(99)	(100)	(99)	(107)
Paid guaranteed benefits	(3)	(3)	(12)	(11)
Other changes in reserves	9	(4)	0	(5)
Balance, end of period	(87)	$ (101)	(87)	$ (101)
GMDB | Equity
Fair Value, Separate Account Investment [Line Items]
Separate Accounts	41,259		41,259		42,489
GMDB | Fixed income
Fair Value, Separate Account Investment [Line Items]
Separate Accounts	5,371		5,371		5,263
GMDB | Balanced
Fair Value, Separate Account Investment [Line Items]
Separate Accounts	43,685		43,685		45,872
GMDB | Other
Fair Value, Separate Account Investment [Line Items]
Separate Accounts	1,008		1,008		865
GMIB
Fair Value, Separate Account Investment [Line Items]
Separate Accounts	56,341		56,341		59,348
GMIB | Equity
Fair Value, Separate Account Investment [Line Items]
Separate Accounts	16,739		16,739		17,941
GMIB | Fixed income
Fair Value, Separate Account Investment [Line Items]
Separate Accounts	2,679		2,679		2,699
GMIB | Balanced
Fair Value, Separate Account Investment [Line Items]
Separate Accounts	36,656		36,656		38,445
GMIB | Other
Fair Value, Separate Account Investment [Line Items]
Separate Accounts	$ 267		$ 267		$ 263

FAIR VALUE DISCLOSURES - Schedu

FAIR VALUE DISCLOSURES - Schedules Of Assets And Liabilities Measured On Recurring Basis (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Assets, Fair Value Disclosure [Abstract]
Fair Value	$ 74,814	$ 62,362
Fair Value, Recurring
Assets, Fair Value Disclosure [Abstract]
Fair Value	74,814	62,362
Other equity investments	24	13
Trading securities	5,787	6,598
Other invested assets:	4,242	3,507
Cash equivalents	3,519	1,155
GMIB reinsurance contracts asset	3,247	2,466
Separate Accounts assets	120,509	124,062
Total Assets	212,142	200,163
Liabilities, Fair Value Disclosure [Abstract]
Total Liabilities	14,487	11,466
Fair Value, Recurring | Level 1
Assets, Fair Value Disclosure [Abstract]
Fair Value	367	237
Other equity investments	20	13
Trading securities	258	321
Other invested assets:	0	0
Cash equivalents	2,488	1,155
GMIB reinsurance contracts asset	0	0
Separate Accounts assets	118,085	121,184
Total Assets	121,218	122,910
Liabilities, Fair Value Disclosure [Abstract]
Total Liabilities	0	0
Fair Value, Recurring | Level 2
Assets, Fair Value Disclosure [Abstract]
Fair Value	72,916	60,740
Other equity investments	0	0
Trading securities	5,529	6,277
Other invested assets:	4,230	3,491
Cash equivalents	1,031	0
GMIB reinsurance contracts asset	0	0
Separate Accounts assets	2,424	2,878
Total Assets	86,130	73,386
Liabilities, Fair Value Disclosure [Abstract]
Total Liabilities	2,502	3,150
Fair Value, Recurring | Level 3
Assets, Fair Value Disclosure [Abstract]
Fair Value	1,531	1,385
Other equity investments	4	0
Trading securities	0	0
Other invested assets:	12	16
Cash equivalents	0	0
GMIB reinsurance contracts asset	3,247	2,466
Separate Accounts assets	0	0
Total Assets	4,794	3,867
Liabilities, Fair Value Disclosure [Abstract]
Total Liabilities	11,985	8,316
Fair Value, Recurring | Fair Value Measured at Net Asset Value Per Share
Assets, Fair Value Disclosure [Abstract]
Separate Accounts assets	356	356
Corporate | Fair Value, Recurring
Assets, Fair Value Disclosure [Abstract]
Fair Value	51,519	44,464
Corporate | Fair Value, Recurring | Level 1
Assets, Fair Value Disclosure [Abstract]
Fair Value	0	0
Corporate | Fair Value, Recurring | Level 2
Assets, Fair Value Disclosure [Abstract]
Fair Value	50,040	43,218
Corporate | Fair Value, Recurring | Level 3
Assets, Fair Value Disclosure [Abstract]
Fair Value	1,479	1,246
U.S. Treasury, government and agency
Assets, Fair Value Disclosure [Abstract]
Fair Value	17,284	15,231
U.S. Treasury, government and agency | Fair Value, Recurring
Assets, Fair Value Disclosure [Abstract]
Fair Value	17,284	15,231
U.S. Treasury, government and agency | Fair Value, Recurring | Level 1
Assets, Fair Value Disclosure [Abstract]
Fair Value	0	0
U.S. Treasury, government and agency | Fair Value, Recurring | Level 2
Assets, Fair Value Disclosure [Abstract]
Fair Value	17,284	15,231
U.S. Treasury, government and agency | Fair Value, Recurring | Level 3
Assets, Fair Value Disclosure [Abstract]
Fair Value	0	0
States and political subdivisions
Assets, Fair Value Disclosure [Abstract]
Fair Value	815	649
States and political subdivisions | Fair Value, Recurring
Assets, Fair Value Disclosure [Abstract]
Fair Value	815	649
States and political subdivisions | Fair Value, Recurring | Level 1
Assets, Fair Value Disclosure [Abstract]
Fair Value	0	0
States and political subdivisions | Fair Value, Recurring | Level 2
Assets, Fair Value Disclosure [Abstract]
Fair Value	776	610
States and political subdivisions | Fair Value, Recurring | Level 3
Assets, Fair Value Disclosure [Abstract]
Fair Value	39	39
Foreign governments
Assets, Fair Value Disclosure [Abstract]
Fair Value	902	490
Foreign governments | Fair Value, Recurring
Assets, Fair Value Disclosure [Abstract]
Fair Value	902	490
Foreign governments | Fair Value, Recurring | Level 1
Assets, Fair Value Disclosure [Abstract]
Fair Value	0	0
Foreign governments | Fair Value, Recurring | Level 2
Assets, Fair Value Disclosure [Abstract]
Fair Value	902	490
Foreign governments | Fair Value, Recurring | Level 3
Assets, Fair Value Disclosure [Abstract]
Fair Value	0	0
Residential mortgage-backed
Assets, Fair Value Disclosure [Abstract]
Fair Value	145	173
Residential mortgage-backed | Fair Value, Recurring
Assets, Fair Value Disclosure [Abstract]
Fair Value	145	173
Residential mortgage-backed | Fair Value, Recurring | Level 1
Assets, Fair Value Disclosure [Abstract]
Fair Value	0	0
Residential mortgage-backed | Fair Value, Recurring | Level 2
Assets, Fair Value Disclosure [Abstract]
Fair Value	145	173
Residential mortgage-backed | Fair Value, Recurring | Level 3
Assets, Fair Value Disclosure [Abstract]
Fair Value	0	0
Asset-backed
Assets, Fair Value Disclosure [Abstract]
Fair Value	2,591	844
Asset-backed | Fair Value, Recurring
Assets, Fair Value Disclosure [Abstract]
Fair Value	2,591	844
Asset-backed | Fair Value, Recurring | Level 1
Assets, Fair Value Disclosure [Abstract]
Fair Value	0	0
Asset-backed | Fair Value, Recurring | Level 2
Assets, Fair Value Disclosure [Abstract]
Fair Value	2,578	744
Asset-backed | Fair Value, Recurring | Level 3
Assets, Fair Value Disclosure [Abstract]
Fair Value	13	100
Commercial mortgage-backed
Assets, Fair Value Disclosure [Abstract]
Fair Value	1,117
Commercial mortgage-backed | Fair Value, Recurring
Assets, Fair Value Disclosure [Abstract]
Fair Value	1,117
Commercial mortgage-backed | Fair Value, Recurring | Level 1
Assets, Fair Value Disclosure [Abstract]
Fair Value	0
Commercial mortgage-backed | Fair Value, Recurring | Level 2
Assets, Fair Value Disclosure [Abstract]
Fair Value	1,117
Commercial mortgage-backed | Fair Value, Recurring | Level 3
Assets, Fair Value Disclosure [Abstract]
Fair Value	0
Redeemable preferred stock
Assets, Fair Value Disclosure [Abstract]
Fair Value	441	511
Redeemable preferred stock | Fair Value, Recurring
Assets, Fair Value Disclosure [Abstract]
Fair Value	441	511
Redeemable preferred stock | Fair Value, Recurring | Level 1
Assets, Fair Value Disclosure [Abstract]
Fair Value	367	237
Redeemable preferred stock | Fair Value, Recurring | Level 2
Assets, Fair Value Disclosure [Abstract]
Fair Value	74	274
Redeemable preferred stock | Fair Value, Recurring | Level 3
Assets, Fair Value Disclosure [Abstract]
Fair Value	0	0
Short-term investments | Fair Value, Recurring
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	106	468
Short-term investments | Fair Value, Recurring | Level 1
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	0	0
Short-term investments | Fair Value, Recurring | Level 2
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	106	468
Short-term investments | Fair Value, Recurring | Level 3
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	0	0
Assets of consolidated VIEs/VOEs | Fair Value, Recurring
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	12	16
Assets of consolidated VIEs/VOEs | Fair Value, Recurring | Level 1
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	0	0
Assets of consolidated VIEs/VOEs | Fair Value, Recurring | Level 2
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	0	0
Assets of consolidated VIEs/VOEs | Fair Value, Recurring | Level 3
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	12	16
Swaps | Fair Value, Recurring
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	1,367	(326)
Swaps | Fair Value, Recurring | Level 1
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	0	0
Swaps | Fair Value, Recurring | Level 2
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	1,367	(326)
Swaps | Fair Value, Recurring | Level 3
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	0	0
Credit default swaps | Fair Value, Recurring
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	5	18
Credit default swaps | Fair Value, Recurring | Level 1
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	0	0
Credit default swaps | Fair Value, Recurring | Level 2
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	5	18
Credit default swaps | Fair Value, Recurring | Level 3
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	0	0
Options | Fair Value, Recurring
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	2,752	3,331
Options | Fair Value, Recurring | Level 1
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	0	0
Options | Fair Value, Recurring | Level 2
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	2,752	3,331
Options | Fair Value, Recurring | Level 3
Assets, Fair Value Disclosure [Abstract]
Other invested assets:	0	0
GMxB derivative features’ liability | Fair Value, Recurring
Liabilities, Fair Value Disclosure [Abstract]
Liabilities	11,985	8,316
GMxB derivative features’ liability | Fair Value, Recurring | Level 1
Liabilities, Fair Value Disclosure [Abstract]
Liabilities	0	0
GMxB derivative features’ liability | Fair Value, Recurring | Level 2
Liabilities, Fair Value Disclosure [Abstract]
Liabilities	0	0
GMxB derivative features’ liability | Fair Value, Recurring | Level 3
Liabilities, Fair Value Disclosure [Abstract]
Liabilities	11,985	8,316
SCS, SIO, MSO and IUL indexed features’ liability | Fair Value, Recurring
Liabilities, Fair Value Disclosure [Abstract]
Liabilities	2,502	3,150
SCS, SIO, MSO and IUL indexed features’ liability | Fair Value, Recurring | Level 1
Liabilities, Fair Value Disclosure [Abstract]
Liabilities	0	0
SCS, SIO, MSO and IUL indexed features’ liability | Fair Value, Recurring | Level 2
Liabilities, Fair Value Disclosure [Abstract]
Liabilities	2,502	3,150
SCS, SIO, MSO and IUL indexed features’ liability | Fair Value, Recurring | Level 3
Liabilities, Fair Value Disclosure [Abstract]
Liabilities	$ 0	$ 0

FAIR VALUE DISCLOSURES - Narrat

FAIR VALUE DISCLOSURES - Narrative (Details) - USD ($) $ in Millions	9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value adjustments on GMIB asset	$ 263		$ 175
AFS fixed maturities transferred from Level 3 to Level 2	103	$ 104
AFS fixed maturities transferred from Level 3 to Level 2	$ 189	$ 14
AFS fixed maturities transferred between Level 2 and 3 (percentage)	2.00%	0.90%
Level 3 | Fair Value, Nonrecurring
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value measurements not included in quantitative information about level 3 fair value measurements	$ 417		$ 325

FAIR VALUE DISCLOSURES - Fair V

FAIR VALUE DISCLOSURES - Fair Value Measurement Reconciliation For All Levels (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Total gains (losses), realized and unrealized, included in:
Investment gains (losses), net			$ 262	$ 181
Transfers into level 3			189	14
Transfers out of Level 3			(103)	(104)
Corporate
Total gains (losses), realized and unrealized, included in:
Investment gains (losses), net			0	0
Other comprehensive income (loss)			(37)	3
States and political subdivisions
Total gains (losses), realized and unrealized, included in:
Investment gains (losses), net			0	0
Other comprehensive income (loss)			2	3
Asset- backed
Total gains (losses), realized and unrealized, included in:
Investment gains (losses), net				0
Other comprehensive income (loss)				4
GMIB Reinsurance Contract Asset
Total gains (losses), realized and unrealized, included in:
Investment gains (losses), net			0	0
Other comprehensive income (loss)			0	0
Nonperformance risk	$ 6		(50)
GMxB Derivative Features Liability
Total gains (losses), realized and unrealized, included in:
Nonperformance risk	(458)		35
Level 3 | Corporate
Total gains (losses), realized and unrealized, included in:
Beginning Balance	1,652	$ 1,290	1,246	1,174
Net investment income (loss)	0	0	2	3
Investment gains (losses), net	(1)	0	(14)	0
Subtotal	(1)	0	(12)	3
Other comprehensive income (loss)	18	(7)	(36)	3
Purchases	(138)	(2)	207	219
Sales	(22)	(42)	(112)	(101)
Transfers into level 3	(30)	0	189	14
Transfers out of Level 3	0	(31)	(3)	(104)
Closing Balance	1,479	1,208	1,479	1,208
Level 3 | States and political subdivisions
Total gains (losses), realized and unrealized, included in:
Beginning Balance	40	39	39	38
Net investment income (loss)	0	0	0	0
Investment gains (losses), net	0	0	0	0
Subtotal	0	0	0	0
Other comprehensive income (loss)	(1)	1	1	3
Purchases	0	0	0	0
Sales	0	(1)	(1)	(2)
Transfers into level 3	0	0	0	0
Transfers out of Level 3	0	0	0	0
Closing Balance	39	39	39	39
Level 3 | Asset- backed
Total gains (losses), realized and unrealized, included in:
Beginning Balance	0	534	100	519
Net investment income (loss)	0	0	0	0
Investment gains (losses), net	0	0	0	0
Subtotal	0	0	0	0
Other comprehensive income (loss)	0	0	0	5
Purchases	13	71	13	81
Sales	0	(73)	0	(73)
Transfers into level 3	0	0	0	0
Transfers out of Level 3	0	0	(100)	0
Closing Balance	13	532	13	532
Level 3 | Other equity investments
Total gains (losses), realized and unrealized, included in:
Beginning Balance	16	16	16	48
Net investment income (loss)	0	0	0	0
Net derivative gain (losses)	0	0	0	0
Subtotal	0	0	0	0
Other comprehensive income (loss)	0	0	0	0
Purchases	3	0	4	0
Sales	0	0	0	0
Settlements		0	0	0
Change in estimate	0		0
Activity related to consolidated VIEs/VOEs	(3)	0	(4)	(3)
Transfers into level 3	0	0	0	0
Transfers out of Level 3	0	0	0	(29)
Closing Balance	16	16	16	16
Level 3 | GMIB Reinsurance Contract Asset
Total gains (losses), realized and unrealized, included in:
Beginning Balance	3,433	2,198	2,466	1,993
Net investment income (loss)	0	0	0	0
Net derivative gain (losses)	(177)	664	849	881
Subtotal	(177)	664	849	881
Other comprehensive income (loss)	0	0		0
Purchases	11	11	34	34
Sales	(21)	(20)	(58)	(55)
Settlements		0	0	0
Change in estimate	1		(44)
Activity related to consolidated VIEs/VOEs	0	0	0	0
Transfers into level 3	0	0	0	0
Transfers out of Level 3	0	0	0	0
Closing Balance	3,247	2,853	3,247	2,853
Level 3 | Separate Accounts Assets
Total gains (losses), realized and unrealized, included in:
Beginning Balance	0	25	0	21
Net investment income (loss)	0	0	0	0
Net derivative gain (losses)	0	0	0	0
Subtotal	0	0	0	0
Other comprehensive income (loss)	0	0		0
Purchases	0	(5)	0	3
Sales	0	(1)	0	(1)
Settlements		(1)	0	(4)
Change in estimate	0		0
Activity related to consolidated VIEs/VOEs	0	0	0	0
Transfers into level 3	0	0	0	0
Transfers out of Level 3	0	(11)	0	(12)
Closing Balance	0	7	0	7
Level 3 | GMxB Derivative Features Liability
Total gains (losses), realized and unrealized, included in:
Beginning Balance	(12,458)	(6,813)	(8,316)	(5,491)
Net investment income (loss)	0	0	0	0
Net derivative gain (losses)	570	(2,535)	(3,382)	(3,656)
Subtotal	570	(2,535)	(3,382)	(3,656)
Other comprehensive income (loss)	0	0		0
Purchases	(113)	(100)	(328)	(309)
Sales	16	12	41	20
Settlements		0	0	0
Change in estimate	0		0
Activity related to consolidated VIEs/VOEs	0	0	0	0
Transfers into level 3	0	0	0	0
Transfers out of Level 3	0	0	0	0
Closing Balance	$ (11,985)	$ (9,436)	$ (11,985)	$ (9,436)

FAIR VALUE DISCLOSURES - Unreal

FAIR VALUE DISCLOSURES - Unrealized Gains (Losses) For Level 3 Instruments (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment gains (losses), net	$ 262	$ 181
Level 3 Assets And Liabilities Held
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment gains (losses), net	0	(14)
Net Derivative Gains (Losses)	(2,533)	(2,775)
OCI	(35)	10
Corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment gains (losses), net	0	0
Net Derivative Gains (Losses)	0	0
OCI	(37)	3
States and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment gains (losses), net	0	0
Net Derivative Gains (Losses)	0	0
OCI	2	3
Asset-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment gains (losses), net		0
Net Derivative Gains (Losses)		0
OCI		4
Fixed maturities, AFS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment gains (losses), net	0	0
Net Derivative Gains (Losses)	0	0
OCI	(35)	10
GMIB reinsurance contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment gains (losses), net	0	0
Net Derivative Gains (Losses)	849	881
OCI	0	0
Separate account assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment gains (losses), net		(14)
Net Derivative Gains (Losses)		0
OCI		0
GMxB derivative features liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment gains (losses), net	0	0
Net Derivative Gains (Losses)	(3,382)	(3,656)
OCI	$ 0	$ 0

FAIR VALUE DISCLOSURES - Quanti

FAIR VALUE DISCLOSURES - Quantitative Information About Level 3 (Details) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2020USD ($)	Dec. 31, 2019USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Assets	$ 10,576	$ 8,271
Corporate | Level 3 | Matrix pricing model
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, fair value	$ 25	$ 51
Corporate | Level 3 | Matrix pricing model | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Spread over Benchmark	0.027	0.0065
Corporate | Level 3 | Matrix pricing model | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Spread over Benchmark	0.061	0.058
Corporate | Level 3 | Matrix pricing model | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Spread over Benchmark	0.0288	0.0186
Corporate | Level 3 | Market comparable companies
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, fair value	$ 1,105	$ 1,025
Corporate | Level 3 | EBITDA multiple | Market comparable companies | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	3.5	3.3
Corporate | Level 3 | EBITDA multiple | Market comparable companies | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	31.8	56.7
Corporate | Level 3 | EBITDA multiple | Market comparable companies | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	14.4	14.3
Corporate | Level 3 | Discount rate | Market comparable companies | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	0.051	0.039
Corporate | Level 3 | Discount rate | Market comparable companies | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	0.254	0.165
Corporate | Level 3 | Discount rate | Market comparable companies | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	0.10	0.100
Corporate | Level 3 | Cash flow multiples | Market comparable companies | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	0.9	0.8
Corporate | Level 3 | Cash flow multiples | Market comparable companies | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	25	48.1
Corporate | Level 3 | Cash flow multiples | Market comparable companies | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	10.7	10.7
Other equity investments | Level 3 | Market comparable companies
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, fair value	$ 4
Other equity investments | Level 3 | Revenue multiple | Market comparable companies | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	3.5
Other equity investments | Level 3 | Revenue multiple | Market comparable companies | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	18
Other equity investments | Level 3 | Revenue multiple | Market comparable companies | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	9.5
GMIB reinsurance contracts | Level 3 | Discounted cash flow
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Assets	$ 3,247	$ 2,466
GMIB reinsurance contracts | Level 3 | Non-performance risk | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.006	0.0055
GMIB reinsurance contracts | Level 3 | Non-performance risk | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0125	0.0109
GMIB reinsurance contracts | Level 3 | Non-performance risk | Discounted cash flow | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0072
GMIB reinsurance contracts | Level 3 | Lapse rate | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.006	0.008
GMIB reinsurance contracts | Level 3 | Lapse rate | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.16	0.1000
GMIB reinsurance contracts | Level 3 | Lapse rate | Discounted cash flow | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0156
GMIB reinsurance contracts | Level 3 | Withdrawal rate | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0	0
GMIB reinsurance contracts | Level 3 | Withdrawal rate | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.02	0.080
GMIB reinsurance contracts | Level 3 | Withdrawal rate | Discounted cash flow | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0096
GMIB reinsurance contracts | Level 3 | Utilization rate | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0	0
GMIB reinsurance contracts | Level 3 | Utilization rate | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.61	0.490
GMIB reinsurance contracts | Level 3 | Utilization rate | Discounted cash flow | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0637
GMIB reinsurance contracts | Level 3 | Volatility rates - Equity | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.16	0.090
GMIB reinsurance contracts | Level 3 | Volatility rates - Equity | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.34	0.300
GMIB reinsurance contracts | Level 3 | Volatility rates - Equity | Discounted cash flow | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.25
GMIB reinsurance contracts | Level 3 | Mortality rates | Discounted cash flow | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0272
GMIBNLG | Level 3 | Discounted cash flow
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Embedded Derivative, Fair Value of Embedded Derivative Liability	$ 11,682	$ 8,135
GMIBNLG | Level 3 | Non-performance risk | Discounted cash flow
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0141	0.0124
GMIBNLG | Level 3 | Lapse rate | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.011	0.008
GMIBNLG | Level 3 | Lapse rate | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.257	0.199
GMIBNLG | Level 3 | Lapse rate | Discounted cash flow | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0306
GMIBNLG | Level 3 | Withdrawal rate | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.004	0.003
GMIBNLG | Level 3 | Withdrawal rate | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.020	0.110
GMIBNLG | Level 3 | Withdrawal rate | Discounted cash flow | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0096
GMIBNLG | Level 3 | Annuitization rate | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0	0
GMIBNLG | Level 3 | Annuitization rate | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	1	1
GMIBNLG | Level 3 | Annuitization rate | Discounted cash flow | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0592
GMIBNLG | Level 3 | Mortality rates | Discounted cash flow | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0148
GWBL/GMWB | Level 3 | Discounted cash flow
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Embedded Derivative, Fair Value of Embedded Derivative Liability	$ 220	$ 172
GWBL/GMWB | Level 3 | Non-performance risk | Discounted cash flow
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0141	0.0124
GWBL/GMWB | Level 3 | Lapse rate | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.008	0.008
GWBL/GMWB | Level 3 | Lapse rate | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.16	0.100
GWBL/GMWB | Level 3 | Lapse rate | Discounted cash flow | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0156
GWBL/GMWB | Level 3 | Withdrawal rate | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0	0
GWBL/GMWB | Level 3 | Withdrawal rate | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.080	0.070
GWBL/GMWB | Level 3 | Withdrawal rate | Discounted cash flow | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0096
GWBL/GMWB | Level 3 | Utilization rate | Discounted cash flow
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	1	1
GWBL/GMWB | Level 3 | Volatility rates - Equity | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.16	0.090
GWBL/GMWB | Level 3 | Volatility rates - Equity | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.34	0.300
GWBL/GMWB | Level 3 | Volatility rates - Equity | Discounted cash flow | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.2457
GIB | Level 3 | Discounted cash flow
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Embedded Derivative, Fair Value of Embedded Derivative Liability	$ 77	$ 5
GIB | Level 3 | Non-performance risk | Discounted cash flow
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0141
GIB | Level 3 | Lapse rate | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.008	0.012
GIB | Level 3 | Lapse rate | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.156	0.199
GIB | Level 3 | Lapse rate | Discounted cash flow | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0156
GIB | Level 3 | Withdrawal rate | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0	0
GIB | Level 3 | Withdrawal rate | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.02	0.080
GIB | Level 3 | Withdrawal rate | Discounted cash flow | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0096
GIB | Level 3 | Utilization rate | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0	0
GIB | Level 3 | Utilization rate | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	1	1
GIB | Level 3 | Utilization rate | Discounted cash flow | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0637
GIB | Level 3 | Volatility rates - Equity | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.16	0.090
GIB | Level 3 | Volatility rates - Equity | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.34	0.300
GIB | Level 3 | Volatility rates - Equity | Discounted cash flow | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.2500
GMAB | Level 3 | Discounted cash flow
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Embedded Derivative, Fair Value of Embedded Derivative Liability	$ 6	$ 4
GMAB | Level 3 | Non-performance risk | Discounted cash flow
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0141
GMAB | Level 3 | Lapse rate | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.008	0.010
GMAB | Level 3 | Lapse rate | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.160	0.100
GMAB | Level 3 | Volatility rates - Equity | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.160	0.090
GMAB | Level 3 | Volatility rates - Equity | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.340	0.300
Age 0-40 | GMIB reinsurance contracts | Level 3 | Mortality rates | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0001	0.0001
Age 0-40 | GMIB reinsurance contracts | Level 3 | Mortality rates | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0018	0.0018
Age 0-40 | GMIBNLG | Level 3 | Mortality rates | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0001	0.0001
Age 0-40 | GMIBNLG | Level 3 | Mortality rates | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0019	0.0019
Age 41-60 | GMIB reinsurance contracts | Level 3 | Mortality rates | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0007	0.0007
Age 41-60 | GMIB reinsurance contracts | Level 3 | Mortality rates | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0054	0.0054
Age 41-60 | GMIBNLG | Level 3 | Mortality rates | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0006	0.0006
Age 41-60 | GMIBNLG | Level 3 | Mortality rates | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0053	0.0053
Ages 61 - 115 | GMIB reinsurance contracts | Level 3 | Mortality rates | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0042
Ages 61 - 115 | GMIB reinsurance contracts | Level 3 | Mortality rates | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.422
Ages 61 - 115 | GMIBNLG | Level 3 | Mortality rates | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0041
Ages 61 - 115 | GMIBNLG | Level 3 | Mortality rates | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.4139
Ages 60 - 115 | GMIB reinsurance contracts | Level 3 | Mortality rates | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input		0.0042
Ages 60 - 115 | GMIB reinsurance contracts | Level 3 | Mortality rates | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input		0.4220
Ages 60 - 115 | GMIBNLG | Level 3 | Mortality rates | Discounted cash flow | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input		0.0041
Ages 60 - 115 | GMIBNLG | Level 3 | Mortality rates | Discounted cash flow | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input		0.414

FAIR VALUE DISCLOSURES - Carryi

FAIR VALUE DISCLOSURES - Carrying Values And Fair Values Of Financial Instruments (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Consolidated Amounts [Abstract]
Mortgage loans on real estate	$ 12,785	$ 12,090
Policy loans	3,647	3,270
Policyholders’ liabilities: Investment contracts	59,099	55,421
Separate Accounts liabilities	121,099	124,646
Carrying Value
Consolidated Amounts [Abstract]
Mortgage loans on real estate	12,785	12,090
Policy loans	3,647	3,270
Loans to affiliates	1,200	1,200
Policyholders’ liabilities: Investment contracts	2,063	1,922
FHLB funding agreements	6,848	6,909
FABN funding agreements	1,143
Separate Accounts liabilities	9,000	9,041
Fair Value
Consolidated Amounts [Abstract]
Mortgage loans on real estate	13,032	12,317
Policy loans	4,726	4,199
Loans to affiliates	1,241	1,224
Policyholders’ liabilities: Investment contracts	2,280	2,029
FHLB funding agreements	6,940	6,957
FABN funding agreements	1,168
Separate Accounts liabilities	9,000	9,041
Fair Value | Level 1
Consolidated Amounts [Abstract]
Mortgage loans on real estate	0	0
Policy loans	0	0
Loans to affiliates	0	0
Policyholders’ liabilities: Investment contracts	0	0
FHLB funding agreements	0	0
FABN funding agreements	0
Separate Accounts liabilities	0	0
Fair Value | Level 2
Consolidated Amounts [Abstract]
Mortgage loans on real estate	0	0
Policy loans	0	0
Loans to affiliates	1,241	1,224
Policyholders’ liabilities: Investment contracts	0	0
FHLB funding agreements	6,940	6,957
FABN funding agreements	1,168
Separate Accounts liabilities	0	0
Fair Value | Level 3
Consolidated Amounts [Abstract]
Mortgage loans on real estate	13,032	12,317
Policy loans	4,726	4,199
Loans to affiliates	0	0
Policyholders’ liabilities: Investment contracts	2,280	2,029
FHLB funding agreements	0	0
FABN funding agreements	0
Separate Accounts liabilities	$ 9,000	$ 9,041

LOANS TO AFFILIATES (Details)

LOANS TO AFFILIATES (Details) - USD ($)	1 Months Ended				9 Months Ended
	Dec. 31, 2019	Nov. 30, 2019	Dec. 31, 2018	Apr. 30, 2018	Sep. 30, 2020	Sep. 30, 2019
Related Party Transaction [Line Items]
Repayments of related party debt					$ 0	$ 572,000,000
Parent | EQH-AEL internal debt (3.69%, due 2021)
Related Party Transaction [Line Items]
Loans from affiliates				$ 800,000,000
Related party transaction, rate (as a percent)				3.69%
Repayments of related party debt	$ 300,000,000		$ 200,000,000
Outstanding debt					300,000,000
Parent | EQH-AEL internal debt (one-month LIBOR 1.33%, due 2024)
Related Party Transaction [Line Items]
Loans from affiliates		$ 900,000,000
Related party transaction, rate (as a percent)		1.33%
Outstanding debt					$ 900,000,000

EQUITY - Components of AOCI (De

EQUITY - Components of AOCI (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2018
Equity [Abstract]
Unrealized gains (losses) on investments	$ 4,927		$ 2,226
Defined benefit pension plans	(4)		(7)
Accumulated other comprehensive income (loss) attributable to Equitable Financial	$ 4,923	$ 1,596	$ 2,220	$ (501)

EQUITY - Changes in AOCI (Detai

EQUITY - Changes in AOCI (Details) - USD ($) $ in Millions	3 Months Ended							6 Months Ended		9 Months Ended				12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019		Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2020		Sep. 30, 2019		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Other Comprehensive Income (Loss), Tax [Abstract]
Net unrealized gains (losses) arising during the period	$ 295			$ 1,224						$ 4,524		$ 3,750
(Gains) losses reclassified into net income (loss) during the period	(23)			(159)						(205)		(157)
Net unrealized gains (losses) on investments	271			1,065						4,318		3,593
Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other	(24)			(335)						(992)		(872)
Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of 66, $194, $884 and $718)	247	$ 1,569	$ 1,510	730	[1]	$ 1,226	$ 765	$ 3,079	$ 1,991	3,327	[1]	2,721	[1]	$ 2,095	$ (1,221)	$ 564
Other comprehensive income (loss), attributable to Equitable Financial	247			730						3,327		2,721
Deferred income taxes	66			194						884		718
Unrealized gains (losses) on investments
Other Comprehensive Income (Loss), Tax [Abstract]
Reclassification from AOCI, current period, tax	$ (6)			$ (42)						$ (55)		$ (42)
[1]	See Note 11 for details of Change in unrealized gains (losses), net of adjustments.

REDEEMABLE NONCONTROLLING INT_3

REDEEMABLE NONCONTROLLING INTEREST - Summary of Redeemable Noncontrolling Interest (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]
Net earnings (loss) attributable to redeemable noncontrolling interests	$ 2	$ 0	$ (1)	$ 3
Redeemable Noncontrolling Interest
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]
Balance, beginning of period	36	42	39	39
Net earnings (loss) attributable to redeemable noncontrolling interests	3	0	0	3
Purchase/change of redeemable noncontrolling interests	(1)	4	(1)	4
Balance, end of period	$ 38	$ 46	$ 38	$ 46

COMMITMENTS AND CONTINGENT LI_3

COMMITMENTS AND CONTINGENT LIABILITIES - Narrative (Details) $ in Millions	Sep. 30, 2020USD ($)	Feb. 29, 2016USD ($)legalActionfederalAction
Loss Contingencies [Line Items]
Unaccrued amounts of reasonably possible range of losses	$ 100
Federal home loan bank stock	320
Carrying value of collateral pledged for federal home loan bank	8,700
Trust Notes
Loss Contingencies [Line Items]
Line of credit facility, maximum borrowing capacity	5,000
Brach Family Foundation Litigation
Loss Contingencies [Line Items]
Liability for future policy benefits, face value of policy		$ 1
Letter of Credit
Loss Contingencies [Line Items]
Undrawn balance	17
AXA
Loss Contingencies [Line Items]
Commitments by the Company to provide equity financing	1,200
Commitments under existing mortgage loan agreements	469
Equitable Financial [Member]
Loss Contingencies [Line Items]
Loss Contingency, Number of Federal Actions | federalAction		5
Equitable Financial [Member] | NEW YORK
Loss Contingencies [Line Items]
Loss Contingency, Number of Actions | legalAction		3
Affiliated Entity | AXA
Loss Contingencies [Line Items]
Commitments by the Company to provide equity financing	$ 248

COMMITMENTS AND CONTINGENT LI_4

COMMITMENTS AND CONTINGENT LIABILITIES - Funding Agreements (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Federal Home Loan Bank (FHLB)
Restructuring Reserve [Roll Forward]
Outstanding Balance, period start	$ 6,900
Issued During the Period	34,298
Repaid During the Period	34,358
Long-term Agreements Maturing Within One Year	0
Long-term Agreements Maturing Within Five Years	0
Outstanding Balance, period end	6,840
Difference related to remaining amortization	8	$ 9
Funding Agreement-Backed Notes Program (FABN)
Restructuring Reserve [Roll Forward]
Outstanding Balance, period start	0
Issued During the Period	1,150
Repaid During the Period	0
Long-term Agreements Maturing Within One Year	0
Long-term Agreements Maturing Within Five Years	0
Outstanding Balance, period end	1,150
Difference related to remaining amortization	7
Short-Term Funding Agreements Maturing in Less Than One Year | Federal Home Loan Bank (FHLB)
Restructuring Reserve [Roll Forward]
Outstanding Balance, period start	4,608
Issued During the Period	34,298
Repaid During the Period	34,358
Long-term Agreements Maturing Within One Year	490
Long-term Agreements Maturing Within Five Years	0
Outstanding Balance, period end	5,038
Short-Term Funding Agreements Maturing in Less Than One Year | Funding Agreement-Backed Notes Program (FABN)
Restructuring Reserve [Roll Forward]
Outstanding Balance, period start	0
Issued During the Period	0
Repaid During the Period	0
Long-term Agreements Maturing Within One Year	0
Long-term Agreements Maturing Within Five Years	0
Outstanding Balance, period end	0
Long-Term Funding Agreements Maturing Between Two and Five Years | Federal Home Loan Bank (FHLB)
Restructuring Reserve [Roll Forward]
Outstanding Balance, period start	1,646
Issued During the Period	0
Repaid During the Period	0
Long-term Agreements Maturing Within One Year	(490)
Long-term Agreements Maturing Within Five Years	112
Outstanding Balance, period end	1,268
Long-Term Funding Agreements Maturing Between Two and Five Years | Funding Agreement-Backed Notes Program (FABN)
Restructuring Reserve [Roll Forward]
Outstanding Balance, period start	0
Issued During the Period	650
Repaid During the Period	0
Long-term Agreements Maturing Within One Year	0
Long-term Agreements Maturing Within Five Years	0
Outstanding Balance, period end	650
Long-Term Funding Agreements Maturing in Greater than Five Years | Federal Home Loan Bank (FHLB)
Restructuring Reserve [Roll Forward]
Outstanding Balance, period start	646
Issued During the Period	0
Repaid During the Period	0
Long-term Agreements Maturing Within One Year	0
Long-term Agreements Maturing Within Five Years	(112)
Outstanding Balance, period end	534
Long-Term Funding Agreements Maturing in Greater than Five Years | Funding Agreement-Backed Notes Program (FABN)
Restructuring Reserve [Roll Forward]
Outstanding Balance, period start	0
Issued During the Period	500
Repaid During the Period	0
Long-term Agreements Maturing Within One Year	0
Long-term Agreements Maturing Within Five Years	0
Outstanding Balance, period end	500
Long-Term Funding Agreements | Federal Home Loan Bank (FHLB)
Restructuring Reserve [Roll Forward]
Outstanding Balance, period start	2,292
Issued During the Period	0
Repaid During the Period	0
Long-term Agreements Maturing Within One Year	(490)
Long-term Agreements Maturing Within Five Years	0
Outstanding Balance, period end	1,802
Long-Term Funding Agreements | Funding Agreement-Backed Notes Program (FABN)
Restructuring Reserve [Roll Forward]
Outstanding Balance, period start	0
Issued During the Period	1,150
Repaid During the Period	0
Long-term Agreements Maturing Within One Year	0
Long-term Agreements Maturing Within Five Years	0
Outstanding Balance, period end	$ 1,150

REVISION OF PRIOR PERIOD FINA_3

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Balance Sheet (Details) - USD ($) $ in Millions	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
ASSETS
Other invested assets	$ 1,523	$ 1,962	$ 1,607	$ 2,156
Deferred policy acquisition costs	3,735	3,676	3,983	4,222				$ 4,959
Amounts due from reinsurers	3,032			3,002				3,124
Guaranteed minimum income benefit reinsurance asset, at fair value	3,247			2,466				1,992
Current and deferred income taxes	0			249				473
Other assets	3,854			3,050				2,785
Total Assets	239,945	232,308	218,768	227,952				199,958
LIABILITIES
Policyholders’ account balances	59,099			55,421
Future policy benefits and other policyholders' liabilities	41,117	41,411	37,862	33,979				29,883
Current and deferred income taxes	1,130	999	1,615	0
Other liabilities	2,519			1,769				1,460
Total Liabilities	225,508	217,184	199,938	216,348				187,560
Equity:
Retained earnings	1,634	2,580	7,870	2,145				5,039
Accumulated other comprehensive income (loss)	4,923			1,596	$ 2,220			(501)
Total equity attributable to Equitable Financial	14,390	15,079	18,789	11,552				12,347
Total Equity	14,399	15,088	18,798	11,565	13,254	$ 13,781	$ 12,281	12,359	$ 19,395
Total Liabilities, Redeemable Noncontrolling Interest and Equity	$ 239,945	232,308	218,768	227,952				199,958
As Previously Reported
ASSETS
Other invested assets		1,962	1,595
Deferred policy acquisition costs		3,746	4,068	4,337				5,011
Amounts due from reinsurers				3,001				3,124
Guaranteed minimum income benefit reinsurance asset, at fair value				2,466				1,991
Current and deferred income taxes				224				438
Other assets				3,050				2,763
Total Assets		232,378	218,841	228,041				199,952
LIABILITIES
Future policy benefits and other policyholders' liabilities		41,382	37,830	33,976				29,808
Current and deferred income taxes		1,020	1,637
Other liabilities				1,768				1,460
Total Liabilities		217,176	199,928	216,344				187,485
Equity:
Retained earnings		2,658	7,953	2,242				5,098
Accumulated other comprehensive income (loss)				1,592				(491)
Total equity attributable to Equitable Financial		15,157	18,872	11,645				12,416
Total Equity		15,166	18,881	11,658	13,251	13,932	12,370	12,428	19,492
Total Liabilities, Redeemable Noncontrolling Interest and Equity		232,378	218,841	228,041				199,952
Impact of Revisions
ASSETS
Other invested assets		0	12
Deferred policy acquisition costs		(70)	(85)	(115)				(52)
Amounts due from reinsurers				1				0
Guaranteed minimum income benefit reinsurance asset, at fair value				0				1
Current and deferred income taxes				25				35
Other assets				0				22
Total Assets		(70)	(73)	(89)				6
LIABILITIES
Future policy benefits and other policyholders' liabilities		29	32	3				75
Current and deferred income taxes		(21)	(22)
Other liabilities				1				0
Total Liabilities		8	10	4				75
Equity:
Retained earnings		(78)	(83)	(97)				(59)
Accumulated other comprehensive income (loss)				4				(10)
Total equity attributable to Equitable Financial		(78)	(83)	(93)				(69)
Total Equity		(78)	(83)	(93)	$ 3	$ (151)	$ (89)	(69)	$ (97)
Total Liabilities, Redeemable Noncontrolling Interest and Equity		$ (70)	$ (73)	$ (89)				$ 6

REVISION OF PRIOR PERIOD FINA_4

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Income Statement (Details) - USD ($) $ in Millions	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
REVENUES
Policy charges and fee income	$ 853	$ 824	$ 905	$ 899	$ 863	$ 857	$ 1,729	$ 1,720	$ 2,582	$ 2,619	$ 3,487	$ 3,515	$ 3,289
Net derivative gains (losses)		(5,908)	9,532	(343)	(179)	(1,558)	3,624	(1,737)	2,097	(2,080)	(3,831)	(1,034)	854
Net derivative gains (losses)													878
Net investment income (loss)	809	921	604	744		904	1,525		2,334	2,527
Other income	18	10	15	(1)		10	25		43	39	56	64
Total Revenues	603	(3,574)	11,599	1,990	2,068	685	8,025	2,753	8,628	4,743	5,174	6,918	8,435
BENEFITS AND OTHER DEDUCTIONS
Policyholders’ benefits	950	691	2,626	1,642	861	853	3,317	1,714	4,267	3,356	4,088	2,960	3,481
Interest credited to policyholder's account balances	277		289	296	291	272		563	845	859	1,149	979
Commissions	153			153					462	462	629	625	635
Amortization of deferred policy acquisition costs	119	149	1,022	54	142	149	1,171	291	1,290	345	520	451	925
Other operating costs and expenses	221	218	214	214		184	432		653	614	912	2,919
Total benefits and other deductions	1,796	1,539	4,392	2,429	1,747	1,701	5,931	3,448	7,727	5,877	7,637	8,390	6,947
Income (loss) from continuing operations, before income taxes	(1,193)	(5,113)	7,207	(439)	321	(1,016)	2,094	(695)	901	(1,134)	(2,463)	(1,472)	1,488
Income tax expense (benefit) from continuing operations	249	1,027	(1,457)	175	(53)	167	(430)	114	(181)	289	579	456	1,218
Net income (loss) from continuing operations													2,706
Net income (loss)	(944)	(4,086)	5,750	(264)	268	(849)	1,664	(581)	720	(845)	(1,884)	(902)	2,791
Net income (loss) attributable to Equitable Financial	$ (946)	(4,090)	5,757	(264)	267	(851)	1,667	(584)	$ 721	(848)	(1,889)	(899)	2,790
As Previously Reported
REVENUES
Policy charges and fee income		825	904	853	865	859	1,729	1,724		2,577	3,450	3,523	3,294
Net derivative gains (losses)		(5,903)	9,533	(342)	(178)	(1,555)	3,630	(1,733)		(2,075)	(3,820)	(1,010)	870
Net derivative gains (losses)													894
Net investment income (loss)		934	591			904	1,525
Other income		8	17	0		10	25			40	56	65
Total Revenues		(3,557)	11,588	1,946	2,071	690	8,031	2,761		4,707	5,148	6,951	8,456
BENEFITS AND OTHER DEDUCTIONS
Policyholders’ benefits		700	2,597	1,634	868	819	3,297	1,687		3,321	4,119	3,005	3,473
Interest credited to policyholder's account balances			289	280	288	269		557		837	1,127	1,002
Commissions											629	620	628
Amortization of deferred policy acquisition costs		164	1,058	32	144	165	1,222	309		341	452	431	900
Other operating costs and expenses		218	213			184	431				912	2,918
Total benefits and other deductions		1,563	4,398	2,383	1,753	1,680	5,961	3,433		5,816	7,578	8,432	6,907
Income (loss) from continuing operations, before income taxes		(5,120)	7,190	(437)	318	(990)	2,070	(672)		(1,109)	(2,430)	(1,481)	1,549
Income tax expense (benefit) from continuing operations		1,029	(1,454)	175	(53)	162	(425)	109		284	584	446	1,210
Net income (loss) from continuing operations													2,759
Net income (loss)		(4,091)	5,736	(262)	265	(828)	1,645	(563)		(825)	(1,846)	(921)	2,844
Net income (loss) attributable to Equitable Financial		(4,095)	5,743	(262)	264	(830)	1,648	(566)		(828)	(1,851)	(918)	2,843
Impact of Revisions
REVENUES
Policy charges and fee income		(1)	1	46	(2)	(2)	0	(4)		42	37	(8)	(5)
Net derivative gains (losses)		(5)	(1)	(1)	(1)	(3)	(6)	(4)		(5)	(11)	(24)	(16)
Net derivative gains (losses)													(16)
Net investment income (loss)		(13)	13			0	0
Other income		2	(2)	(1)		0	0			(1)	0	(1)
Total Revenues		(17)	11	44	(3)	(5)	(6)	(8)		36	26	(33)	(21)
BENEFITS AND OTHER DEDUCTIONS
Policyholders’ benefits		(9)	29	8	(7)	34	20	27		35	(31)	(45)	8
Interest credited to policyholder's account balances			0	16	3	3		6		22	22	(23)
Commissions											0	5	7
Amortization of deferred policy acquisition costs		(15)	(36)	22	(2)	(16)	(51)	(18)		4	68	20	25
Other operating costs and expenses		0	1			0	1				0	1
Total benefits and other deductions		(24)	(6)	46	(6)	21	(30)	15		61	59	(42)	40
Income (loss) from continuing operations, before income taxes		7	17	(2)	3	(26)	24	(23)		(25)	(33)	9	(61)
Income tax expense (benefit) from continuing operations		(2)	(3)	0	0	5	(5)	5		5	(5)	10	8
Net income (loss) from continuing operations													(53)
Net income (loss)		5	14	(2)	3	(21)	19	(18)		(20)	(38)	19	(53)
Net income (loss) attributable to Equitable Financial		$ 5	$ 14	$ (2)	$ 3	$ (21)	$ 19	$ (18)		$ (20)	$ (38)	$ 19	$ (53)

REVISION OF PRIOR PERIOD FINA_5

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Comprehensive Income (Details) - USD ($) $ in Millions	3 Months Ended								6 Months Ended		9 Months Ended				12 Months Ended
	Sep. 30, 2020		Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019		Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2020		Sep. 30, 2019		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Statements of Comprehensive Income (Loss):
Net income (loss)	$ (944)		$ (4,086)	$ 5,750	$ (264)		$ 268	$ (849)	$ 1,664	$ (581)	$ 720		$ (845)		$ (1,884)	$ (902)	$ 2,791
Change in unrealized gains (losses), net of reclassification adjustment	247		1,569	1,510	730	[1]	1,226	765	3,079	1,991	3,327	[1]	2,721	[1]	2,095	(1,221)	564
Other comprehensive income (loss)	247		1,570	1,510	730		1,226	765	3,080	1,991	3,327		2,721		2,097	(1,225)	582
Comprehensive income (loss)	(697)		(2,516)	7,260	466		1,494	(84)	4,744	1,410	4,047		1,876	[2]	213	(2,127)	3,373
Less: Comprehensive income (loss) attributable to the noncontrolling interest	2	[2]	4		0	[2]	1	2	(3)	3	(1)	[2]	3	[2]	5	(3)	1
Comprehensive income (loss) attributable to Equitable Financial	$ (699)		(2,520)	7,267	466		1,493	(86)	4,747	1,407	$ 4,048		1,873		208	(2,124)	3,372
As Previously Reported
Statements of Comprehensive Income (Loss):
Net income (loss)			(4,091)	5,736	(262)		265	(828)	1,645	(563)			(825)		(1,846)	(921)	2,844
Change in unrealized gains (losses), net of reclassification adjustment			1,569	1,514	574		1,291	764	3,083	2,055			2,629		2,081	(1,230)	584
Other comprehensive income (loss)			1,570	1,514	574		1,291	764	3,084	2,055			2,629		2,083	(1,234)	602
Comprehensive income (loss)			(2,521)	7,250	312		1,556	(64)	4,729	1,492			1,804		237	(2,155)	3,446
Less: Comprehensive income (loss) attributable to the noncontrolling interest			(3)		0		0	0	(3)	0			0		0	0	0
Comprehensive income (loss) attributable to Equitable Financial			(2,518)	7,257	312		1,556	(64)	4,732	1,492			1,804		237	(2,155)	3,446
Impact of Revisions
Statements of Comprehensive Income (Loss):
Net income (loss)			5	14	(2)		3	(21)	19	(18)			(20)		(38)	19	(53)
Change in unrealized gains (losses), net of reclassification adjustment			0	(4)	156		(65)	1	(4)	(64)			92		14	9	(20)
Other comprehensive income (loss)			0	(4)	156		(65)	1	(4)	(64)			92		14	9	(20)
Comprehensive income (loss)			5	10	154		(62)	(20)	15	(82)			72		(24)	28	(73)
Less: Comprehensive income (loss) attributable to the noncontrolling interest			7		0		1	2	0	3			3		5	(3)	1
Comprehensive income (loss) attributable to Equitable Financial			$ (2)	$ 10	$ 154		$ (63)	$ (22)	$ 15	$ (85)			$ 69		$ (29)	$ 31	$ (74)
[1]	See Note 11 for details of Change in unrealized gains (losses), net of adjustments.
[2]	Amounts for the three and nine months ended September 30, 2019 were reclassified to conform to the current year’s presentation.

REVISION OF PRIOR PERIOD FINA_6

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Equity (Details) - USD ($) $ in Millions	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	$ 15,088	$ 18,798	$ 11,565	$ 13,781	$ 12,281	$ 12,359	$ 11,565	$ 12,359	$ 11,565	$ 12,359	$ 12,359	$ 19,395
Net income (loss) attributable to Equitable Financial	(946)	(4,090)	5,757	(264)	267	(851)	1,667	(584)	721	(848)	(1,889)	(899)	$ 2,790
Other comprehensive income (loss)	247	1,570	1,510	730	1,226	765	3,080	1,991	3,327	2,721	2,097	(1,225)	582
Ending balance	14,399	15,088	18,798	13,254	13,781	12,281	15,088	13,781	14,399	13,254	11,565	12,359	19,395
As Previously Reported
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	15,166	18,881	11,658	13,932	12,370	12,428	11,658	12,428	11,658	12,428	12,428	19,492
Net income (loss) attributable to Equitable Financial		(4,095)	5,743	(262)	264	(830)	1,648	(566)		(828)	(1,851)	(918)	2,843
Other comprehensive income (loss)		1,570	1,514	574	1,291	764	3,084	2,055		2,629	2,083	(1,234)	602
Ending balance		15,166	18,881	13,251	13,932	12,370	15,166	13,932		13,251	11,658	12,428	19,492
Impact of Revisions
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(78)	(83)	(93)	(151)	(89)	(69)	(93)	(69)	(93)	(69)	(69)	(97)
Net income (loss) attributable to Equitable Financial		5	14	(2)	3	(21)	19	(18)		(20)	(38)	19	(53)
Other comprehensive income (loss)		0	(4)	156	(65)	1	(4)	(64)		92	14	9	(20)
Ending balance		(78)	(83)	3	(151)	(89)	(78)	(151)		3	(93)	(69)	(97)
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	2,580	7,870	2,145	4,455	4,188	5,039	2,145	5,039	2,145	5,039	5,039	8,860	6,070
Net income (loss) attributable to Equitable Financial		(4,090)	5,757	(264)	267	(851)	1,667	(584)		(848)	(1,889)	(899)	2,790
Ending balance	1,634	2,580	7,870	3,191	4,455	4,188	2,580	4,455	1,634	3,191	2,145	5,039	8,860
Retained Earnings | As Previously Reported
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	2,658	7,953	2,242	4,532	4,268	5,098	2,242	5,098	2,242	5,098	5,098	8,938	6,095
Net income (loss) attributable to Equitable Financial		(4,095)	5,743	(262)	264	(830)	1,648	(566)		(828)	(1,851)	(918)	2,843
Ending balance		2,658	7,953	3,270	4,532	4,268	2,658	4,532		3,270	2,242	5,098	8,938
Retained Earnings | Impact of Revisions
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(78)	(83)	(97)	(77)	(80)	(59)	(97)	(59)	(97)	(59)	(59)	(78)	(25)
Net income (loss) attributable to Equitable Financial		5	14	(2)	3	(21)	19	(18)		(20)	(38)	19	(53)
Ending balance		(78)	(83)	(79)	(77)	(80)	(78)	(77)		(79)	(97)	(59)	(78)
Accumulated Other Comprehensive Income (Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	4,676	3,106	1,596	1,490	264	(501)	1,596	(501)	1,596	(501)	(501)	579	(3)
Other comprehensive income (loss)	247			730	1,226	765		1,991	3,327	2,721	2,097	(1,225)	582
Ending balance	4,923	4,676	3,106	2,220	1,490	264	4,676	1,490	4,923	2,220	1,596	(501)	579
Accumulated Other Comprehensive Income (Loss) | As Previously Reported
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		3,106	1,592	1,564	273	(491)	1,592	(491)	1,592	(491)	(491)	598	(4)
Other comprehensive income (loss)				574	1,291	764		2,055		2,629	2,083	(1,234)	602
Ending balance			3,106	2,138	1,564	273		1,564		2,138	1,592	(491)	598
Accumulated Other Comprehensive Income (Loss) | Impact of Revisions
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		0	4	(74)	(9)	(10)	4	(10)	4	(10)	(10)	(19)	1
Other comprehensive income (loss)				156	(65)	1		(64)		92	14	9	(20)
Ending balance			0	82	(74)	(9)		(74)		82	4	(10)	(19)
Parent
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	15,079	18,789	11,552	13,769	12,269	12,347	11,552	12,347	11,552	12,347	12,347	16,300
Other comprehensive income (loss)	247			730					3,327	2,721
Ending balance	14,390	15,079	18,789	13,242	13,769	12,269	15,079	13,769	14,390	13,242	11,552	12,347	16,300
Parent | As Previously Reported
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	15,157	18,872	11,645	13,920	12,358	12,416	11,645	12,416	11,645	12,416	12,416	16,397
Ending balance		15,157	18,872	13,239	13,920	12,358	15,157	13,920		13,239	11,645	12,416	16,397
Parent | Impact of Revisions
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	$ (78)	(83)	(93)	(151)	(89)	(69)	(93)	(69)	$ (93)	(69)	(69)	(97)
Ending balance		$ (78)	$ (83)	$ 3	$ (151)	$ (89)	$ (78)	$ (151)		$ 3	$ (93)	$ (69)	$ (97)

REVISION OF PRIOR PERIOD FINA_7

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Cash Flow (Details) - USD ($) $ in Millions	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Cash flow from operating activities:
Net income (loss)												$ (339)	$ 3,323
Net income (loss)	$ (944)	$ (4,086)	$ 5,750	$ (264)	$ 268	$ (849)	$ 1,664	$ (581)	$ 720	$ (845)	$ (1,884)	(902)	2,791
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Policy charges and fee income	(853)	(824)	(905)	(899)	(863)	(857)	(1,729)	(1,720)	(2,582)	(2,619)	(3,487)	(3,515)	(3,289)
Interest credited to policyholder's account balances	277		289	296	291	272		563	845	859	1,149	979
Net derivative (gains) losses		5,908	(9,532)	343	179	1,558	(3,624)	1,737	(2,097)	2,080	3,831	1,034	(854)
Amortization and depreciation			990			127	1,130	250		271	391	360	850
Capitalization of DAC									(414)	(466)	(648)	(592)
Future policy benefits			1,846			75	1,686	118	1,811	1,075	1,084	(330)	1,197
Reinsurance recoverable			(96)				(149)	(59)		(127)
Current and deferred income taxes			1,465			49	439	94	502	(86)	(329)	(563)
Net cash provided by (used in) operating activities			(609)			(148)	(868)	(283)	(637)	(712)	(606)	1,418	(381)
Cash flows from financing activities:
Change in collateralized pledged assets			44				58		58	3
Change in collateralized pledged liabilities			656				247		(1,981)	(1,898)
Net cash provided by (used in) financing activities			2,492				2,308		7,256	7,228
Cash and cash equivalents	$ 3,962	4,318	7,492	1,553	3,093	2,922	4,318	3,093	$ 3,962	1,553	1,492	2,622	3,409
Net income (loss) from discontinued operations												563	533
As Previously Reported
Cash flow from operating activities:
Net income (loss)												(358)	3,377
Net income (loss)		(4,091)	5,736	(262)	265	(828)	1,645	(563)		(825)	(1,846)	(921)	2,844
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Policy charges and fee income		(825)	(904)	(853)	(865)	(859)	(1,729)	(1,724)		(2,577)	(3,450)	(3,523)	(3,294)
Interest credited to policyholder's account balances			289	280	288	269		557		837	1,127	1,002
Net derivative (gains) losses		5,903	(9,533)	342	178	1,555	(3,630)	1,733		2,075	3,820	1,010	(870)
Amortization and depreciation			1,025			143	1,181	268		267	323	340	825
Capitalization of DAC											(648)	(597)
Future policy benefits			1,817			41	1,666	91		1,035	1,115	(284)	1,189
Reinsurance recoverable			(97)				(149)	(59)		(123)
Current and deferred income taxes			1,462			54	433	99		(81)	(334)	(556)
Net cash provided by (used in) operating activities			(621)			(148)	(868)	(283)		(712)	(606)	1,418	(381)
Cash flows from financing activities:
Change in collateralized pledged assets			45				58
Change in collateralized pledged liabilities			667				247
Net cash provided by (used in) financing activities			2,504				2,308
Cash and cash equivalents		4,318	7,492	1,553	3,093	2,922	4,318	3,093		1,553	1,492	2,622	3,409
Impact of Revisions
Cash flow from operating activities:
Net income (loss)												19	(54)
Net income (loss)		5	14	(2)	3	(21)	19	(18)		(20)	(38)	19	(53)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Policy charges and fee income		1	(1)	(46)	2	2	0	4		(42)	(37)	8	5
Interest credited to policyholder's account balances			0	16	3	3		6		22	22	(23)
Net derivative (gains) losses		5	1	1	1	3	6	4		5	11	24	16
Amortization and depreciation			(35)			(16)	(51)	(18)		4	68	20	25
Capitalization of DAC											0	5
Future policy benefits			29			34	20	27		40	(31)	(46)	8
Reinsurance recoverable			1				0	0		(4)
Current and deferred income taxes			3			(5)	6	(5)		(5)	5	(7)
Net cash provided by (used in) operating activities			12			0	0	0		0	0	0	0
Cash flows from financing activities:
Change in collateralized pledged assets			(1)				0
Change in collateralized pledged liabilities			(11)				0
Net cash provided by (used in) financing activities			(12)				0
Cash and cash equivalents		$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0		$ 0	$ 0	$ 0	$ 0

SUBSEQUENT EVENTS - Narrative (

SUBSEQUENT EVENTS - Narrative (Details) - Subsequent Event	Oct. 27, 2020USD ($)
Subsequent Event [Line Items]
Coinsurance, general asset account	$ 12,000,000,000
Surplus notes	$ 50,000,000